Long COVID / ME/CFS and Brain Fog
Choose where you are now
Select a guide to start reading. You can switch later.
Quick answer
Evidence consensus
High - NICE NG188/NG206
NICE NG188 Long COVID (updated Jan 2024); NICE NG206 ME/CFS (2021, surveillance 2025)
Evidence and recovery context
Investigating: I think I have Long COVID or ME/CFS
Check what changed after the illness
Compare your daily abilities before and after the infection. Record symptoms during activity and any worsening later. These details help a clinician assess Long COVID, ME/CFS and other possible causes.
What is usually happening here?
Long COVID and ME/CFS can cause trouble with attention, memory and thinking speed. Some people with Long COVID also have post-exertional malaise: symptoms worsen after physical or mental activity, often 12–48 hours later. PEM is required for an ME/CFS diagnosis, but not everyone with Long COVID has it.
PEM screen
Screen for symptoms after activity
Five DePaul Symptom Questionnaire items covering the past six months. Use the answers to discuss possible PEM with a clinician.
Symptom screening
Post-Exertional Malaise (PEM) Screen
These five DePaul Symptom Questionnaire items ask about symptoms after activity. They are the first step in assessing post-exertional malaise (PEM), not a diagnosis of PEM, ME/CFS or Long COVID.
The research at a glance
PEM changes the plan
If physical or mental activity causes delayed symptom flares, adapt activity and rest to your current limits. Tell your clinician about the delay so it is considered in testing and rehabilitation.
NICE NG188 Long COVID; NICE NG206 ME/CFS
Brain Imaging
Finding: A 2022 UK Biobank study found average imaging changes after COVID in adults aged 51–81. It doesn't show visible damage in every person with brain fog.
Douaud et al., Nature 2022. DOI 10.1038/s41586-022-04569-5
Cognitive Scores
Finding: A large 2024 community study found lower average cognitive scores in people with unresolved symptoms. Group differences do not measure an individual’s lost IQ.
Hampshire et al., NEJM 2024. PMID 38416429
Activity Guidance
Finding: NICE NG206 advises against fixed incremental exercise programs for ME/CFS and recommends individualized energy management.
NICE NG206, recommendations 1.11.2–1.11.14
Urgent Help
When to seek urgent medical attention
Get urgent care for a sudden severe headache unlike any before, new focal neurological symptoms (vision loss, one-sided weakness, trouble speaking), chest pain, high fever with confusion, or thinking that gets worse fast over days. These may mean stroke, encephalitis or another emergency, not typical post-viral illness.
One thing to do next
Write down one task that became harder after the illness, what happens when you try it, and how you feel later that day and the next. The activity plan and PEM screen below can help you prepare for an appointment.
CDC Long COVID clinical guidance; Cotler et al., Diagnostics 2018, PMID 30208578
Support Now
Immediate support actions
Body
Break up tasks that repeatedly cause delayed symptom flares and plan rest before and afterward. Use the amount of activity you can manage without a flare as a starting point.
Food
Use simple foods you can prepare or ask someone to bring: soup, eggs on toast, canned fish, rice or a sandwich. Enough food matters more than an elaborate diet. Ask for help if poor appetite or gut symptoms are causing weight loss.
Water
Drink regularly according to your needs and medical advice. If you have confirmed POTS, ask whether extra fluid or salt fits your health. Extra salt or fluid can be unsafe with some heart, kidney or blood-pressure conditions.
Environment
Reduce light, noise and interruptions when they worsen symptoms. Keep the sleeping space comfortable and discuss persistent insomnia, snoring or daytime sleepiness. No fixed room temperature or screen rule treats Long COVID.
Connection
Ask for one specific kind of help, such as a meal, grocery delivery or a ride to an appointment. Explain that long calls or busy visits may worsen symptoms, and suggest a manageable way to stay in touch.
Ask
Record activities and symptoms briefly, including delayed flares. A wearable may add information, but no heart-rate formula guarantees that an activity is safe.
Avoid
If you have PEM, avoid fixed exercise increases that ignore symptoms. Ask for an individualized plan. Treatment for coexisting stress, anxiety or depression can help those problems without replacing physical assessment.
What it often feels like
Thinking problems after COVID can include poor concentration, slow thinking, trouble finding words or mental exhaustion. Some people also have delayed symptom flares after activity.
What changed after the illness, and what happens during and after ordinary activities?
Sleep problems, symptoms while upright and medicine effects may need assessment alongside the post-COVID symptoms.
- Timing
A normal errand or mental push can wipe me out at the time and later too.
- Helped
Rest helps a little, but it doesn't bring me back to my old baseline.
- Trigger
All of this started after a viral illness and never really went away.
- Symptom
When I crash, it's more than fatigue. My body, brain, and sensory tolerance all drop together.
- Harmed
Pushing through usually costs me later, even if I look fine while I am doing it.
Clinical Fit
How this cause is evaluated
History and symptoms to assess
For ME/CFS, assess whether physical or mental effort causes disproportionate symptom worsening, often delayed 12–48 hours. PEM is not required in every person with Long COVID.
For Long COVID, assess symptoms following SARS-CoV-2 infection. ME/CFS can follow other infections or have no clear infectious onset.
Symptoms to discuss
Waking unrefreshed regardless of sleep duration
Word-finding difficulty, memory problems, confusion
Symptoms worse standing, better lying down
Unpredictable good and bad days
Delayed crashes that last days after overdoing it
Reasons to assess further
Some activity is tolerated or helpful: this does not by itself exclude Long COVID or ME/CFS.
Sudden weakness, new trouble speaking or other focal neurological symptoms require urgent assessment.
Symptoms that predate COVID need assessment in their own right; a new post-COVID problem may coexist.
How to tell this apart from nearby causes
Do ordinary physical or mental activities repeatedly leave several symptoms worse later?
If yes: Discuss PEM as well as mood. Depression and a post-infectious illness can coexist.
If no: A lack of delayed flares doesn't prove depression or rule out Long COVID. Review mood, sleep and the symptom timeline.
Do you snore loudly, wake gasping or have witnessed breathing pauses during sleep?
If yes: Ask about sleep apnea assessment. Sleep apnea can occur alongside Long COVID.
If no: These symptoms are clues, not a rule-out test. Persistent unrefreshing sleep or daytime sleepiness still deserves review.
Have you also developed cold intolerance, constipation or an unexplained weight change?
If yes: Ask whether thyroid testing is appropriate.
If no: A thyroid disorder can occur without all these symptoms. Review whether testing is indicated rather than choosing a cause from this question.
Do episodes occur with thirst, frequent urination, shakiness or a clear relation to meals?
If yes: Describe the episodes and ask whether glucose testing would help.
If no: This answer does not establish a post-viral cause. Consider the wider history and any indicated tests.
Key Takeaways
Long COVID, ME/CFS and brain fog in brief
- Long COVID and ME/CFS can both cause thinking problems, but they are not interchangeable diagnoses. PEM is required for ME/CFS; it occurs in some, not all, people with Long COVID.
- When activity causes delayed symptom flares, plan rest and adjust activity to your current limits. NICE advises against fixed increases in exercise for ME/CFS.
- No single laboratory test confirms either illness. Tests can identify other causes and treatable problems such as anemia, thyroid disease, sleep apnea or POTS.
- Recovery varies. Some people improve, while others remain substantially limited for years. Continuing symptoms do not mean that someone has failed at pacing.
- Bring a record of symptoms, daily function and delayed effects of activity. A normal routine test or a brief good performance does not explain everything a person can sustain at home.
- Treatments should have a specific purpose and a way to judge benefit and harm. Low-dose naltrexone and several other proposed medicines remain off-label and uncertain; they should not be treated as established cures.
How people describe it
People describe several kinds of thinking problems. One person may lose words during a conversation; another can think clearly for a few minutes but becomes exhausted by reading or a meeting. Some also feel worse later that day or the next.
-
Some people report delayed flares after physical, mental or social activity. This is important to assess, but not everyone with Long COVID has PEM.
-
Some can think clearly for a short time but cannot sustain reading, work or conversation. Others struggle with memory or word finding from the start.
-
Describe the task, how long you can manage it and what happens afterward, rather than relying only on the phrase brain fog.
Common Confusions
How this differs from conditions it gets mistaken for
Sleep Apnea
Both can involve poor concentration, unrefreshing sleep and daytime fatigue. Snoring, breathing pauses and sleepiness suggest checking for apnea. Delayed flares after activity suggest assessing PEM. Both conditions can coexist.
Key question: Do you have snoring or breathing pauses, delayed flares after activity, or both?
Sleep
Poor sleep can worsen thinking whether or not Long COVID is present. Improvement after better sleep does not rule out Long COVID, and persistent symptoms do not identify one cause.
Key question: Which symptoms change when sleep improves, and which remain?
POTS
POTS and other causes of symptoms while upright can occur alongside Long COVID. Dizziness, palpitations or worse thinking while standing need assessment.
Key question: Do standing or sitting upright worsen symptoms, and does lying down help?
EBV
EBV can cause an acute illness and remains in the body afterward. Evidence of past EBV infection is common and doesn't show that EBV is causing current Long COVID symptoms.
Key question: Is there evidence of a current EBV-related illness, or only antibodies from a past infection?
Hypoperfusion
Reduced brain blood flow is being studied in some patients, especially during upright testing. It is a possible contributor, not a separate diagnosis that can be chosen from a symptom list.
Key question: Are symptoms related to being upright, and would supervised circulation testing change care?
Medication Side Effects
Medicines used for sleep, allergies, pain or heart rate can add sleepiness or thinking problems. Medicine effects and post-viral symptoms may occur together.
Key question: What changed after each medicine or dose change, and what was already happening before it?
Burnout
Work stress, poor sleep and Long COVID can all reduce concentration. Delayed flares after ordinary activity warrant assessment for PEM, but improvement on vacation or a difficult workday cannot by itself separate the causes.
Key question: What happens after small amounts of activity on workdays and days off, and when did the change begin?
Where the evidence is contested
It's just anxiety or depression
Anxiety and depression can occur alongside Long COVID and deserve treatment. They do not explain every case of persistent cognitive symptoms. Studies have found group differences in cognitive performance and brain imaging after COVID, but neither finding identifies the cause of one person’s symptoms. Assess physical symptoms, sleep and mental health together rather than using one diagnosis to dismiss the others.
Hampshire et al., NEJM 2024; Douaud et al., Nature 2022
Graded Exercise Therapy (GET) will help you recover
NICE advises against exercise programs for ME/CFS that increase activity by fixed amounts regardless of symptoms. Physical and mental effort can trigger PEM, sometimes after a delay. Activity plans need to account for this response and change during a flare or relapse. Pacing aims to reduce worsening; it does not promise recovery.
NICE NG206 2021 (GET removal); ME/CFS Clinician Coalition
Your tests are normal, so nothing is wrong
There is no single laboratory test for Long COVID or ME/CFS. Routine tests can help find other conditions, and normal results do not rule out either illness. Symptoms may justify a sleep assessment, a medication review or measurements while lying and standing. Research tests of immune proteins, microclots or gut bacteria are not established diagnostic panels.
CDC Long COVID Clinical Guidance; NICE NG188; NICE NG206
You should be better by now
Long COVID can last months or years, with improvement, relapse or continuing symptoms. There is no deadline after which persistent illness means someone has failed to recover properly. Support should address current needs: daily activities, work or school, sleep, symptoms while upright and access to care. Follow-up matters even when the recovery timeline is uncertain.
Institute of Medicine (US) Committee on the Diagnostic Criteria for ME/CFS 2015 report (NCBI NBK274235); NICE NG206 ME/CFS 2021; NICE NG188 Long COVID 2024
There is a single clinical diagnostic test for Long COVID
No single test can diagnose Long COVID. A clinician considers the illness history, symptoms and other possible causes. The 2024 RECOVER-Adult Research Index, developed using 13,647 participants, classifies people for research; it is not a clinical diagnostic test. A positive test from the original infection is not required for a clinical diagnosis.
RECOVER-Adult 2024 Long COVID Research Index, JAMA 2024 (PMID 39693079); WHO Post COVID-19 condition clinical case definition 2021; NICE NG188 Long COVID 2024
There's no treatment - just wait it out
There is no established treatment that cures Long COVID, but there are symptoms and related conditions worth treating. Examples include sleep apnea, migraine and orthostatic intolerance. Pacing may reduce PEM. Small observational studies suggest possible benefit from low-dose naltrexone, but controlled evidence is still lacking. Rehabilitation should match the person’s difficulties and avoid worsening symptoms.
CDC Long COVID Clinical Guidance; NICE NG206; Byambasuren et al., BMJ Open 2026 (PMID 42463201)
Long COVID is the same as ME/CFS
Some people with Long COVID meet the criteria for ME/CFS, but many do not. PEM is a required part of ME/CFS and occurs in a subset of people with Long COVID. Long COVID can also involve lung, heart and other problems. Assessing the actual symptoms matters more than assuming that one label describes every person.
Komaroff & Lipkin, Lancet 2023; Davis et al., Nat Rev Microbiol 2023
Compare
Long COVID Brain Fog vs Depression
Similar symptoms can have more than one cause. These clues guide assessment; none diagnoses or excludes Long COVID by itself.
vs Depression
Depression can affect concentration, energy, sleep and interest in activities. A delayed flare of several symptoms after small amounts of physical or mental activity raises a separate question about PEM. Neither motivation nor a response to exercise can diagnose the cause. Depression and Long COVID can coexist and each deserves care.
vs Sleep Apnea
Snoring, witnessed breathing pauses and daytime sleepiness suggest checking for sleep apnea. Long COVID can include delayed worsening after activity and symptoms while standing. Timing alone can't separate them, and both can occur together. Treating sleep apnea may help even when some Long COVID symptoms remain.
vs Thyroid
Thyroid disease can cause fatigue and slow thinking, sometimes with constipation, cold intolerance or weight changes. Blood tests can check thyroid function. A thyroid problem and Long COVID can occur together.
When brain fog tends to show up
Worse after exertion
With PEM, symptoms often worsen 12–48 hours after effort, though they can start sooner. Other Long COVID symptoms can occur without that delay.
Unpredictable episodes
Persistent through the day
Worse in the morning
Evidence
What people often miss
Research is beginning to explain some post-COVID symptoms, but it has not found one cause or treatment for everyone. These studies show what is known, what remains uncertain and which findings may be useful at an appointment.
Brain-scan changes have been found after COVID. In the UK Biobank study, 785 adults aged 51–81 had scans before and after the pandemic; 401 had COVID between scans and 384 were controls. The COVID group had greater average loss of gray-matter thickness in some regions and greater reduction in total brain size. Findings remained after hospitalized cases were excluded. This was a group comparison, not proof that every person with brain fog has visible brain damage or that the changes are permanent.
Douaud et al., Nature 2022
[DOI]Two-day cardiopulmonary exercise testing (CPET) measures how the body responds to a second exercise test 24 hours after the first. Some ME/CFS studies find lower oxygen use or work capacity on day two, including at the ventilatory threshold. The size of the change varies; there is no universal 30% drop that diagnoses PEM. Testing can provoke a substantial symptom flare. It is not needed for routine diagnosis and should be considered only for a clear purpose with informed consent and specialist supervision.
Stevens S et al., Front Pediatr 2018;6:242. PMID 30234078
A 2024 NIH study examined 17 people with post-infectious ME/CFS and 21 healthy volunteers using neurological, immune, autonomic and exercise tests. On a task offering choices of effort for reward, the ME/CFS group chose fewer difficult tasks. The authors proposed a role for brain circuits involved in effort. That interpretation has been disputed, including in published correspondence. The small, selected study doesn't show that unwillingness to try causes ME/CFS.
Walitt B et al., Nat Commun 2024 (PMID 38383456)
Joint hypermobility, POTS, ME/CFS and Long COVID can overlap. A 2024 perspective summarized selected studies reporting hypermobility in about 30% of Long COVID patients, 49% of ME/CFS patients and 57% of POTS patients. These are different study populations, not estimates that apply to every clinic. Mast-cell and connective-tissue mechanisms remain proposed explanations. Recurrent joint instability, pain, dizziness while standing or allergy-like episodes can guide an assessment for a coexisting condition.
Ganesh R et al., Front Neurol 2024 (PMID 39301475)
Sleep apnea can be a treatable contributor after COVID. A study of 34 patients referred with new fatigue and sleepiness found obstructive sleep apnea in 35%. Six patients who continued treatment reported that their daytime symptoms resolved. This small, selected group does not show how common apnea is in everyone with Long COVID. Snoring, witnessed breathing pauses or persistent daytime sleepiness are reasons to ask about sleep testing; a Long COVID diagnosis does not replace that assessment.
Menzler K et al., Eur J Neurol 2024 (PMID 37987095)
ME/CFS diagnostic criteria share important symptoms but are not identical. NICE, the 2015 IOM/NAM criteria, the Canadian Consensus Criteria and the International Consensus Criteria all include post-exertional symptoms. Their required symptom combinations, duration and severity differ. For example, the IOM criteria require more than six months of reduced function, PEM, unrefreshing sleep, and either thinking problems or orthostatic intolerance. Ask which criteria the clinician is using and which requirements you meet. No questionnaire score alone establishes the diagnosis.
Carruthers BM et al., J Intern Med 2011 (PMID 21777306) - ICC; Carruthers BM et al., J Chronic Fatigue Syndr 2003;11(1):7-115 - CCC; IOM/NAM 2015 Beyond ME/CFS report (NCBI Bookshelf NBK284898); NICE NG206 2021
A large UK study found lower average cognitive scores after COVID. Of 112,964 adults completing online testing, those with unresolved persistent symptoms had an average deficit equivalent to about six IQ points compared with the reference group; smaller differences, roughly three points, were seen after symptoms had resolved. Larger differences were seen after intensive care. These are comparisons between groups, not before-and-after IQ losses measured in each person. They cannot tell you how many points you personally lost or whether you will recover.
Hampshire A et al., NEJM 2024 (PMID 38416429)
[DOI]A 2025 UK Biobank study followed adults aged 50 and older for more than two years. New dementia diagnoses, especially vascular dementia, were more frequent after COVID than in uninfected controls. The risk was not higher than after other respiratory illnesses. This observational result cannot predict an individual outcome, and brain fog is not itself a dementia diagnosis. A continuing loss of everyday skills needs assessment rather than an assumption that it is ordinary Long COVID.
Shan D et al., npj Dementia 2025;1:28
[DOI]EBV reactivation is one research question, not an explanation for every case of Long COVID. In a small 2021 study, 20 of 30 participants with persistent symptoms had selected EBV antibody markers, compared with 2 of 20 controls: 66.7% versus 10%. The study found an association. It did not establish that EBV caused the symptoms or test whether antivirals improved them.
Gold et al., Pathogens 2021
[DOI]Researchers have studied how cells make and use energy in ME/CFS. A 2009 study of 71 patients and 53 controls found an association between illness severity and measures of ATP production in blood cells. ATP is a molecule cells use for energy. The study proposed a mechanism; it did not establish that a four-day ATP replacement process explains the timing of every PEM episode, or validate a treatment for Long COVID.
Myhill et al., Int J Clin Exp Med 2009
Mental activity can trigger PEM as well as physical activity. Reading, work, conversation and screens may need to be included in activity planning. Resting physically while doing demanding mental work may therefore not provide the break you need. Which activities are tiring, and how much you can tolerate, varies between people.
NICE NG206 ME/CFS guideline 2021
Dizziness, a racing heart or worse thinking while upright are reasons to ask for standing measurements. A clinician can record heart rate, blood pressure and symptoms while lying down and standing, sometimes for up to ten minutes. POTS requires more than one high pulse reading: symptoms, duration, blood-pressure behavior and other causes matter. Do not stand through faintness or severe symptoms to complete a home test.
Blitshteyn & Whitelaw, Immunol Res 2021
[DOI]The DePaul Symptom Questionnaire records symptoms used in ME/CFS research and assessment. The five-item PEM screen on this page asks about the past six months. At least one symptom rated moderate or worse and occurring at least half the time meets its first-step threshold. A clinician must then assess the history, duration and other possible causes.
Cotler J et al., Diagnostics 2018;8(3):66
The Daily activity plan lists what you intend to do. It does not convert an energy rating into a safe activity allowance. Keep a brief separate record of what you actually did and whether symptoms worsened later. Comparing manageable days with flare days may help you and your clinician adjust the plan.
NICE NG188 Long COVID guideline; NICE NG206 ME/CFS guideline
NICE recommends a validated screening tool when someone reports new cognitive symptoms after COVID. A clinician may use a tool such as the MoCA, but a brief result does not capture every problem with mental endurance or daily tasks. Bring examples of what goes wrong, how long you can concentrate and what happens after effort, even if a screening score is normal.
NICE NG188 Long COVID guideline 2024
EBV antibody results need clinical interpretation. Most adults have evidence of past EBV infection, and some antibodies can remain positive without explaining current symptoms. A small association study is not a reason for everyone with Long COVID to request an EBV panel or start antivirals. Ask what question testing would answer and how the result would change care.
CDC: Laboratory testing for Epstein-Barr virus; Gold et al., Pathogens 2021
[DOI]Describe symptoms during standing, not just the pulse reading. Note whether dizziness, blurred vision, palpitations or thinking problems improve when you sit or lie down. The clinician can choose an active stand, NASA Lean Test or tilt-table test and check other causes such as dehydration, anemia and medicine effects.
Blitshteyn & Whitelaw, Immunol Res 2021
[DOI]In 2021, NICE advised against fixed increases in exercise for ME/CFS, including the approach it calls graded exercise therapy. That does not forbid every form of movement or rehabilitation. A person who chooses an activity program should have an individualized plan that can be reduced or adjusted when symptoms worsen, with specialist support where available.
NICE NG206 2021
Repeatedly exceeding your current limits can worsen symptoms and lead to prolonged setbacks when you have PEM. Plan necessary activities with breaks and practical help, and review a plan that keeps causing flares. Pacing aims to reduce those flares; it cannot guarantee that symptoms will stop or that the illness will recover.
ME/CFS Clinician Coalition clinical management guidance
Long COVID and ME/CFS can last for years, but improvement is still possible. Address treatable symptoms, adjust daily tasks and protect time for rest when activity causes PEM. Do not use a better day as proof that you can safely return to your old schedule. Changes in activity should reflect what remains manageable afterward.
NICE NG188 Long COVID guideline; NICE NG206 ME/CFS guideline
If symptoms are new, start with the assessment, PEM screen and appointment preparation. If you already know the diagnosis and pacing basics, the What helps guide compares practical support, symptom treatments and current trial results. Neither illness duration nor familiarity with research determines which treatment will work for you.
Researchers are investigating blood flow, immune changes and cell energy, but these findings do not yet form one proven explanation. In a 2020 tilt-table study, brain blood flow fell by an average of 26% in 429 ME/CFS patients compared with 7% in 44 controls; 90% of the patient group crossed the study’s abnormal threshold. These were selected patients, and the result does not diagnose an individual without testing. Separately, Greene and colleagues found blood-brain barrier differences in a small Long COVID study. Receptor autoantibodies and impaired energy production remain mechanisms to investigate, not proof that everyone needs immune treatment.
Wirth K, Scheibenbogen C, Autoimmun Rev 2020 (PMID 32247028); van Campen CLMC, Verheugt FWA, Rowe PC, Visser FC, Clin Neurophysiol Pract 2020 (PMID 32140630); Greene C et al., Nat Neurosci 2024 (PMID 38388736)
Small-fiber neuropathy can cause burning pain, tingling, altered sweating and other autonomic symptoms. In a selected series of 17 people referred for prolonged Long COVID, 59% had at least one test confirming neuropathy, and 63% of the skin biopsies were abnormal. Those figures do not show its prevalence in all Long COVID. An examination can guide whether nerve testing or a skin biopsy is useful. Reports of improvement with immune treatment are not enough to make IVIG routine treatment for Long COVID or unexplained brain fog.
Oaklander AL, Mills AJ, Kelley M, Toran LS, Smith B, Dalakas MC, Nath A, Neurol Neuroimmunol Neuroinflamm 2022 (PMID 35232750)
The Patient-Led Research Collaborative documented symptoms that were easy to miss in routine appointments. Its peer-reviewed 2021 survey included 3,762 people from 56 countries and asked about 203 symptoms across 10 organ systems. More than 85% reported relapses; fatigue, post-exertional malaise and cognitive problems were prominent at six months. Participants came mainly through online support groups, so this was not a population prevalence survey. Its lasting contribution was to document the range, duration and daily impact of symptoms, including trouble working, in patients’ own reports.
Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, Redfield S, Austin JP, Akrami A. Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact. eClinicalMedicine 2021;38:101019 (PMID 34308300)
[DOI]A New York study examined health records for 62,339 patients with COVID-19. During days 31–180 after infection, hospitalized Black patients had about twice the adjusted odds of a diabetes diagnosis and 1.5 times the odds of a headache diagnosis compared with hospitalized white patients. Hospitalized Hispanic patients also had higher odds of headaches. These are differences in recorded diagnoses. They don't prove one biological or social cause. The authors called for research into the reasons. At an appointment, ask how your symptoms are being assessed and what follow-up is planned. A normal routine test does not explain away continuing symptoms.
Khullar D et al., Racial/Ethnic Disparities in Post-acute Sequelae of SARS-CoV-2 Infection in New York: an EHR-Based Cohort Study from the RECOVER Program, J Gen Intern Med 2023 (PMID 36795327, n=62,339)
In an Italian prospective study of 377 patients, being female was associated with Long COVID after researchers accounted for other measured factors. A 2022 review also found higher odds among women. These studies support a difference in risk; they do not show that a fixed 65–80% of all people with Long COVID are women, or explain every individual’s illness. Immune and hormonal explanations remain under study. Sex should not determine whether someone’s post-COVID symptoms receive a careful assessment.
Bai F et al., Clin Microbiol Infect 2022 (PMID 34763058, prospective cohort n=377); Sylvester SV et al., Curr Med Res Opin 2022 (PMID 35726132, systematic review)
Researchers have described persistent symptoms beginning after COVID-19 vaccination, sometimes called post-acute COVID-19 vaccination syndrome (PACVS). A 2024 registry study included 191 selected patients and reported fatigue, nerve symptoms, cardiovascular symptoms and cognitive problems. More than 80% had elevated IL-6 and IL-8 or low free T3; these findings were not tied to specific symptoms and are not a validated diagnostic panel. The authors assigned 131 of 191 participants to an ME/CFS-like group using their study method. This registry can't show how often the syndrome happens among vaccinated people. A separate NIH-led report described 23 patients with new nerve symptoms within a month of vaccination. It remains a preprint. Seven of 12 steroid-treated patients had complete or near-complete improvement after two weeks, and three later received IVIG with reported improvement. Treatment wasn't randomized, so these observations don't prove it works or justify self-treatment. Record the timing, symptoms and any infections for a medical assessment; timing alone can't prove the cause.
Safavi F et al., Neuropathic symptoms with SARS-CoV-2 vaccination, medRxiv preprint 2022 (PMID 35611338; not peer reviewed); Mundorf AK et al., Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome, Vaccines 2024 (PMID 39066428). Further reading: Platschek B and Boege F, Vaccines 2024 (PMID 39772040); Scholkmann F and May CA, Pathology Research and Practice 2023 (PMID 37192595).
Key Research Milestones in Long COVID / ME/CFS and Brain Fog
Research has identified group differences and tested several treatments. These milestones also show why a proposed mechanism is not yet a diagnostic test or a proven treatment.
Myhill and colleagues study cell energy in CFS
A study of 71 patients and 53 controls linked measures of ATP production in blood cells with illness severity. It proposed a mitochondrial explanation but did not establish the cause or timing of PEM in every patient.
IOM publishes ME/CFS diagnostic criteria
The criteria include a substantial loss of function lasting more than six months, fatigue, PEM, unrefreshing sleep, and either cognitive impairment or orthostatic intolerance.
NICE changes its ME/CFS activity guidance
The guideline advises against programs with fixed increases in exercise. Energy management and any chosen activity program should be individualized and adjusted when symptoms change.
Gold and colleagues examine EBV markers
A small study found EBV reactivation markers more often in participants with Long COVID. It did not show that EBV caused their symptoms or that antiviral treatment would help.
Douaud and colleagues compare brain scans before and after COVID
The UK Biobank study found average imaging changes in people who had COVID compared with controls. It did not show that every infected person developed brain damage or explain every case of brain fog.
Hampshire and colleagues measure cognition after COVID
In a large community study, people with unresolved symptoms had lower average cognitive scores. These between-group differences are not an individual measurement of lost IQ.
Greene and colleagues investigate the blood-brain barrier
A small study found differences in the blood-brain barrier in participants with Long COVID brain fog. This supports further vascular and immune research; it does not establish a single cause or routine diagnostic scan.
RECOVER-NEURO tests three cognitive treatments
RECOVER-NEURO trial (328 participants, JAMA Neurology): cognitive rehab, brain training (BrainHQ), and brain stimulation (tDCS) didn't outperform active control for long COVID brain fog. All groups improved over time, but no intervention was superior.
Researchers test a five-item brain fog questionnaire
Researchers tested the five-item Brief Brain Fog Scale in an online survey of 844 people: 686 reporting post-COVID brain fog and 158 controls. It measures reported symptoms.
A review proposes a role for brain waste clearance
A 2025 review proposed that impaired glymphatic clearance, the removal of waste products from the brain, might contribute to ME/CFS. It called for investigation rather than establishing this mechanism in patients.
Doctor Prep
How to bring this to a clinician
Opening script
Since [infection and date], I have had [thinking problems] and can no longer manage [specific tasks] as before. I want to discuss Long COVID, whether I meet ME/CFS criteria, and other treatable causes. I have noticed [describe any worsening after activity, its timing and duration, or say that you have not noticed this].
Tests to discuss
- CBC and CMP when symptoms or history warrant blood counts and metabolic checks
- TSH, B12 and ferritin when symptoms or history suggest a thyroid problem or deficiency
- HbA1c when blood sugar assessment is indicated
- Lying and standing vital signs or an active stand test for symptoms while upright
- Sleep study when symptoms suggest sleep apnea or another sleep disorder
- Cognitive assessment to document thinking difficulties
- Medication review for possible effects on thinking, sleep or fatigue
Points to raise
- Long COVID can cause symptoms in several body systems. Symptoms can stay, go away and return, or begin after the first illness seemed to end. A positive COVID test is helpful but is not required by CDC guidance.
- Post-exertional malaise means that activity causes an unusually large worsening of symptoms. Walking, showering, reading, talking, concentrating, stress, or social time can bring it on. Symptoms often worsen 12–48 hours later, but can begin sooner and last for days or longer.
- Under the US Institute of Medicine criteria, ME/CFS requires a major drop in previous activity for more than six months, post-exertional malaise, and unrefreshing sleep. The person must also have thinking problems or symptoms that become worse while upright.
- NICE uses a three-month symptom duration for an ME/CFS diagnosis in the UK. Long COVID and ME/CFS overlap, but a person with Long COVID does not automatically have ME/CFS.
- No post-exertional malaise makes ME/CFS less likely. It does not rule out Long COVID, because not everyone with Long COVID has post-exertional malaise.
- Anemia, thyroid disease, vitamin B12 deficiency, diabetes, sleep apnea, migraine, and medicine effects can cause similar symptoms. Depression, anxiety, heart or lung disease, and an abnormal response to standing may also need checking.
What to bring
- Bring a dated list of suspected or confirmed COVID infections and other infections. Include positive tests if you have them, but do not worry if testing was unavailable or negative.
- Write what you could do before the illness and what you can do now. Use real examples from work, school, reading, driving, shopping, showering, cooking, childcare, exercise, and social time.
- If you can, keep brief notes on demanding activities and how you feel later that day and over the next two days. Bring the notes you have; do not delay an appointment or cause a crash to complete a diary.
- List the symptoms that become worse together, such as brain fog, heavy fatigue, pain, sore throat, headache, poor sleep, dizziness, racing heart, breathlessness, or sound and light sensitivity.
- Bring prior blood tests, heart or lung tests, scans, sleep results, and visit notes from before and after the infection. Dates matter.
- Bring every prescription, over-the-counter medicine, supplement, inhaler, stimulant, sleep aid, antihistamine, and pain medicine. Include timing and what changed after starting it.
- If you already measure heart rate, blood pressure, oxygen, temperature, sleep, or steps, bring a short dated summary. Skip repeated testing or exercise done just to produce data.
- Bring forms or a short list of the work, school, driving, mobility, or care tasks that now need an adjustment.
Screening tools
- Long COVID is diagnosed from the infection and symptom history, examination, and tests chosen for the symptoms. CDC says a positive COVID test is not required and there is no laboratory test that can rule Long COVID in or out.
- The US Institute of Medicine criteria check for more than six months of reduced function, post-exertional malaise, unrefreshing sleep, and either thinking problems or symptoms that become worse while upright.
- NICE allows an ME/CFS diagnosis after three months when the required symptoms persist and another condition does not explain them. Ask which criteria the clinician is using.
- A short activity and symptom diary can show whether several symptoms get worse after physical, mental, emotional, or social activity. Record ordinary life only and skip any planned exercise challenge.
- Heart rate and blood pressure while lying and standing can identify an abnormal response to being upright. A clinician may use an active stand or tilt table test when the symptoms give a reason. A pulse number alone can't confirm the diagnosis; blood pressure, symptoms and medical history matter too.
- A brief thinking test can record attention, memory, language, or processing problems. Describe everyday difficulties even if the test score is normal.
- A sleep study can identify sleep apnea or another sleep disorder. Unrefreshing sleep can also occur in ME/CFS even when a sleep study does not find apnea.
When concerns are dismissed
- Treatment Not Working
Activity makes my symptoms worse after [delay]. How will the plan account for possible PEM? I understand NICE advises against fixed increases in exercise for ME/CFS.
NICE NG206 2021; NICE NG188 2024; Institute of Medicine diagnostic criteria 2015
- Test Results
I understand normal tests do not rule out Long COVID. Could we document the effect on daily life and agree what needs assessment or treatment next?
NICE NG206 2021; NICE NG188 2024; Institute of Medicine diagnostic criteria 2015
- Second Opinion
I am open to assessing depression. Could we also assess my physical symptoms, thinking problems and any worsening after activity, rather than assume one diagnosis explains everything?
NICE NG206 2021; NICE NG188 2024; Institute of Medicine diagnostic criteria 2015
Escalation
When Should You See a Doctor for Long COVID Brain Fog?
Arrange an assessment when brain fog after COVID persists, worsens or interferes with daily life. Bring examples of what changed and any delayed symptoms after activity.
Symptoms affect everyday tasks
Ask for an assessment if concentration, memory or fatigue interferes with work, study, driving or self-care.
Your abilities are declining
Seek earlier review if you need increasing help or cannot manage food, fluids, medicines or basic care.
Another problem may be treatable
Mention snoring or breathing pauses, dizziness while standing, new headaches, medicine changes and other symptoms that may guide testing.
A new emergency symptom
Sudden weakness or speech trouble, a sudden severe headache, severe breathlessness or persistent chest pain needs urgent care.
FAQ
Questions that actually matter here
Is it this cause
How is Long COVID / ME/CFS brain fog different from sleep apnea?
Snoring, witnessed breathing pauses and daytime sleepiness suggest checking for sleep apnea. Long COVID can include delayed worsening after activity and symptoms while standing. Timing alone can't separate them, and both can occur together. Treating sleep apnea may help even when some Long COVID symptoms remain.
Clinical observation consistent with NICE NG206 ME/CFS 2021 and NICE NG188 Long COVID 2024. These timing differences come from clinical observation, not one study.
Can Long COVID / ME/CFS cause brain fog?
Yes. Both can affect attention, memory and thinking speed. They overlap but are different diagnoses. Some people with Long COVID meet ME/CFS criteria, which include post-exertional malaise, unrefreshing sleep and a lasting reduction in activity. Others have cognitive symptoms without PEM.
What does Long COVID / ME/CFS brain fog usually feel like?
You may lose words, forget instructions or need longer to follow a conversation. Some people can think clearly for a short time but become exhausted after reading or talking. Record both what is difficult and how long you can do it. If symptoms worsen later after activity, tell your clinician about that delay too.
Long COVID brain fog vs depression: how to tell
Depression can affect concentration, energy, sleep and interest in activities. A delayed flare of several symptoms after small amounts of physical or mental activity raises a separate question about PEM. Neither motivation nor a response to exercise can diagnose the cause. Depression and Long COVID can coexist and each deserves care.
How quickly can I tell whether this path is helping?
Compare symptoms and ordinary activities over time, including the day or two after demanding tasks. Look for fewer flares or a specific task you can manage more reliably. If a plan repeatedly worsens symptoms, ask for it to be adjusted rather than continuing to increase activity.
Does metformin or blood sugar overlap matter in Long COVID / ME/CFS brain fog?
Meal-related symptoms deserve assessment, but they do not by themselves prove a blood-sugar problem. Blood pressure changes after meals and diabetes are among the possibilities. Metformin studied during acute COVID to reduce later Long COVID risk is a different question from using it for established Long COVID. Do not start it for brain fog without a medical indication.
Testing
What tests should I discuss for Long COVID / ME/CFS brain fog?
No single test confirms Long COVID or ME/CFS. The history and examination guide checks for other causes and treatable problems. Depending on your symptoms, these may include blood counts, thyroid function, B12, iron, glucose, sleep testing or supervised heart-rate and blood-pressure measurements while standing. Cognitive testing can document difficulties but doesn't identify the cause by itself. Two-day exercise testing can provoke a prolonged flare and is not routine screening. Research tests of microclots, immune proteins or brain inflammation are not established diagnostic tests.
Treatment
Long COVID hit and my brain never recovered. Does anyone actually get better?
Some people improve or recover, while others remain limited for years. There is no reliable individual recovery deadline. Track changes in everyday function as well as symptoms: fewer crashes, longer manageable conversations or less help with self-care may matter. Pacing aims to reduce post-exertional flares; it does not guarantee recovery.
Clinical observation consistent with NICE NG206 ME/CFS 2021 and NICE NG188 Long COVID 2024. These timing differences come from clinical observation, not one study.
What should I try first if I think Long COVID / ME/CFS is involved?
Record when symptoms began, what you can do now compared with before the infection, and whether physical or mental activity makes symptoms worse later. The five-question PEM screen on this page can help organize part of that history. If activity causes delayed flares, reduce or break up those activities and plan rest while you arrange an assessment.
When to see a clinician
My doctor says Long COVID brain fog will resolve on its own. Should I trust that?
Improvement is possible, but no one can promise when your symptoms will resolve. Ask what supports that expectation in your case, what treatable problems have been checked, and when to review progress. A follow-up plan should include changes in daily function and what to do if symptoms worsen. Waiting for recovery should not mean going without symptom treatment or practical support.
NICE NG188: COVID-19 rapid guideline: managing the long-term effects of COVID-19
When should I bring Long COVID / ME/CFS brain fog to a clinician?
Arrange an assessment when brain fog persists, affects daily tasks or worsens after COVID. You do not need to finish a trial of pacing first. Ask sooner if you are losing the ability to work, study or care for yourself. Sudden one-sided weakness, new speech trouble, a sudden severe headache, severe breathlessness or persistent chest pain needs urgent care.
Managing: I know it's Long COVID or ME/CFS. What helps?
Choose help for the problem you have now
Start with the symptom or daily task causing the most trouble. If activity triggers delayed flares, plan around them. Sleep, standing symptoms, pain and thinking problems may each need different care.
Managing Long COVID / ME/CFS
What helps with Long COVID and ME/CFS brain fog?
Choose the symptom or task you need help with most. If activity causes delayed worsening, use the PEM route before any exercise or rehabilitation plan.
First, check whether delayed worsening after effort mainly limits your thinking.
3 places to startCheck whether effort causes PEMA delayed crash changes which activity advice makes sense.
Try this
Use the PEM questionnaire to describe the past six months. Separately, note how you feel after usual activities over the next few days, including thinking, social contact and time upright. Do not add activity to provoke a crash.
What may improve: A record of delayed symptoms to discuss before planning activity or rehabilitation.
Keep in mind: New chest pain, fainting or neurological symptoms need their own assessment.
If this does not help: If the relationship to activity remains unclear, take the examples to a clinician and review sleep, symptoms while upright and other possible contributors.
Find the level you can repeat without crashing · Check what standing does to you · Check for sleep apnea
Find the level you can repeat without crashingWhat you can do once on a better day may be more than you can sustain.
Try this
Plan around activities you can repeat without a major delayed flare. Include thinking, social contact, time upright and physical tasks, with room for rest.
What may improve: A plan aimed at reducing flares while keeping essential activities manageable.
Keep in mind: The safe amount can change. A fixed calorie, step or heart-rate target can turn from a useful limit into another demand.
If this does not help: If crashes continue, reduce optional load and look for the tasks that cost more than they appear to, including thinking and standing.
Plan rest before the crash · Make necessary tasks cost less energy · Check what standing does to you
Keep demanding thinking manageableMental effort can trigger PEM even when you stay physically still.
Try this
Break reading, screen use, meetings or problem-solving into shorter periods. Notice early signs that you are losing accuracy or feeling worse, and allow rest afterward.
What may improve: A way to preserve essential thinking tasks while trying to reduce symptom flares.
Keep in mind: The right block length is individual and can change. A timer should serve your symptoms, not force a quota.
If this does not help: If even very short thinking causes prolonged worsening, reduce sensory/input load and prioritize home/work accommodations.
Reduce switching, interruptions and sensory load · Make light, sound and communication more manageable · Ask for concrete work or study changes
See all optionsSearch all 68 options and open the evidence only when you want it.68
68 options
Check whether effort causes PEMA delayed crash changes which activity advice makes sense.
Try this
Use the PEM questionnaire to describe the past six months. Separately, note how you feel after usual activities over the next few days, including thinking, social contact and time upright. Do not add activity to provoke a crash.
What may improve: A record of delayed symptoms to discuss before planning activity or rehabilitation.
Keep in mind: New chest pain, fainting or neurological symptoms need their own assessment.
If this does not help: If the relationship to activity remains unclear, take the examples to a clinician and review sleep, symptoms while upright and other possible contributors.
Find the level you can repeat without crashing · Check what standing does to you · Check for sleep apnea
Read the evidence 3 sources
What the research says: Guideline-backed first decision
People with delayed worsening after exertion or unexplained fatigue.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)WHO: Clinical management of COVID-19 living guideline and post-COVID rehabilitationInternational guidance · Guidance
Who was studied: People with post-COVID condition
How long: Ongoing care
What it found: Supports individualized rehabilitation and screening for post-exertional symptom exacerbation before exercise-oriented rehabilitation.
Thinking and memory: Rehabilitation can work on thinking, but there's little evidence any one treatment restores it.
Important limit: Implementation varies by country and phenotype.
(9)Find the level you can repeat without crashingWhat you can do once on a better day may be more than you can sustain.
Try this
Plan around activities you can repeat without a major delayed flare. Include thinking, social contact, time upright and physical tasks, with room for rest.
What may improve: A plan aimed at reducing flares while keeping essential activities manageable.
Keep in mind: The safe amount can change. A fixed calorie, step or heart-rate target can turn from a useful limit into another demand.
If this does not help: If crashes continue, reduce optional load and look for the tasks that cost more than they appear to, including thinking and standing.
Plan rest before the crash · Make necessary tasks cost less energy · Check what standing does to you
Read the evidence 2 sources
What the research says: Guideline-backed energy management
People with PEM, or Long COVID that behaves like ME/CFS.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)Plan rest before the crashProtect recovery time before symptoms force you to stop.
Try this
Plan rest before and after demanding tasks. Split long calls, reading or other work into shorter periods that you can manage.
What may improve: Rest becomes part of the plan before symptoms force you to stop.
Keep in mind: Rest does not need to mean lying in a dark room for everyone. Match it to the kind of exertion and your sensory needs.
Open the crash activity record
If this does not help: If rests are not enough, shorten demanding tasks, ask for help and review what happened before recent flares.
Use the crash log to compare preceding events · Make necessary tasks cost less energy
Read the evidence 2 sources
What the research says: Guideline-backed practical pacing
People with PEM who need to keep doing essential tasks.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)Use the crash log to compare preceding eventsCompare what happened before different flares without assuming every event was a cause.
Try this
Use the tool to record activities and symptoms before a flare. In separate notes, include occasions when the same activity was manageable. The tool counts events recorded before crashes; it does not compare them with days without a crash.
What may improve: Concrete examples of what happened before different flares, ready to discuss at an appointment.
Keep in mind: This can become exhausting. Keep it brief and stop collecting details that never change a decision.
Open the crash activity record
If this does not help: If the relationship to activity is unclear, review symptoms while upright, sleep and other possible contributors with a clinician.
Check what standing does to you · Check for sleep apnea · Separate nerve pain from aching and joint pain
Read the evidence 2 sources
What the research says: Practical; based on observation rather than trials
People with PEM whose triggers are hard to identify.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)Use a wearable as a meter, not a targetNumbers can show strain without becoming a demand to do more.
Try this
Use heart rate, time upright or step data only if it helps you spot overexertion. Turn off goals, streaks and alerts that pressure you to exceed your repeatable capacity.
What may improve: Earlier recognition of high-load days and fewer target-driven crashes.
Keep in mind: Consumer wearables don't define one safe heart rate for everyone.
If this does not help: If the numbers make you anxious or you start chasing them, go back to pacing by symptoms and what you can do.
Find the level you can repeat without crashing · Use the crash log to compare preceding events
Read the evidence 2 sources
What the research says: Practical monitoring; limited trial evidence
People who already own or want to use a wearable for pacing.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)Make necessary tasks cost less energySitting, moving supplies closer and sharing tasks can make everyday activities less demanding.
Try this
Sit for tasks you usually stand for and keep often-used items close. Prepare first, do the task later, and ask someone to take the hardest step.
What may improve: More capacity left for eating, washing, thinking and contact with other people.
Keep in mind: Task adaptation supports function; it does not prove the underlying illness is improving.
If this does not help: If basic self-care still consumes most of your capacity, prioritize home-based support and assessment of orthostatic, sleep, nutritional and pain contributors.
Use mobility and seating aids to preserve capacity · Check what standing does to you · Correct confirmed deficiencies instead of taking everything
Read the evidence 3 sources
What the research says: Low-risk functional support
People limited by fatigue, PEM or upright intolerance.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)WHO: Clinical management of COVID-19 living guideline and post-COVID rehabilitationInternational guidance · Guidance
Who was studied: People with post-COVID condition
How long: Ongoing care
What it found: Supports individualized rehabilitation and screening for post-exertional symptom exacerbation before exercise-oriented rehabilitation.
Thinking and memory: Rehabilitation can work on thinking, but there's little evidence any one treatment restores it.
Important limit: Implementation varies by country and phenotype.
(9)Match rehabilitation to symptoms and delayed effectsA rehabilitation plan should account for PEM, standing symptoms and the function you want to improve.
Try this
Ask a clinician or therapist to assess the limitation, such as strength, breathing, balance or endurance, and any delayed symptom flares. Agree how the plan will change if symptoms worsen.
What may improve: Better function, exercise capacity or confidence in selected Long COVID populations.
Keep in mind: A negative symptom screen alone doesn't clear you for exercise. Many trials did not include people with severe PEM or those who are housebound.
If this does not help: If activity starts causing delayed crashes, stop increasing it and switch to the PEM-first route instead of pushing through.
Check whether effort causes PEM · Find the level you can repeat without crashing
Read the evidence 3 sources
What the research says: Selected-population rehabilitation evidence
People with Long COVID who have no repeatable delayed crash.
WHO: Clinical management of COVID-19 living guideline and post-COVID rehabilitationInternational guidance · Guidance
Who was studied: People with post-COVID condition
How long: Ongoing care
What it found: Supports individualized rehabilitation and screening for post-exertional symptom exacerbation before exercise-oriented rehabilitation.
Thinking and memory: Rehabilitation can work on thinking, but there's little evidence any one treatment restores it.
Important limit: Implementation varies by country and phenotype.
(9)Pulmonary rehabilitation in Long COVID: systematic review/meta-analysisSystematic review and meta-analysis · Multiple rehabilitation studies
Who was studied: People with Long COVID in pulmonary rehabilitation studies
How long: Published 2024
What it found: Reported improvements in exercise capacity and selected symptoms in studied populations.
Thinking and memory: Cognition was not the central outcome.
Important limit: PEM identification and severe/housebound representation varied. The results shouldn't be applied to people with delayed crashes.
(10)STIMULATE-ICP integrated care pathway trialPhase 3 cluster-randomized trial · 1,152 participants; 122 primary-care clusters
Who was studied: Adults referred to six NHS Long COVID clinics
How long: 12 and 24 weeks
What it found: All specialist-care groups improved in fatigue. Added multi-organ MRI did not improve fatigue; digital rehabilitation did not improve the 12-week primary outcome and showed only small secondary differences later.
Thinking and memory: The main endpoint was fatigue, not cognition.
Important limit: Cluster design; usual specialist care itself was active and multidisciplinary.
(11)Know why fixed activity increases don't fit PEMA preset progression ignores the delayed feedback that defines PEM.
Try this
Reject programs that require you to increase activity on schedule regardless of delayed worsening. Ask how the plan changes when symptoms flare one or two days later.
What may improve: Avoiding a treatment structure that can conflict with ME/CFS guidance.
Keep in mind: Some movement or rehabilitation may be appropriate. The plan needs to account for the person’s symptoms and change when they worsen.
If this does not help: Ask a clinician or therapist to assess the goal, current function and delayed symptoms before deciding what activity is appropriate.
Match rehabilitation to symptoms and delayed effects · Find the level you can repeat without crashing
Read the evidence 2 sources
What the research says: Guidance advises against fixed-increment GET for ME/CFS/PEM
People with confirmed or likely PEM.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)WHO: Clinical management of COVID-19 living guideline and post-COVID rehabilitationInternational guidance · Guidance
Who was studied: People with post-COVID condition
How long: Ongoing care
What it found: Supports individualized rehabilitation and screening for post-exertional symptom exacerbation before exercise-oriented rehabilitation.
Thinking and memory: Rehabilitation can work on thinking, but there's little evidence any one treatment restores it.
Important limit: Implementation varies by country and phenotype.
(9)Check what standing does to youUpright symptoms can explain why thinking changes by position.
Try this
Tell a clinician what happens when you sit or stand and whether lying down helps. Ask whether supervised pulse and blood-pressure measurements while lying and standing would help. Stop a standing test if you feel unsafe.
What may improve: Recognition of POTS or another orthostatic problem that can be treated separately.
Keep in mind: Anemia, dehydration, medicines and other causes of a fast heart rate need checking too.
If this does not help: If initial readings do not explain the symptoms, discuss whether further assessment would change care. The Hypoperfusion page describes more specialized tests.
Reduce heat and long upright periods · Compare POTS medicines by the problem they target
Read the evidence 3 sources
What the research says: Core assessment pathway
People whose cognition, dizziness, palpitations or weakness worsen upright.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Diagnosis and management of POTSClinical review · Review
Who was studied: People with POTS
How long: Current clinical management
What it found: Supports fluids/sodium when appropriate, compression, trigger reduction and individualized medicines such as beta-blockers, ivabradine, midodrine, fludrocortisone and pyridostigmine.
Thinking and memory: Treating standing symptoms may help you function upright. It's unproven for Long COVID thinking itself.
Important limit: Most treatment evidence is small and this is not Long COVID-specific disease-modification evidence.
(13)POTS after COVID-19: systematic review of interventionsSystematic review of reports · 21 reports; 68 people
Who was studied: Reported cases of POTS after COVID-19
How long: Reports through Sep 2022
What it found: Describes diagnostic and treatment strategies used for post-COVID POTS.
Thinking and memory: Cognitive outcomes were not established.
Important limit: Mostly case reports/series; no strong comparative treatment estimate.
(14)Use fluids and salt only when they fit your healthVolume support can help orthostatic symptoms in selected people.
Try this
If your clinician has confirmed an orthostatic problem and no heart, kidney or blood-pressure reason blocks it, use the fluid and sodium plan made for that condition.
What may improve: Less dizziness, tachycardia or upright cognitive strain in some POTS patients.
Keep in mind: Long COVID-specific drug-free trials are limited, and salt/fluid advice is unsafe for some medical conditions.
See the POTS treatment evidence
If this does not help: If fluids and salt barely help, look at compression, medicines and cutting triggers instead of adding more salt.
Try compression that targets pooling · Reduce heat and long upright periods · Compare POTS medicines by the problem they target
Read the evidence 2 sources
What the research says: POTS evidence, mostly extrapolated
People with confirmed orthostatic intolerance or POTS.
Diagnosis and management of POTSClinical review · Review
Who was studied: People with POTS
How long: Current clinical management
What it found: Supports fluids/sodium when appropriate, compression, trigger reduction and individualized medicines such as beta-blockers, ivabradine, midodrine, fludrocortisone and pyridostigmine.
Thinking and memory: Treating standing symptoms may help you function upright. It's unproven for Long COVID thinking itself.
Important limit: Most treatment evidence is small and this is not Long COVID-specific disease-modification evidence.
(13)POTS after COVID-19: systematic review of interventionsSystematic review of reports · 21 reports; 68 people
Who was studied: Reported cases of POTS after COVID-19
How long: Reports through Sep 2022
What it found: Describes diagnostic and treatment strategies used for post-COVID POTS.
Thinking and memory: Cognitive outcomes were not established.
Important limit: Mostly case reports/series; no strong comparative treatment estimate.
(14)Try compression that targets poolingAbdominal or lower-body compression can reduce upright blood pooling.
Try this
Test a properly fitted abdominal binder or lower-body compression during the activities that trigger upright symptoms. Compare function with and without it.
What may improve: Longer upright tolerance and less orthostatic discomfort in some people.
Keep in mind: Heat, fit, skin sensitivity and dressing effort can make compression impractical.
If this does not help: If compression does not help, focus on heat, meals, standing time and medication selection rather than wearing tighter garments.
Reduce heat and long upright periods · Change meals and position when eating triggers symptoms · Compare POTS medicines by the problem they target
Read the evidence 1 source
What the research says: POTS evidence, extrapolated to Long COVID POTS
People with orthostatic intolerance and suspected blood pooling.
Diagnosis and management of POTSClinical review · Review
Who was studied: People with POTS
How long: Current clinical management
What it found: Supports fluids/sodium when appropriate, compression, trigger reduction and individualized medicines such as beta-blockers, ivabradine, midodrine, fludrocortisone and pyridostigmine.
Thinking and memory: Treating standing symptoms may help you function upright. It's unproven for Long COVID thinking itself.
Important limit: Most treatment evidence is small and this is not Long COVID-specific disease-modification evidence.
(13)Reduce heat and long upright periodsHeat and still standing can amplify orthostatic symptoms.
Try this
Sit for queues and showers, cool the environment, break up upright chores, and move tasks to the time of day when standing is easiest.
What may improve: Fewer episodes of dizziness, tachycardia and upright cognitive strain.
Keep in mind: These adaptations manage a trigger; they do not replace assessment of fainting, chest pain or severe breathlessness.
See the cerebral perfusion guide
If this does not help: If position changes still dominate your cognition, use the POTS or Hypoperfusion pathway for a more specific evaluation.
Check what standing does to you · Compare POTS medicines by the problem they target
Read the evidence 2 sources
What the research says: Standard orthostatic management
People whose symptoms worsen with heat or prolonged standing.
Diagnosis and management of POTSClinical review · Review
Who was studied: People with POTS
How long: Current clinical management
What it found: Supports fluids/sodium when appropriate, compression, trigger reduction and individualized medicines such as beta-blockers, ivabradine, midodrine, fludrocortisone and pyridostigmine.
Thinking and memory: Treating standing symptoms may help you function upright. It's unproven for Long COVID thinking itself.
Important limit: Most treatment evidence is small and this is not Long COVID-specific disease-modification evidence.
(13)CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Use simple counter-maneuvers and seatingChange the circulation problem before abandoning the activity.
Try this
When safe, sit or lie down early, cross or tense the legs, and plan access to seating before symptoms peak.
What may improve: Shorter orthostatic episodes and fewer forced stops.
Keep in mind: These techniques are for orthostatic symptoms, not unexplained collapse or new neurological symptoms.
If this does not help: If symptoms still break through, assess whether a medicine or different diagnosis is needed.
Compare POTS medicines by the problem they target · Check what standing does to you
Read the evidence 1 source
What the research says: Standard orthostatic management
People with recognized orthostatic intolerance.
Diagnosis and management of POTSClinical review · Review
Who was studied: People with POTS
How long: Current clinical management
What it found: Supports fluids/sodium when appropriate, compression, trigger reduction and individualized medicines such as beta-blockers, ivabradine, midodrine, fludrocortisone and pyridostigmine.
Thinking and memory: Treating standing symptoms may help you function upright. It's unproven for Long COVID thinking itself.
Important limit: Most treatment evidence is small and this is not Long COVID-specific disease-modification evidence.
(13)Compare POTS medicines by the problem they targetOne drug does not fit every kind of orthostatic problem.
Try this
For confirmed POTS or orthostatic intolerance, compare options that lower excessive heart rate, support blood pressure or improve vascular tone. Base the choice on your actual circulation problem and other medicines.
What may improve: Less tachycardia, presyncope or upright limitation in selected patients.
Keep in mind: Most efficacy evidence comes from broader POTS care, not Long COVID disease-modification trials.
Compare POTS medication options
If this does not help: If the first medicine changes heart rate but not function, reassess the target instead of stacking drugs by trial and error.
Check what standing does to you · Use pyridostigmine only for a selected autonomic target
Read the evidence 3 sources
What the research says: Condition-specific prescribing, mostly extrapolated
People with confirmed POTS/orthostatic intolerance not controlled by non-drug measures.
Diagnosis and management of POTSClinical review · Review
Who was studied: People with POTS
How long: Current clinical management
What it found: Supports fluids/sodium when appropriate, compression, trigger reduction and individualized medicines such as beta-blockers, ivabradine, midodrine, fludrocortisone and pyridostigmine.
Thinking and memory: Treating standing symptoms may help you function upright. It's unproven for Long COVID thinking itself.
Important limit: Most treatment evidence is small and this is not Long COVID-specific disease-modification evidence.
(13)POTS after COVID-19: systematic review of interventionsSystematic review of reports · 21 reports; 68 people
Who was studied: Reported cases of POTS after COVID-19
How long: Reports through Sep 2022
What it found: Describes diagnostic and treatment strategies used for post-COVID POTS.
Thinking and memory: Cognitive outcomes were not established.
Important limit: Mostly case reports/series; no strong comparative treatment estimate.
(14)Pyridostigmine physiology trial in ME/CFSRandomized double-blind placebo-controlled physiology trial · 45 participants
Who was studied: Adults with ME/CFS undergoing invasive exercise testing
How long: Acute repeat exercise testing
What it found: Pyridostigmine improved acute peak oxygen uptake and hemodynamics compared with placebo.
Thinking and memory: Cognition was not the treatment endpoint.
Important limit: A short-term exercise-test result doesn't prove lasting symptom or cognitive benefit. The study was not a Long COVID trial.
(15)Change meals and position when eating triggers symptomsLarge meals can worsen pooling and upright symptoms in dysautonomia.
Try this
Compare smaller meals and less standing immediately after eating. Keep the experiment focused on orthostatic symptoms; only cut food groups for a reason.
What may improve: Less post-meal dizziness, tachycardia or cognitive slowing in some people with dysautonomia.
Keep in mind: Evidence is mainly physiologic and extrapolated; restrictive diets create their own risks.
If this does not help: If meals trigger bloating or bowel symptoms without orthostatic changes, use the GI/SIBO route instead.
Use a dietitian when gut symptoms shrink your food list · Treat SIM01 as one product-specific positive trial
Read the evidence 1 source
What the research says: Low-risk dysautonomia strategy
People with orthostatic symptoms that reliably worsen after meals.
Diagnosis and management of POTSClinical review · Review
Who was studied: People with POTS
How long: Current clinical management
What it found: Supports fluids/sodium when appropriate, compression, trigger reduction and individualized medicines such as beta-blockers, ivabradine, midodrine, fludrocortisone and pyridostigmine.
Thinking and memory: Treating standing symptoms may help you function upright. It's unproven for Long COVID thinking itself.
Important limit: Most treatment evidence is small and this is not Long COVID-specific disease-modification evidence.
(13)Check for sleep apneaLong sleep does not rule out broken sleep from breathing events.
Try this
If you snore, gasp, wake with a headache or dry mouth, or stay sleepy after a full night, use the Sleep Apnea guide and ask about sleep testing.
What may improve: Better daytime alertness and cognition if an untreated sleep-breathing disorder is contributing.
Keep in mind: Treating sleep apnea helps the apnea, but that doesn't prove every Long COVID symptom came from it.
If this does not help: If apnea testing is negative, check insomnia, body-clock timing, restless legs and PEM-related unrefreshing sleep.
Check restless legs and limb movements · Use CBT-I for insomnia · Reset timing when your body clock has drifted
Read the evidence 2 sources
What the research says: Standard treatable-overlap pathway
People with Long COVID/ME/CFS plus signs of sleep-disordered breathing.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)Check restless legs and limb movementsNight-time leg symptoms can fragment sleep without obvious insomnia.
Try this
Notice an urge to move the legs at rest, evening worsening, or repeated kicking your bed partner has mentioned. Check iron status and ask for sleep assessment when that fits.
What may improve: Better sleep and daytime function when a treatable sleep-movement disorder is found.
Keep in mind: Low iron and medication effects can contribute; Long COVID does not make those causes disappear.
See when iron deficiency matters
If this does not help: If legs are quiet but sleep remains unrefreshing, move to apnea, insomnia/circadian or medication review.
Check for sleep apnea · Use CBT-I for insomnia · Review medicines that worsen sleep or thinking
Read the evidence 2 sources
What the research says: Standard treatable-overlap pathway
People with unrefreshing sleep and restless-leg symptoms.
CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)Use CBT-I for insomniaInsomnia treatment fits difficulty sleeping, not every kind of unrefreshing sleep.
Try this
Use an evidence-based insomnia program adapted so sleep restriction or scheduling does not worsen PEM or severe fatigue. Focus on the insomnia problem you actually have.
What may improve: Easier sleep onset, fewer long wake periods and better daytime function when insomnia is present.
Keep in mind: CBT-I is not a treatment for PEM or proof that Long COVID symptoms are psychological.
If this does not help: If sleep timing improves but you still wake unrefreshed, check apnea, restless legs, orthostatic symptoms and PEM rather than intensifying insomnia rules.
Check for sleep apnea · Check restless legs and limb movements · Check whether effort causes PEM
Read the evidence 2 sources
What the research says: Standard insomnia evidence; Long COVID extrapolation
People with Long COVID or ME/CFS who also have insomnia.
CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)Interventions for long COVID: living systematic reviewLiving systematic review · 24 trials; 3,695 participants
Who was studied: Adults with Long COVID in randomized trials
How long: Search through Dec 2023
What it found: Some rehab, behavioural, diet, device and drug treatments showed hints of benefit, but results were mixed and many comparisons stayed uncertain.
Thinking and memory: Some interventions measured concentration; this does not establish a universal cognitive treatment.
Important limit: This review predates several important 2025-2026 trials included separately below.
(17)Reset timing when your body clock has driftedLight and schedule changes fit a circadian problem, not every sleep complaint.
Try this
Keep wake time and morning light consistent within what your energy limits allow. Reduce late bright light when your sleep phase has shifted later.
What may improve: More stable sleep timing and easier daytime scheduling.
Keep in mind: Rigid schedules can be counterproductive during severe PEM or unstable illness.
If this does not help: If timing is stable but sleep still does not restore you, check apnea, restless legs, and ME/CFS itself.
Check for sleep apnea · Check restless legs and limb movements · Treat the sleep diagnosis you actually have
Read the evidence 1 source
What the research says: Circadian evidence extrapolated
People whose body clock has shifted or turned irregular.
CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)Review medicines that worsen sleep or thinkingA useful medicine can still make daytime cognition harder.
Try this
List prescription, over-the-counter and sedating allergy/pain medicines. Identify which change came before worse sleepiness, insomnia, dizziness or concentration.
What may improve: A better balance between symptom relief and alertness.
Keep in mind: Some medicines need gradual changes. Being on a side-effect list is no reason to stop a prescription suddenly.
Review medication-related brain fog
If this does not help: If you need the medicine, keep taking it while you ask about timing, alternatives and what happens without it.
Use antidepressants for the problem they actually treat · Treat wake-promoting drugs as selected symptom tools
Read the evidence 2 sources
What the research says: Medication review
People whose symptoms changed after starting or changing medicines.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)Treat the sleep diagnosis you actually haveSleep apnea, insomnia, RLS and circadian problems need different treatment.
Try this
Name the sleep problem before choosing the treatment. Use the relevant sleep test or specialist pathway when symptoms point to apnea, movement disorder or hypersomnia.
What may improve: More restorative sleep when a specific sleep disorder is contributing.
Keep in mind: A sleep diagnosis can coexist with Long COVID or ME/CFS rather than replacing it.
If this does not help: If the sleep disorder improves but cognition does not, move to orthostatic and cognitive-function routes.
Check what standing does to you · Use written reminders and fixed places for essentials
Read the evidence 2 sources
What the research says: Symptom-directed standard care
People with persistent unrefreshing sleep.
CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)Use written reminders and fixed places for essentialsLists and reminders reduce what you need to remember during a task.
Try this
Keep one calendar, one capture place for tasks, written meeting actions, and essential items in fixed locations. Put reminders where the action happens.
What may improve: Fewer missed tasks and less mental effort spent holding instructions.
Keep in mind: This is compensation, not proof that memory itself has recovered.
If this does not help: If external memory helps logistics but thinking still crashes, shorten cognitive blocks and check upright/sleep triggers.
Keep demanding thinking manageable · Check what standing does to you · Check for sleep apnea
Read the evidence 2 sources
What the research says: Low-risk cognitive rehabilitation strategy
People with Long COVID/ME/CFS memory and executive-function problems.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Systematic review of mental health, cognition and wellbeing interventions in Long COVIDSystematic review · Multiple intervention studies
Who was studied: People with Long COVID
How long: Search in late 2023
What it found: Found a small and heterogeneous evidence base for cognitive and psychological interventions.
Thinking and memory: Direct cognition evidence was limited and heterogeneous.
Important limit: Evidence was sparse and predates RECOVER-NEURO.
(18)Keep demanding thinking manageableMental effort can trigger PEM even when you stay physically still.
Try this
Break reading, screen use, meetings or problem-solving into shorter periods. Notice early signs that you are losing accuracy or feeling worse, and allow rest afterward.
What may improve: A way to preserve essential thinking tasks while trying to reduce symptom flares.
Keep in mind: The right block length is individual and can change. A timer should serve your symptoms, not force a quota.
If this does not help: If even very short thinking causes prolonged worsening, reduce sensory/input load and prioritize home/work accommodations.
Reduce switching, interruptions and sensory load · Make light, sound and communication more manageable · Ask for concrete work or study changes
Read the evidence 2 sources
What the research says: Cognitive pacing
People whose thinking itself triggers delayed worsening or severe mental fatigue.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)Reduce switching, interruptions and sensory loadFewer interruptions mean less information to keep track of at once.
Try this
Do one cognitively demanding task at a time. Use quieter rooms, fewer notifications, written agendas, headphones or lower screen brightness when those reduce load.
What may improve: Longer attention and fewer errors with the same available energy.
Keep in mind: Sensory reduction can become isolating if used more broadly than needed.
If this does not help: If a quieter setup barely changes cognition, check sleep, orthostatic problems, migraine and medicine effects.
Check for sleep apnea · Check what standing does to you · Treat migraine as migraine · Review medicines that worsen sleep or thinking
Read the evidence 2 sources
What the research says: Practical cognitive/occupational strategy
People with attention, sensory or multitasking problems.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Systematic review of mental health, cognition and wellbeing interventions in Long COVIDSystematic review · Multiple intervention studies
Who was studied: People with Long COVID
How long: Search in late 2023
What it found: Found a small and heterogeneous evidence base for cognitive and psychological interventions.
Thinking and memory: Direct cognition evidence was limited and heterogeneous.
Important limit: Evidence was sparse and predates RECOVER-NEURO.
(18)Work on daily tasks with an occupational or speech-language therapistWork on specific daily tasks with a therapist and judge whether they become more manageable.
Try this
Choose a therapist who works on real tasks: reading, conversation, memory, planning, work return or communication. Agree what daily function would count as progress.
What may improve: Better strategies and daily function even when the underlying illness persists.
Keep in mind: The 2026 trial measured reported attainment of personal goals. It doesn't prove every cognitive skill recovers or that the therapy suits severe PEM.
If this does not help: If structured rehab costs more energy than it returns, cut back and use workarounds and accommodations.
Use written reminders and fixed places for essentials · Ask for concrete work or study changes · Make light, sound and communication more manageable
Read the evidence 4 sources
What the research says: Mixed randomized evidence: benefit for personal goals in one small 2026 trial; no added benefit from the different RECOVER-NEURO programs.
People with persistent cognitive disability who can tolerate rehabilitation.
RECOVER-NEURO randomized cognitive intervention trialMulticenter randomized trial · 328 participants; 22 US sites
Who was studied: Adults with cognitive Long COVID
How long: 10 weeks
What it found: Adaptive BrainHQ, PASC-CoRE plus BrainHQ, and tDCS plus BrainHQ did no better than comparisons on the main self-rated thinking measure. Secondary thinking measures showed no extra benefit.
Thinking and memory: The trial measured cognition directly; no treatment group did better.
Important limit: The trial tested specific remote protocols, not every form of cognitive rehabilitation or compensatory OT.
(19)Systematic review of mental health, cognition and wellbeing interventions in Long COVIDSystematic review · Multiple intervention studies
Who was studied: People with Long COVID
How long: Search in late 2023
What it found: Found a small and heterogeneous evidence base for cognitive and psychological interventions.
Thinking and memory: Direct cognition evidence was limited and heterogeneous.
Important limit: Evidence was sparse and predates RECOVER-NEURO.
(18)CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Individual cognitive rehabilitation for Long COVIDRandomized trial · 78 randomized: 38 rehabilitation, 40 usual care
Who was studied: Adults aged 30–60 with Long COVID and measured cognitive impairment at three English sites
How long: Ten weekly one-hour sessions; outcomes at three and six months
What it found: Participants receiving individualized rehabilitation reported greater attainment of three personal functional goals at three months; the difference persisted at six months.
Thinking and memory: The main benefit was that people did better at reaching everyday goals.
Important limit: Small trial with a participant-reported primary outcome. Results concern this program and studied population, not every rehabilitation method or severity of illness.
(20)Treat commercial brain training skepticallyThe largest RECOVER cognitive trial did not find a clear advantage.
Try this
Before paying for a brain-training subscription, ask whether that exact program improved everyday function in Long COVID more than a comparison activity.
What may improve: Less money and effort spent on a program that may only improve practice on its own tasks.
Keep in mind: Enjoyable puzzles are fine as activities. The evidence does not support marketing them as a proven Long COVID cognitive treatment.
If this does not help: If you want cognitive support, prioritize task-specific compensation and work/OT adaptations.
Use written reminders and fixed places for essentials · Work on daily tasks with an occupational or speech-language therapist · Ask for concrete work or study changes
Read the evidence 1 source
What the research says: Negative randomized evidence for tested programs
People considering paid cognitive-training products.
RECOVER-NEURO randomized cognitive intervention trialMulticenter randomized trial · 328 participants; 22 US sites
Who was studied: Adults with cognitive Long COVID
How long: 10 weeks
What it found: Adaptive BrainHQ, PASC-CoRE plus BrainHQ, and tDCS plus BrainHQ did no better than comparisons on the main self-rated thinking measure. Secondary thinking measures showed no extra benefit.
Thinking and memory: The trial measured cognition directly; no treatment group did better.
Important limit: The trial tested specific remote protocols, not every form of cognitive rehabilitation or compensatory OT.
(19)Use stimulants only for a defined targetWake-promoting medicines have far less evidence than their online popularity suggests.
Try this
Before trying a stimulant or wake-promoting drug, name the reason: diagnosed ADHD, severe sleepiness or another specific problem. Check pulse, blood pressure, sleep and standing symptoms.
What may improve: Possible improvement in alertness or attention in selected people with a separate indication.
Keep in mind: Long COVID and ME/CFS trials are sparse. Tachycardia, insomnia and appetite effects can make the trade-off worse.
If this does not help: If you're more alert but crashes or standing symptoms get worse, shift your focus from sleepiness back to PEM and POTS.
Check whether effort causes PEM · Check what standing does to you · Treat wake-promoting drugs as selected symptom tools
Read the evidence 2 sources
What the research says: Very limited disease-specific evidence
People with severe cognitive fatigue, after checks for treatable causes.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)Check whether your breathing has changedBreathlessness can come from different problems that need different care.
Try this
Notice whether breathlessness follows exertion, talking or standing, and whether it brings wheeze, an oxygen drop or rapid upper-chest breathing. Use cardiopulmonary assessment when indicated.
What may improve: A clearer route to lung, heart, autonomic or breathing-retraining treatment.
Keep in mind: Breathing exercises should not substitute for assessment of chest pain, oxygen desaturation or serious cardiopulmonary disease.
If this does not help: If tests exclude major heart-lung disease but breathing stays disordered, consider breathing retraining.
Use breathing retraining for diagnosed dysfunctional breathing · Match pulmonary rehabilitation to the breathing problem
Read the evidence 2 sources
What the research says: Assessment-first respiratory pathway
People with breathlessness or abnormal breathing after COVID.
NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)WHO: Clinical management of COVID-19 living guideline and post-COVID rehabilitationInternational guidance · Guidance
Who was studied: People with post-COVID condition
How long: Ongoing care
What it found: Supports individualized rehabilitation and screening for post-exertional symptom exacerbation before exercise-oriented rehabilitation.
Thinking and memory: Rehabilitation can work on thinking, but there's little evidence any one treatment restores it.
Important limit: Implementation varies by country and phenotype.
(9)Use breathing retraining for diagnosed dysfunctional breathingRetraining suits disordered breathing, not every case of breathlessness.
Try this
Choose a physical therapist or respiratory program that teaches quieter, slower breathing and symptom control without exertion that triggers PEM.
What may improve: Less breathlessness and better control of dysfunctional breathing in selected people.
Keep in mind: Studies concern particular breathing problems and programs.
If this does not help: If retraining does not help, revisit pulmonary, cardiac and orthostatic causes rather than doing more breathing drills.
Check whether your breathing has changed · Check what standing does to you
Read the evidence 2 sources
What the research says: Selected rehabilitation evidence
People with diagnosed dysfunctional breathing and tolerable training load.
WHO: Clinical management of COVID-19 living guideline and post-COVID rehabilitationInternational guidance · Guidance
Who was studied: People with post-COVID condition
How long: Ongoing care
What it found: Supports individualized rehabilitation and screening for post-exertional symptom exacerbation before exercise-oriented rehabilitation.
Thinking and memory: Rehabilitation can work on thinking, but there's little evidence any one treatment restores it.
Important limit: Implementation varies by country and phenotype.
(9)Interventions for long COVID: living systematic reviewLiving systematic review · 24 trials; 3,695 participants
Who was studied: Adults with Long COVID in randomized trials
How long: Search through Dec 2023
What it found: Some rehab, behavioural, diet, device and drug treatments showed hints of benefit, but results were mixed and many comparisons stayed uncertain.
Thinking and memory: Some interventions measured concentration; this does not establish a universal cognitive treatment.
Important limit: This review predates several important 2025-2026 trials included separately below.
(17)Consider respiratory muscle training after assessmentRespiratory muscle work is still exertion.
Try this
Ask whether respiratory muscle training fits the assessed breathing problem. Agree how to adjust or stop sessions if they cause immediate or delayed worsening.
What may improve: Possible improvement in breathing capacity or exercise tolerance in selected Long COVID groups.
Keep in mind: Trials vary, and few include people with severe PEM.
If this does not help: Stop increasing the training if it causes a delayed flare, and review the plan with the therapist.
Check whether effort causes PEM · Find the level you can repeat without crashing
Read the evidence 2 sources
What the research says: Low-to-moderate selected-population evidence
People without PEM whose limitation includes respiratory muscle weakness or breathlessness.
Pulmonary rehabilitation in Long COVID: systematic review/meta-analysisSystematic review and meta-analysis · Multiple rehabilitation studies
Who was studied: People with Long COVID in pulmonary rehabilitation studies
How long: Published 2024
What it found: Reported improvements in exercise capacity and selected symptoms in studied populations.
Thinking and memory: Cognition was not the central outcome.
Important limit: PEM identification and severe/housebound representation varied. The results shouldn't be applied to people with delayed crashes.
(10)Interventions for long COVID: living systematic reviewLiving systematic review · 24 trials; 3,695 participants
Who was studied: Adults with Long COVID in randomized trials
How long: Search through Dec 2023
What it found: Some rehab, behavioural, diet, device and drug treatments showed hints of benefit, but results were mixed and many comparisons stayed uncertain.
Thinking and memory: Some interventions measured concentration; this does not establish a universal cognitive treatment.
Important limit: This review predates several important 2025-2026 trials included separately below.
(17)Match pulmonary rehabilitation to the breathing problemA rehab program should match the limitation and respect delayed worsening.
Try this
Use pulmonary (lung) rehab for documented breathing or activity limits, after PEM screening, if the program adjusts to your symptoms.
What may improve: Improved exercise capacity and selected symptoms in some Long COVID studies.
Keep in mind: Reviews combine different programs and patient groups. Their results don't show safety for people with severe PEM.
If this does not help: If delayed worsening appears, stop progression and switch to energy management.
Check whether effort causes PEM · Match rehabilitation to symptoms and delayed effects
Read the evidence 2 sources
What the research says: Selected-population rehabilitation evidence
People with Long COVID without disabling PEM and with respiratory/functional impairment.
Pulmonary rehabilitation in Long COVID: systematic review/meta-analysisSystematic review and meta-analysis · Multiple rehabilitation studies
Who was studied: People with Long COVID in pulmonary rehabilitation studies
How long: Published 2024
What it found: Reported improvements in exercise capacity and selected symptoms in studied populations.
Thinking and memory: Cognition was not the central outcome.
Important limit: PEM identification and severe/housebound representation varied. The results shouldn't be applied to people with delayed crashes.
(10)WHO: Clinical management of COVID-19 living guideline and post-COVID rehabilitationInternational guidance · Guidance
Who was studied: People with post-COVID condition
How long: Ongoing care
What it found: Supports individualized rehabilitation and screening for post-exertional symptom exacerbation before exercise-oriented rehabilitation.
Thinking and memory: Rehabilitation can work on thinking, but there's little evidence any one treatment restores it.
Important limit: Implementation varies by country and phenotype.
(9)Use vestibular rehabilitation for a vestibular problemDizziness from the inner ear differs from dizziness caused by standing.
Try this
If head movement, visual motion or a diagnosed vestibular (inner-ear balance) disorder triggers dizziness, use vestibular assessment and targeted exercises.
What may improve: Better balance and motion tolerance when a vestibular condition is present.
Keep in mind: Vestibular exercises do not treat orthostatic tachycardia or cerebral-perfusion problems.
If this does not help: If dizziness is mainly upright with pulse or blood-pressure change, use the orthostatic pathway.
Check what standing does to you · Reduce heat and long upright periods
Read the evidence 2 sources
What the research says: Related-condition rehabilitation evidence
People with a diagnosed or strongly suspected vestibular disorder.
WHO: Clinical management of COVID-19 living guideline and post-COVID rehabilitationInternational guidance · Guidance
Who was studied: People with post-COVID condition
How long: Ongoing care
What it found: Supports individualized rehabilitation and screening for post-exertional symptom exacerbation before exercise-oriented rehabilitation.
Thinking and memory: Rehabilitation can work on thinking, but there's little evidence any one treatment restores it.
Important limit: Implementation varies by country and phenotype.
(9)NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)Treat migraine as migraineUse proven migraine care before buying a Long COVID headache protocol.
Try this
Look for migraine signs: light or sound sensitivity, nausea, aura or one-sided throbbing. Then follow the Migraine guide for treatment and prevention.
What may improve: Fewer headache days and less migraine-related cognitive disruption when migraine is the driver.
Keep in mind: Improving migraine does not prove other Long COVID symptoms will improve.
If this does not help: If headache treatment works but cognition stays poor, check PEM, sleep and orthostatic causes separately.
Check whether effort causes PEM · Check for sleep apnea · Check what standing does to you
Read the evidence 2 sources
What the research says: Standard condition-specific care
People with a migraine phenotype after COVID.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)Separate nerve pain from aching and joint painDifferent pain types respond to different treatments.
Try this
Describe each pain: burning, electric, numb, deep aching, joint or movement-linked. Get examined and tested if small-fiber neuropathy or another nervous-system cause could fit.
What may improve: A treatment matched to the type of pain rather than a mixture of medicines for an undefined problem.
Keep in mind: Pain labels overlap, and small-fiber neuropathy testing is not a universal Long COVID test.
Compare fibromyalgia-like pain
If this does not help: If widespread pain and sleep problems dominate, compare the Fibromyalgia pathway; if focal neurological deficits progress, seek neurological assessment.
Read the evidence 2 sources
What the research says: Assessment-first pain pathway
People with persistent pain after COVID.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Small-fiber neuropathy after COVID-19: retrospective case-control studyRetrospective case-control study · 16 patients: 9 received IVIG, 7 did not
Who was studied: Selected patients with skin-biopsy-confirmed small-fiber neuropathy after COVID-19
How long: Retrospective clinical follow-up
What it found: Neuropathic symptoms improved in all 9 IVIG-treated patients and in 3 of 7 patients who did not receive IVIG.
Thinking and memory: The study did not establish a cognitive treatment benefit.
Important limit: Small, nonrandomized study. Treatment selection, insurance access and lack of blinding limit causal interpretation. It does not establish routine IVIG treatment for Long COVID.
(21)Use heat, TENS or gentle physical measures for symptom reliefSymptom relief can be useful even when it does not treat the underlying illness.
Try this
Use comfortable heat, TENS (mild electrical pulses) or another physical measure only if it eases the specific pain without adding fatigue or skin problems.
What may improve: Short-term pain relief and easier movement for some people.
Keep in mind: Most evidence comes from other pain conditions, not Long COVID trials.
If this does not help: If these measures do little, identify the pain mechanism before adding more devices.
Separate nerve pain from aching and joint pain · Choose pain medicines by the pain problem
Read the evidence 1 source
What the research says: Symptom relief; extrapolated evidence
People with musculoskeletal or neuropathic pain seeking low-risk adjuncts.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Choose pain medicines by the pain problemSedation can trade pain relief for worse thinking.
Try this
Match treatment to migraine, nerve pain, inflammatory disease or musculoskeletal pain. Check whether gabapentinoids, tricyclics or other sedating medicines worsen thinking or standing symptoms.
What may improve: Less pain with a tolerable effect on alertness and function.
Keep in mind: Long COVID-specific drug trials are limited; standard pain evidence is condition-specific.
Review medication-related cognition
If this does not help: If pain improves but thinking worsens, review dose/timing or alternatives rather than adding another sedating medicine.
Review medicines that worsen sleep or thinking · Use antidepressants for the problem they actually treat
Read the evidence 2 sources
What the research says: Standard symptom-directed care
People with persistent pain that warrants medication.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)Use CBT or ACT for pain coping without calling it a cureSkills can reduce pain interference while the illness remains physical.
Try this
Use therapy for sleep, fear of movement, loss, stress and living with persistent pain when those are real treatment targets. Keep physical causes and PEM management active alongside it.
What may improve: Less distress, better coping and sometimes better daily function.
Keep in mind: NICE does not support CBT as a cure for ME/CFS or as proof that illness beliefs cause the disease.
If this does not help: If therapy helps distress but physical symptoms remain, continue the symptom-specific routes instead of escalating psychological treatment as the explanation.
Check whether effort causes PEM · Check what standing does to you · Check for sleep apnea
Read the evidence 2 sources
What the research says: Supportive behavioral evidence
People who want help with coping, pain interference or adjustment.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)Interventions for long COVID: living systematic reviewLiving systematic review · 24 trials; 3,695 participants
Who was studied: Adults with Long COVID in randomized trials
How long: Search through Dec 2023
What it found: Some rehab, behavioural, diet, device and drug treatments showed hints of benefit, but results were mixed and many comparisons stayed uncertain.
Thinking and memory: Some interventions measured concentration; this does not establish a universal cognitive treatment.
Important limit: This review predates several important 2025-2026 trials included separately below.
(17)See what the Paxlovid trials actually foundLarge trials do not support routine longer-course Paxlovid for established Long COVID.
Try this
Separate treatment of a new acute infection from treatment of symptoms that have already persisted for months. Review RECOVER-VITAL and STOP-PASC before paying for extended antiviral protocols.
What may improve: A more accurate decision about antivirals and viral-persistence claims.
Keep in mind: These trials don't rule out every antiviral or every viral-persistence subgroup. But they are direct randomized evidence against routine nirmatrelvir/ritonavir as a general Long COVID treatment.
If this does not help: With a new infection, you may still qualify for antivirals. For long-standing symptoms, go back to symptom-specific care or clinical trials.
Keep antiviral and viral-persistence treatment inside trial evidence · Consider a registered clinical trial for experimental treatment
Read the evidence 2 sources
What the research says: Negative randomized evidence for established Long COVID
Adults with established Long COVID considering nirmatrelvir/ritonavir.
RECOVER-VITAL: nirmatrelvir/ritonavir for established Long COVIDPhase 2 randomized placebo-controlled trial · 964 randomized; 959 modified intention-to-treat
Who was studied: Adults with Long COVID across symptom phenotypes
How long: 15 or 25 days of treatment; follow-up after treatment
What it found: Compared with placebo, longer nirmatrelvir/ritonavir courses didn't significantly help any pre-planned symptom group (thinking, autonomic or exercise).
Thinking and memory: Cognition was a prespecified phenotype and did not show a meaningful treatment benefit.
Important limit: This addresses treatment of established Long COVID, not use during a new acute infection.
(22)STOP-PASC nirmatrelvir/ritonavir trialRandomized placebo-controlled trial · 155 randomized
Who was studied: Adults with moderate-to-severe PASC for at least 3 months
How long: 15-day treatment; 15-week follow-up
What it found: A 15-day course did not significantly improve pooled Long COVID symptom severity compared with control.
Thinking and memory: The pooled symptom score included brain fog; the trial showed no overall treatment effect.
Important limit: Smaller than RECOVER-VITAL and used a pooled symptom endpoint.
(23)Treat LDN as promising, not provenThe 2026 review found hints of benefit, but still no randomized Long COVID trial.
Try this
If you're considering off-label LDN, pick the target, such as pain, fatigue or cognitive symptoms, and agree how to judge benefit and side effects.
What may improve: Possible improvement in fatigue, pain, sleep, function or subjective cognition in observational studies.
Keep in mind: The 2026 review pooled four observational before-and-after studies with 155 people and no randomized trial. Naltrexone blocks opioids and can precipitate withdrawal in someone dependent on them; the prescriber must check opioid use.
See LDN evidence in Fibromyalgia too
If this does not help: If there is no meaningful functional benefit, do not keep escalating because a mechanism sounds plausible. Reassess the symptom target.
Use antidepressants for the problem they actually treat · Compare POTS medicines by the problem they target
Read the evidence 1 source
What the research says: Low-certainty observational evidence
Adults with Long COVID considering off-label LDN.
Low-dose naltrexone for Long COVID: systematic review and meta-analysisSystematic review and meta-analysis · 4 observational pre-post studies; 155 participants; no RCTs
Who was studied: Adults with Long COVID in LDN studies
How long: Search through 5 May 2026
What it found: Pooled before-and-after results favored fatigue, brain fog, sleep, pain and function, but the review found no randomized trial.
Thinking and memory: Brain fog improved in pooled before-and-after data (Hedges g about -0.53), but randomized proof is missing.
Important limit: Without concurrent controls, natural change, selection and placebo/context effects stay mixed together. Certainty is low.
(24)Antihistamines now have one small randomized resultThe 2026 trial found a small short-term fatigue difference, not a Long COVID cure.
Try this
If you have allergy-like symptoms or another standard reason, choose a suitable non-drowsy antihistamine. Judge it by fatigue and side effects.
What may improve: A small average fatigue improvement at 12 weeks in the STIMULATE trial; some observational reports also suggest benefit.
Keep in mind: The benefit wasn't sustained at 24 weeks.
If this does not help: If fatigue barely changes, do not infer you need a bigger mast-cell stack. Reassess sleep, POTS, PEM and other symptoms.
A response to antihistamines (H1/H2 drugs) isn't an MCAS diagnosis · Check for sleep apnea · Check what standing does to you
Read the evidence 1 source
What the research says: One randomized fatigue result; limited durability
Adults with Long COVID fatigue in specialist care.
STIMULATE-ICP pharmacologic trialMultisite open-label randomized controlled trial · Nearly 800 randomized across drug comparisons
Who was studied: Adults with post-COVID condition in UK specialist clinics
How long: 12-week primary outcome; 24-week follow-up
What it found: Famotidine-loratadine and colchicine produced small extra fatigue improvements at 12 weeks that were not sustained at 24 weeks. Rivaroxaban did not improve fatigue.
Thinking and memory: Cognition was not the primary outcome; no direct cognitive-treatment claim follows.
Important limit: Open-label and fatigue-focused. Small average changes aren't grounds for cure claims.
(25)A response to antihistamines (H1/H2 drugs) isn't an MCAS diagnosisA treatment response cannot tell you which mechanism caused the symptoms.
Try this
If the symptoms fit, ask for an MCAS or histamine check using the actual diagnostic criteria. Check whether sedating antihistamines slow your thinking.
What may improve: Better targeting of allergy/mast-cell care without self-confirming a diagnosis.
Keep in mind: Long COVID can include flushing, hives or GI symptoms without proving MCAS. Evidence for broad mast-cell protocols remains limited.
Compare MCAS diagnostic criteria
If this does not help: If the mast-cell pathway does not fit, return to the symptom that is actually limiting you.
Check what standing does to you · Check for sleep apnea · Use a dietitian when gut symptoms shrink your food list
Read the evidence 2 sources
What the research says: Uncertain phenotype-specific evidence
People with Long COVID plus allergy-like or mast-cell symptoms.
STIMULATE-ICP pharmacologic trialMultisite open-label randomized controlled trial · Nearly 800 randomized across drug comparisons
Who was studied: Adults with post-COVID condition in UK specialist clinics
How long: 12-week primary outcome; 24-week follow-up
What it found: Famotidine-loratadine and colchicine produced small extra fatigue improvements at 12 weeks that were not sustained at 24 weeks. Rivaroxaban did not improve fatigue.
Thinking and memory: Cognition was not the primary outcome; no direct cognitive-treatment claim follows.
Important limit: Open-label and fatigue-focused. Small average changes aren't grounds for cure claims.
(25)CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Use pyridostigmine only for a selected autonomic targetMestinon has physiology evidence in ME/CFS, not proof of a general cure.
Try this
If tests confirm autonomic dysfunction, compare how pyridostigmine and other POTS options affect your heart rate, blood pressure, gut and main symptom.
What may improve: Possible improvement in blood circulation and exercise-test measurements in selected patients; lasting symptom benefit remains uncertain.
Keep in mind: The randomized ME/CFS study was acute and small; durable cognition and PEM benefit were not established.
Compare autonomic treatment options
If this does not help: If circulation measures change but daily function doesn't, reassess the target instead of treating the lab or pulse number alone.
Compare POTS medicines by the problem they target · Check what standing does to you
Read the evidence 2 sources
What the research says: Small randomized physiology study plus POTS extrapolation
People with ME/CFS or Long COVID with documented dysautonomia.
Pyridostigmine physiology trial in ME/CFSRandomized double-blind placebo-controlled physiology trial · 45 participants
Who was studied: Adults with ME/CFS undergoing invasive exercise testing
How long: Acute repeat exercise testing
What it found: Pyridostigmine improved acute peak oxygen uptake and hemodynamics compared with placebo.
Thinking and memory: Cognition was not the treatment endpoint.
Important limit: A short-term exercise-test result doesn't prove lasting symptom or cognitive benefit. The study was not a Long COVID trial.
(15)Diagnosis and management of POTSClinical review · Review
Who was studied: People with POTS
How long: Current clinical management
What it found: Supports fluids/sodium when appropriate, compression, trigger reduction and individualized medicines such as beta-blockers, ivabradine, midodrine, fludrocortisone and pyridostigmine.
Thinking and memory: Treating standing symptoms may help you function upright. It's unproven for Long COVID thinking itself.
Important limit: Most treatment evidence is small and this is not Long COVID-specific disease-modification evidence.
(13)Use antidepressants for the problem they actually treatMood, anxiety, pain and sleep can deserve treatment alongside Long COVID.
Try this
Treat diagnosed depression, anxiety or a pain indication on its own merits. Check whether fatigue, sleepiness, orthostatic symptoms or cognition change after starting the medicine.
What may improve: Better mood, anxiety or pain when those conditions are present.
Keep in mind: Each antidepressant has its own side effects and interactions.
Compare depression-related cognitive symptoms
If this does not help: If your mood improves but your thinking doesn't, check sleep, PEM, POTS and medicine effects. More antidepressant isn't automatically the answer.
Check for sleep apnea · Check whether effort causes PEM · Check what standing does to you · Review medicines that worsen sleep or thinking
Read the evidence 1 source
What the research says: Standard comorbidity care; one small fatigue result
Adults with Long COVID plus a separate indication for antidepressant treatment.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Treat wake-promoting drugs as selected symptom toolsEvidence for modafinil and stimulants in Long COVID or ME/CFS remains thin.
Try this
Use only when there is a defined indication and a plan to monitor sleep, pulse, blood pressure, appetite and post-exertional symptoms.
What may improve: Possible alertness or attention benefit in selected people.
Keep in mind: These drugs can worsen insomnia or tachycardia and may mask limited capacity without changing PEM.
If this does not help: If you feel more awake but crash harder later, stop using wakefulness as the success measure and reassess PEM.
Check whether effort causes PEM · Use stimulants only for a defined target
Read the evidence 2 sources
What the research says: Very limited disease-specific evidence
People with severe sleepiness/attention problems, after checks for other causes.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)Low-dose aripiprazole remains experimentalA retrospective ME/CFS series is interesting, but there is no controlled efficacy trial.
Try this
If this off-label drug comes up, discuss the lack of a control group in the main ME/CFS study and the risks, including movement problems, restlessness and metabolic effects.
What may improve: Possible fatigue, subjective brain-fog or sleep benefit in a subset in one retrospective series.
Keep in mind: No control group; this was ME/CFS, not Long COVID. Antipsychotic adverse effects matter even at low doses.
If this does not help: If the risk-benefit case is weak, prioritize better-supported symptom pathways or a formal clinical trial.
Treat LDN as promising, not proven · Work on daily tasks with an occupational or speech-language therapist
Read the evidence 1 source
What the research says: Very low-certainty retrospective ME/CFS evidence
People considering off-label low-dose aripiprazole.
Low-dose aripiprazole in ME/CFSRetrospective study · 101 patients
Who was studied: People with ME/CFS treated at one center
How long: Retrospective clinical follow-up
What it found: A subset reported lower fatigue, brain-fog and unrefreshing-sleep scores.
Thinking and memory: It reported brain-fog scores, but an uncontrolled design can't prove benefit.
Important limit: No control group; selection and reporting bias are substantial. This is ME/CFS evidence, not a Long COVID trial.
(26)Keep antiviral and viral-persistence treatment inside trial evidenceA plausible persistence mechanism does not identify an effective regimen.
Try this
Check whether the exact antiviral, duration and Long COVID population have randomized evidence. Distinguish treatment of a new infection from treatment months later.
What may improve: Avoiding expensive or interacting regimens that have not shown benefit.
Keep in mind: RECOVER-VITAL and STOP-PASC are negative for nirmatrelvir/ritonavir; other antiviral hypotheses remain research questions.
If this does not help: If you want access to an experimental antiviral, use a registered trial rather than copying a protocol.
See what the Paxlovid trials actually found · Consider a registered clinical trial for experimental treatment
Read the evidence 2 sources
What the research says: Experimental beyond established acute indications
People considering extended or combination antivirals for established Long COVID.
RECOVER-VITAL: nirmatrelvir/ritonavir for established Long COVIDPhase 2 randomized placebo-controlled trial · 964 randomized; 959 modified intention-to-treat
Who was studied: Adults with Long COVID across symptom phenotypes
How long: 15 or 25 days of treatment; follow-up after treatment
What it found: Compared with placebo, longer nirmatrelvir/ritonavir courses didn't significantly help any pre-planned symptom group (thinking, autonomic or exercise).
Thinking and memory: Cognition was a prespecified phenotype and did not show a meaningful treatment benefit.
Important limit: This addresses treatment of established Long COVID, not use during a new acute infection.
(22)STOP-PASC nirmatrelvir/ritonavir trialRandomized placebo-controlled trial · 155 randomized
Who was studied: Adults with moderate-to-severe PASC for at least 3 months
How long: 15-day treatment; 15-week follow-up
What it found: A 15-day course did not significantly improve pooled Long COVID symptom severity compared with control.
Thinking and memory: The pooled symptom score included brain fog; the trial showed no overall treatment effect.
Important limit: Smaller than RECOVER-VITAL and used a pooled symptom endpoint.
(23)Use immune treatment only for a supported indication or trialA proposed immune mechanism is not enough to show that suppressing or changing immunity will help.
Try this
Ask whether you have a diagnosed condition that warrants the treatment or whether it is experimental for Long COVID. Review controlled evidence for that drug in similar patients.
What may improve: A decision based on the actual diagnosis, expected benefit and treatment risks.
Keep in mind: Rituximab failed in a larger ME/CFS trial after earlier promise. IVIG and other immune therapies remain indication-specific or experimental in Long COVID.
If this does not help: If there's no accepted reason for more immune treatment, choose a trial or symptom-specific care instead.
BC007 is promising proof-of-concept, not established care · Commercial immune protocols need controlled evidence
Read the evidence 2 sources
What the research says: Established only for separate indications; experimental for unselected Long COVID
People considering IVIG, immunosuppression or other immune-modifying treatment.
Rituximab phase III ME/CFS trialRandomized placebo-controlled phase III trial · 151 randomized in the underlying trial report
Who was studied: Adults with ME/CFS
How long: 24-month study
What it found: The larger trial failed to confirm earlier promising B-cell-depletion results.
Thinking and memory: It found no reliable cognitive-treatment benefit.
Important limit: ME/CFS trial, not Long COVID. Useful as a negative precedent for mechanism-led immune therapy.
(27)Small-fiber neuropathy after COVID-19: retrospective case-control studyRetrospective case-control study · 16 patients: 9 received IVIG, 7 did not
Who was studied: Selected patients with skin-biopsy-confirmed small-fiber neuropathy after COVID-19
How long: Retrospective clinical follow-up
What it found: Neuropathic symptoms improved in all 9 IVIG-treated patients and in 3 of 7 patients who did not receive IVIG.
Thinking and memory: The study did not establish a cognitive treatment benefit.
Important limit: Small, nonrandomized study. Treatment selection, insurance access and lack of blinding limit causal interpretation. It does not establish routine IVIG treatment for Long COVID.
(21)Make sure you can eat enoughLow intake can add another layer of weakness and cognitive difficulty.
Try this
Simplify meals, use easy foods and accept help with shopping and cooking. Get nutrition support if nausea, gut or sensory problems limit your eating.
What may improve: More stable energy intake and fewer avoidable nutritional problems.
Keep in mind: This is supportive care, not a Long COVID diet cure.
If this does not help: If intake remains low or weight is changing unintentionally, use dietetic/medical assessment for the cause.
Correct confirmed deficiencies instead of taking everything · Use a dietitian when gut symptoms shrink your food list
Read the evidence 2 sources
What the research says: Standard supportive nutrition
People whose illness makes eating or food preparation difficult.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)Correct confirmed deficiencies instead of taking everythingTreat the result that is actually abnormal.
Try this
Get tested if symptoms or history suggest low iron, B12, folate, vitamin D or another deficiency. Then treat the confirmed problem and its cause.
What may improve: Better cognition, energy or neurological function when a true deficiency contributes.
Keep in mind: Normal values do not make Long COVID disappear; supplements without deficiency can add cost, side effects and interactions.
Check anemia and iron deficiency
If this does not help: If a deficiency normalizes but symptoms remain, move back to PEM, sleep, orthostatic and cognitive routes.
Check whether effort causes PEM · Check for sleep apnea · Check what standing does to you · Use written reminders and fixed places for essentials
Read the evidence 2 sources
What the research says: Standard deficiency care
People with Long COVID/ME/CFS and risk factors or laboratory evidence of deficiency.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)Use a dietitian when gut symptoms shrink your food listThe goal is enough nutrition with fewer symptoms, not permanent restriction.
Try this
If nausea, diarrhea, bloating or food intolerance keeps narrowing intake, use a dietitian to test the smallest useful change and re-expand foods where possible.
What may improve: More adequate nutrition and better control of GI symptoms.
Keep in mind: Low-histamine, gluten-free or low-FODMAP diets treat selected symptoms, not Long COVID as a whole.
If this does not help: If bloating or bowel changes dominate, use the SIBO/GI route instead of adding supplement stacks.
Read the evidence 2 sources
What the research says: Symptom-directed nutrition care
People with persistent GI symptoms or restrictive diets.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)Treat SIM01 as one product-specific positive trialThe microbiome result is interesting, but it does not validate generic probiotics.
Try this
For gut-bacteria products, check which exact product the trial tested. A random probiotic or stool-test recommendation isn't the same.
What may improve: In one 463-person trial, several symptoms including memory and concentration improved more often with SIM01 than placebo.
Keep in mind: One setting and product; replication and generalizability are uncertain.
If this does not help: If an unrelated probiotic does nothing or makes symptoms worse, stop treating all microbiome products as interchangeable.
Use a dietitian when gut symptoms shrink your food list · Check supplements before combining them
Read the evidence 1 source
What the research says: Promising single randomized trial
Adults with post-acute COVID syndrome in the SIM01 trial.
SIM01 synbiotic trial for post-acute COVID syndromeRandomized double-blind placebo-controlled trial · 463 randomized
Who was studied: Adults with post-acute COVID symptoms in Hong Kong
How long: 6 months
What it found: Fatigue, memory loss, trouble concentrating and other symptoms improved more often with the product than placebo.
Thinking and memory: Memory and concentration were directly included as symptom outcomes.
Important limit: Single product-specific trial from one setting; does not validate generic probiotics, microbiome tests or FMT.
(28)Use the CoQ10 trial as a reality checkA plausible mitochondrial story did not translate into clear clinical benefit.
Try this
Before paying for high-dose CoQ10 for Long COVID, read the placebo-controlled trial instead of trusting claims about mitochondria.
What may improve: A clearer decision about an expensive supplement with direct negative trial evidence.
Keep in mind: The trial tested one preparation and regimen; it does not settle every mitochondrial intervention.
If this does not help: If you still want a supplement experiment, choose one product at a time with a defined target and stop rule.
Treat creatine and mitochondrial supplements as preliminary · Check supplements before combining them
Read the evidence 1 source
What the research says: Negative randomized Long COVID evidence
Adults with post-COVID condition in a randomized crossover trial.
High-dose CoQ10 for post-COVID conditionRandomized double-blind crossover trial · 121 randomized
Who was studied: Adults with post-COVID condition
How long: Two 6-week periods with washout
What it found: High-dose CoQ10 did not significantly reduce the number or severity of post-COVID symptoms versus placebo.
Thinking and memory: No convincing cognitive benefit was established.
Important limit: One preparation and regimen; does not answer every mitochondrial supplement question.
(29)Treat creatine and mitochondrial supplements as preliminaryInteresting metabolic findings are not the same as replicated treatment effects.
Try this
Check whether the exact supplement has been tested in a controlled Long COVID or ME/CFS study that measured symptoms or daily function. Starting several products together makes it hard to judge benefit or side effects.
What may improve: Possibly improved energy or function in small preliminary studies, depending on the product.
Keep in mind: Studies are small, mixed or indirect. Few establish a benefit for thinking or memory.
If this does not help: If no clear benefit appears, stop adding adjacent products and return to treatable overlaps or formal trials.
Correct confirmed deficiencies instead of taking everything · Consider a registered clinical trial for experimental treatment
Read the evidence 2 sources
What the research says: Preliminary or product-specific evidence
People considering creatine, carnitine, ribose, NAD-related or mitochondrial supplements.
Interventions for long COVID: living systematic reviewLiving systematic review · 24 trials; 3,695 participants
Who was studied: Adults with Long COVID in randomized trials
How long: Search through Dec 2023
What it found: Some rehab, behavioural, diet, device and drug treatments showed hints of benefit, but results were mixed and many comparisons stayed uncertain.
Thinking and memory: Some interventions measured concentration; this does not establish a universal cognitive treatment.
Important limit: This review predates several important 2025-2026 trials included separately below.
(17)High-dose CoQ10 for post-COVID conditionRandomized double-blind crossover trial · 121 randomized
Who was studied: Adults with post-COVID condition
How long: Two 6-week periods with washout
What it found: High-dose CoQ10 did not significantly reduce the number or severity of post-COVID symptoms versus placebo.
Thinking and memory: No convincing cognitive benefit was established.
Important limit: One preparation and regimen; does not answer every mitochondrial supplement question.
(29)Check supplements before combining themMore ingredients make it harder to know what helped and easier to create interactions.
Try this
If you use an over-the-counter supplement, choose one with a clear target and human evidence. Check bleeding, sedation and medicine interactions before adding products such as nattokinase or serrapeptase.
What may improve: Lower cost and fewer avoidable interactions.
Keep in mind: Direct Long COVID evidence for broad antioxidant, fibrinolytic and “detox” stacks is inadequate.
If this does not help: If your reason is “microclots” or “detox,” read the blood-thinner/apheresis evidence before adding more products.
Do not self-treat a microclot theory with blood thinners · Commercial immune protocols need controlled evidence
Read the evidence 2 sources
What the research says: Insufficient evidence for broad stacks
People considering NAC, omega-3, quercetin, curcumin, nattokinase or multi-supplement protocols.
Interventions for long COVID: living systematic reviewLiving systematic review · 24 trials; 3,695 participants
Who was studied: Adults with Long COVID in randomized trials
How long: Search through Dec 2023
What it found: Some rehab, behavioural, diet, device and drug treatments showed hints of benefit, but results were mixed and many comparisons stayed uncertain.
Thinking and memory: Some interventions measured concentration; this does not establish a universal cognitive treatment.
Important limit: This review predates several important 2025-2026 trials included separately below.
(17)CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Return to work without using work as an endurance testA successful return needs to survive the following days too.
Try this
Start with the tasks, hours and environment you can repeat. Build in recovery time and judge the plan by delayed symptoms, not whether you can force one good day.
What may improve: More sustainable work participation with fewer boom-and-crash cycles.
Keep in mind: A staged return that requires fixed weekly increases can reproduce the same problem as fixed exercise progression when PEM is present.
If this does not help: If work still takes everything, cut thinking or upright time, or request formal accommodations, not more rehab goals.
Ask for concrete work or study changes · Make light, sound and communication more manageable · Use mobility and seating aids to preserve capacity
Read the evidence 3 sources
What the research says: Practical occupational support
People trying to remain at or return to work with Long COVID/ME/CFS.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)Specialist Long COVID integrated-care trialPhase 3 cluster randomized trial · 1,152 participants
Who was studied: Adults in NHS Long COVID clinics
How long: 24 weeks
What it found: Specialist clinic care was linked to fatigue improvement across all groups. Extra MRI or digital rehab added little at the main follow-up.
Thinking and memory: Cognition was not the primary endpoint.
Important limit: Does not isolate which usual-care component mattered.
(30)Ask for concrete work or study changesName the barrier instead of asking for vague flexibility.
Try this
Ask for specific changes such as written instructions, fewer tasks at once, joining remotely, flexible start times, longer deadlines, less standing or protected breaks.
What may improve: Fewer errors and less symptom worsening while preserving participation.
Keep in mind: Rights and processes vary by country and employer. Practical support evidence is stronger than trial evidence for any one accommodation.
If this does not help: If one change is not enough, combine only the adjustments that map to actual barriers and document function clearly.
Make light, sound and communication more manageable · Document function and PEM clearly
Read the evidence 2 sources
What the research says: Practical functional support
People whose symptoms affect work or education.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)Use mobility and seating aids to preserve capacityAn aid can save energy for thinking, eating and relationships.
Try this
Use a stool, wheelchair, mobility aid or shower seat when it reduces upright strain or prevents a crash. Choose it around the task instead of waiting until you can no longer do it at all.
What may improve: More access to daily life with less upright and physical energy cost.
Keep in mind: An aid does not determine prognosis or mean you have stopped trying to improve. Fit and safety matter.
If this does not help: If mobility aids help but cognition remains poor at rest, assess sleep, medications and cognitive load separately.
Check for sleep apnea · Review medicines that worsen sleep or thinking · Use written reminders and fixed places for essentials
Read the evidence 2 sources
What the research says: Practical disability support
People with severe energy or orthostatic limits.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)Make light, sound and communication more manageableAdjust the setting and format when screens, sound or conversation worsen symptoms.
Try this
Use lower light, quieter audio, fewer notifications, shorter conversations, text instead of calls, or audio instead of reading when those formats cost less.
What may improve: More usable attention and less symptom escalation from sensory input.
Keep in mind: If a gentler version stays manageable and worthwhile, choose it over dropping the activity.
If this does not help: If sensory changes do not alter symptoms, return to sleep, migraine, orthostatic or cognitive-rehab routes.
Treat migraine as migraine · Check for sleep apnea · Check what standing does to you · Work on daily tasks with an occupational or speech-language therapist
Read the evidence 2 sources
What the research says: Practical cognitive support
People with screen, light, sound or conversation intolerance.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Systematic review of mental health, cognition and wellbeing interventions in Long COVIDSystematic review · Multiple intervention studies
Who was studied: People with Long COVID
How long: Search in late 2023
What it found: Found a small and heterogeneous evidence base for cognitive and psychological interventions.
Thinking and memory: Direct cognition evidence was limited and heterogeneous.
Important limit: Evidence was sparse and predates RECOVER-NEURO.
(18)Use CBT or ACT for coping, sleep or distressPsychological support can help life with illness without being its explanation.
Try this
Choose a target such as insomnia, fear after repeated crashes, grief, anxiety or adapting to disability. Keep PEM and physical symptom treatment separate.
What may improve: Better coping, distress, sleep or adjustment when those are the treatment goals.
Keep in mind: NICE does not support CBT as a curative ME/CFS treatment based on false illness beliefs or deconditioning.
Compare anxiety-related cognitive symptoms
If this does not help: If distress eases but physical symptoms don't, keep following the physical checks below.
Check whether effort causes PEM · Check what standing does to you · Check for sleep apnea
Read the evidence 2 sources
What the research says: Supportive behavioral evidence
People who want psychological support for a defined problem.
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)Interventions for long COVID: living systematic reviewLiving systematic review · 24 trials; 3,695 participants
Who was studied: Adults with Long COVID in randomized trials
How long: Search through Dec 2023
What it found: Some rehab, behavioural, diet, device and drug treatments showed hints of benefit, but results were mixed and many comparisons stayed uncertain.
Thinking and memory: Some interventions measured concentration; this does not establish a universal cognitive treatment.
Important limit: This review predates several important 2025-2026 trials included separately below.
(17)Document function and PEM clearlyA useful record shows what you cannot sustain, not just symptom adjectives.
Try this
Write two or three concrete examples: how long you can stand, think, travel or work, what happens afterward, and how long recovery takes. Include aids and accommodations already needed.
What may improve: Clearer clinical, workplace or disability communication.
Keep in mind: Documentation supports decisions; it does not validate an unproven mechanism or guarantee benefits.
If this does not help: Pair examples of daily difficulty with the symptom you want assessed, such as delayed flares, dizziness while upright or unrefreshing sleep.
Check whether effort causes PEM · Check what standing does to you · Check for sleep apnea
Read the evidence 2 sources
What the research says: Practical communication support
People preparing clinical, work or disability documentation.
NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Hyperbaric oxygen (HBOT) has conflicting randomized evidenceOne small trial was positive; a later larger placebo-controlled trial was negative.
Try this
Before paying for dozens of chamber sessions, compare both randomized trials, the treatment burden, travel and cost, and what outcome you would require to continue.
What may improve: Possible cognitive or symptom benefit remains uncertain.
Keep in mind: The 73-person 2022 trial reported better thinking. The 101-person double-blind 2025 trial found no significant symptom or thinking benefit.
If this does not help: If the cost or travel would consume your capacity, prioritize lower-burden symptom pathways or a clinical trial.
Work on daily tasks with an occupational or speech-language therapist · Ask for concrete work or study changes
Read the evidence 2 sources
What the research says: Conflicting randomized evidence
Adults with Long COVID considering hyperbaric oxygen therapy.
HBOT sham-controlled Long COVID trialRandomized double-blind sham-controlled trial · 73 randomized
Who was studied: Adults with post-COVID symptoms for at least 3 months
How long: 40 sessions; assessment shortly after course
What it found: Overall thinking, attention, executive function, energy, sleep and pain interference improved more than with sham.
Thinking and memory: Cognition was directly measured and favored HBOT in this study.
Important limit: Small, intensive single-program study with high time/cost burden. It needed independent replication.
(31)Normobaric/hyperbaric oxygen Long COVID trialRandomized placebo-controlled double-blind trial · 101 randomized
Who was studied: Adults with Long COVID
How long: 10 chamber sessions; 3-month follow-up
What it found: Found no significant between-group differences in symptoms, walking capacity or five neurocognitive tests.
Thinking and memory: Five neurocognitive tests showed no significant treatment advantage.
Important limit: Different oxygen/chamber protocol from the earlier positive trial, which may partly explain discordance.
(32)Vagus stimulation is still experimentalA 2026 sham-controlled fatigue pilot did not establish superiority.
Try this
Before buying a vagus-nerve stimulation or tDCS device, check trials of that exact device, including comparison with a sham treatment. Vagus stimulation and tDCS are different methods, so results from one don't prove the other works.
What may improve: Possible autonomic or fatigue effects remain under study.
Keep in mind: COVIVA randomized 45 people and did not establish active taVNS superiority for fatigue. RECOVER-NEURO was also negative for its tDCS cognitive protocol.
If this does not help: If a device has no clear functional effect, stop rather than adding another neuromodulation product.
Treat commercial brain training skeptically · Treat stellate-ganglion block as an invasive experiment
Read the evidence 2 sources
What the research says: Experimental; randomized results not convincing yet
People considering commercial neuromodulation devices.
COVIVA taVNS pilot trialRandomized sham-controlled pilot trial · 45 randomized
Who was studied: Adults with Long COVID-related fatigue
How long: 4 weeks
What it found: The treatment was doable and mostly well tolerated, but real stimulation didn't prove better than sham for fatigue.
Thinking and memory: Cognition was not the primary outcome.
Important limit: Pilot-sized and fatigue-focused; device protocol was intensive.
(33)RECOVER-NEURO randomized cognitive intervention trialMulticenter randomized trial · 328 participants; 22 US sites
Who was studied: Adults with cognitive Long COVID
How long: 10 weeks
What it found: Adaptive BrainHQ, PASC-CoRE plus BrainHQ, and tDCS plus BrainHQ did no better than comparisons on the main self-rated thinking measure. Secondary thinking measures showed no extra benefit.
Thinking and memory: The trial measured cognition directly; no treatment group did better.
Important limit: The trial tested specific remote protocols, not every form of cognitive rehabilitation or compensatory OT.
(19)Treat stellate-ganglion block as an invasive experimentCase reports and series cannot tell you the true benefit rate.
Try this
Before an invasive block, ask about controlled evidence, complication rates, how long relief lasts and what happens if symptoms return.
What may improve: Possible symptom relief remains uncertain.
Keep in mind: No strong randomized Long COVID evidence establishes this as routine care; procedure risks and cost matter.
If this does not help: If the rationale is autonomic dysfunction, use the POTS/orthostatic pathway first.
Check what standing does to you · Compare POTS medicines by the problem they target
Read the evidence 2 sources
What the research says: Very low-certainty invasive evidence
People considering stellate-ganglion block for Long COVID.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Interventions for long COVID: living systematic reviewLiving systematic review · 24 trials; 3,695 participants
Who was studied: Adults with Long COVID in randomized trials
How long: Search through Dec 2023
What it found: Some rehab, behavioural, diet, device and drug treatments showed hints of benefit, but results were mixed and many comparisons stayed uncertain.
Thinking and memory: Some interventions measured concentration; this does not establish a universal cognitive treatment.
Important limit: This review predates several important 2025-2026 trials included separately below.
(17)Do not self-treat a microclot theory with blood thinnersDirect randomized evidence does not support routine rivaroxaban for Long COVID fatigue.
Try this
Use anticoagulants or antiplatelet drugs only for a conventional medical indication or a properly monitored clinical trial. Treat commercial microclot testing and apheresis claims separately from established clotting diagnoses.
What may improve: Avoiding major bleeding risk and expensive invasive treatment without demonstrated net benefit.
Keep in mind: STIMULATE found no fatigue benefit from rivaroxaban. No convincing comparison study yet supports HELP apheresis or triple-therapy claims.
If this does not help: If you have a diagnosed clotting condition, follow that indication. If not, use symptom-specific care or a registered trial, not self-prescribed blood thinners.
Read the evidence 2 sources
What the research says: Negative randomized anticoagulant evidence; apheresis insufficient
People considering anticoagulation, “microclot” protocols or HELP apheresis.
STIMULATE rivaroxaban resultRandomized controlled trial · Part of a multisite trial approaching 800 participants
Who was studied: Adults with post-COVID condition and fatigue
How long: 12 weeks
What it found: Rivaroxaban did not improve fatigue compared with supportive specialist care.
Thinking and memory: Cognition was not the main outcome.
Important limit: The trial tested one use, routine rivaroxaban for fatigue, and is direct evidence against it.
(34)CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Commercial immune protocols need controlled evidenceA blood-test result or proposed mechanism is not enough to establish that a treatment works.
Try this
If a clinic offers maraviroc with a statin, or a similar paid protocol, ask two questions. Has a randomized controlled trial of that exact treatment shown that patients feel or function better? And would the blood test result change your treatment?
What may improve: Avoiding expensive off-label combinations with interactions and unclear benefit.
Keep in mind: Controlled evidence remains inadequate for routine Long COVID use.
If this does not help: Without convincing controlled evidence, consider a registered trial or care for a diagnosed, treatable problem.
Use immune treatment only for a supported indication or trial · BC007 is promising proof-of-concept, not established care
Read the evidence 2 sources
What the research says: Insufficient controlled evidence
People considering proprietary cytokine, CCR5 or immune-treatment protocols.
CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)Interventions for long COVID: living systematic reviewLiving systematic review · 24 trials; 3,695 participants
Who was studied: Adults with Long COVID in randomized trials
How long: Search through Dec 2023
What it found: Some rehab, behavioural, diet, device and drug treatments showed hints of benefit, but results were mixed and many comparisons stayed uncertain.
Thinking and memory: Some interventions measured concentration; this does not establish a universal cognitive treatment.
Important limit: This review predates several important 2025-2026 trials included separately below.
(17)BC007 is promising proof-of-concept, not established careA 30-person biomarker-selected phase IIa trial reported gains in fatigue and quality of life.
Try this
Treat rovunaptabin/BC007 as research. Look for confirmation in larger trials and check whether the studied autoantibody-positive group resembles your situation.
What may improve: Possible fatigue and quality-of-life benefit in a small selected sample.
Keep in mind: Thirty participants is not enough to establish a routine treatment or validate commercial autoantibody testing.
If this does not help: If access is only through commercial claims without confirmatory evidence, wait for larger trial results or use a registered study.
Read the evidence 1 source
What the research says: Small randomized proof-of-concept trial
Post-COVID patients selected for functional GPCR autoantibodies and significant fatigue.
Rovunaptabin (BC007) reCOVer phase IIaExploratory randomized double-blind placebo-controlled phase IIa trial · 30 randomized
Who was studied: Post-COVID patients positive for functional GPCR autoantibodies with fatigue
How long: Crossover treatment with short follow-up
What it found: Reported improvements in fatigue and quality-of-life measures in this small selected group.
Thinking and memory: Cognition was not a primary endpoint.
Important limit: Proof-of-concept sample, biomarker-selected population and secondary clinical endpoints. It needs bigger trials.
(35)Guanfacine for cognition is still case-level evidenceOne detailed case improved, but there is no convincing randomized Long COVID trial.
Try this
If you are considering guanfacine, name the thinking problem you want to improve and review blood pressure, drowsiness and symptoms while standing.
What may improve: Possible attention, working-memory or executive-function benefit remains unproven.
Keep in mind: The published evidence includes single-patient reports.
If this does not help: If the evidence threshold is too low for the risks, use compensation/OT or a clinical trial instead.
Use written reminders and fixed places for essentials · Work on daily tasks with an occupational or speech-language therapist
Read the evidence 1 source
What the research says: Case-level cognitive evidence
People with prominent cognitive Long COVID considering off-label guanfacine.
Guanfacine for marked Long COVID cognitive impairment: case reportCase report · 1 participant
Who was studied: One 32-year-old woman with objective cognitive deficits after COVID-19
How long: 6-month follow-up
What it found: Subjective and objective attention, working-memory and executive-function measures improved after guanfacine treatment.
Thinking and memory: Cognition was directly measured and improved in this single patient.
Important limit: With guanfacine, watch blood pressure, drowsiness and drug interactions.
(36)Consider a registered clinical trial for experimental treatmentA trial can test whether an emerging treatment improves symptoms or daily function.
Try this
For an emerging drug, check trial status, eligibility, comparator, primary outcome and whether results are actually public or peer reviewed. Choose registered trials over copied protocols.
What may improve: An opportunity to contribute to research with monitoring; personal benefit is uncertain.
Keep in mind: Press releases and lab findings on how a treatment might work can arrive years before useful clinical evidence.
If this does not help: If no suitable trial exists, keep symptom-directed care active rather than replacing it with an untested commercial protocol.
Commercial immune protocols need controlled evidence · Use immune treatment only for a supported indication or trial
Read the evidence 3 sources
What the research says: Research pathway
People who have exhausted established symptom-directed routes and want experimental options.
RECOVER-VITAL: nirmatrelvir/ritonavir for established Long COVIDPhase 2 randomized placebo-controlled trial · 964 randomized; 959 modified intention-to-treat
Who was studied: Adults with Long COVID across symptom phenotypes
How long: 15 or 25 days of treatment; follow-up after treatment
What it found: Compared with placebo, longer nirmatrelvir/ritonavir courses didn't significantly help any pre-planned symptom group (thinking, autonomic or exercise).
Thinking and memory: Cognition was a prespecified phenotype and did not show a meaningful treatment benefit.
Important limit: This addresses treatment of established Long COVID, not use during a new acute infection.
(22)Rovunaptabin (BC007) reCOVer phase IIaExploratory randomized double-blind placebo-controlled phase IIa trial · 30 randomized
Who was studied: Post-COVID patients positive for functional GPCR autoantibodies with fatigue
How long: Crossover treatment with short follow-up
What it found: Reported improvements in fatigue and quality-of-life measures in this small selected group.
Thinking and memory: Cognition was not a primary endpoint.
Important limit: Proof-of-concept sample, biomarker-selected population and secondary clinical endpoints. It needs bigger trials.
(35)STIMULATE-ICP pharmacologic trialMultisite open-label randomized controlled trial · Nearly 800 randomized across drug comparisons
Who was studied: Adults with post-COVID condition in UK specialist clinics
How long: 12-week primary outcome; 24-week follow-up
What it found: Famotidine-loratadine and colchicine produced small extra fatigue improvements at 12 weeks that were not sustained at 24 weeks. Rivaroxaban did not improve fatigue.
Thinking and memory: Cognition was not the primary outcome; no direct cognitive-treatment claim follows.
Important limit: Open-label and fatigue-focused. Small average changes aren't grounds for cure claims.
(25)No matches. Try another word or clear the search.
Sources and study details
NICE NG206: ME/CFS diagnosis and managementClinical guideline · Guideline
Who was studied: Children, young people and adults with ME/CFS
How long: Ongoing care
What it found: Recommends energy management and says not to offer fixed-increment graded exercise therapy as treatment for ME/CFS. CBT may support symptom management but is not a cure.
Thinking and memory: The guideline treats cognition as part of symptom management and doesn't back any drug to restore it.
Important limit: Guideline recommendations combine evidence and committee judgement. They apply to ME/CFS, not every person with Long COVID.
(7)NICE NG188: managing the long-term effects of COVID-19Clinical guideline · Guideline
Who was studied: People with new or ongoing symptoms after COVID-19
How long: Ongoing care
What it found: Uses symptom-led assessment, investigation and rehabilitation while considering alternative diagnoses and urgent problems.
Thinking and memory: Supports assessment of cognitive symptoms but does not identify one proven cognitive therapy.
Important limit: Long COVID is heterogeneous; the guideline does not establish one disease-modifying treatment.
(16)CDC: Clinical care of ME/CFSClinical guidance · Guidance
Who was studied: People with ME/CFS
How long: Ongoing care
What it found: Describes PEM, pacing/activity management, orthostatic intolerance, sleep, pain and cognitive symptom management.
Thinking and memory: It advises treating the symptoms themselves and reducing overload.
Important limit: It gives practical care advice but doesn't compare treatment effects.
(8)CDC: Long COVID clinical guidanceClinical guidance · Guidance
Who was studied: People with Long COVID
How long: Ongoing care
What it found: The guidance says to take symptoms seriously, improve function and quality of life, and treat identifiable conditions even when routine tests are normal.
Thinking and memory: Recognizes cognitive dysfunction as a common symptom; treatment remains symptom-directed.
Important limit: Guidance does not prove a single mechanism or therapy for all Long COVID.
(12)WHO: Clinical management of COVID-19 living guideline and post-COVID rehabilitationInternational guidance · Guidance
Who was studied: People with post-COVID condition
How long: Ongoing care
What it found: Supports individualized rehabilitation and screening for post-exertional symptom exacerbation before exercise-oriented rehabilitation.
Thinking and memory: Rehabilitation can work on thinking, but there's little evidence any one treatment restores it.
Important limit: Implementation varies by country and phenotype.
(9)Interventions for long COVID: living systematic reviewLiving systematic review · 24 trials; 3,695 participants
Who was studied: Adults with Long COVID in randomized trials
How long: Search through Dec 2023
What it found: Some rehab, behavioural, diet, device and drug treatments showed hints of benefit, but results were mixed and many comparisons stayed uncertain.
Thinking and memory: Some interventions measured concentration; this does not establish a universal cognitive treatment.
Important limit: This review predates several important 2025-2026 trials included separately below.
(17)RECOVER-NEURO randomized cognitive intervention trialMulticenter randomized trial · 328 participants; 22 US sites
Who was studied: Adults with cognitive Long COVID
How long: 10 weeks
What it found: Adaptive BrainHQ, PASC-CoRE plus BrainHQ, and tDCS plus BrainHQ did no better than comparisons on the main self-rated thinking measure. Secondary thinking measures showed no extra benefit.
Thinking and memory: The trial measured cognition directly; no treatment group did better.
Important limit: The trial tested specific remote protocols, not every form of cognitive rehabilitation or compensatory OT.
(19)RECOVER-VITAL: nirmatrelvir/ritonavir for established Long COVIDPhase 2 randomized placebo-controlled trial · 964 randomized; 959 modified intention-to-treat
Who was studied: Adults with Long COVID across symptom phenotypes
How long: 15 or 25 days of treatment; follow-up after treatment
What it found: Compared with placebo, longer nirmatrelvir/ritonavir courses didn't significantly help any pre-planned symptom group (thinking, autonomic or exercise).
Thinking and memory: Cognition was a prespecified phenotype and did not show a meaningful treatment benefit.
Important limit: This addresses treatment of established Long COVID, not use during a new acute infection.
(22)STOP-PASC nirmatrelvir/ritonavir trialRandomized placebo-controlled trial · 155 randomized
Who was studied: Adults with moderate-to-severe PASC for at least 3 months
How long: 15-day treatment; 15-week follow-up
What it found: A 15-day course did not significantly improve pooled Long COVID symptom severity compared with control.
Thinking and memory: The pooled symptom score included brain fog; the trial showed no overall treatment effect.
Important limit: Smaller than RECOVER-VITAL and used a pooled symptom endpoint.
(23)STIMULATE-ICP pharmacologic trialMultisite open-label randomized controlled trial · Nearly 800 randomized across drug comparisons
Who was studied: Adults with post-COVID condition in UK specialist clinics
How long: 12-week primary outcome; 24-week follow-up
What it found: Famotidine-loratadine and colchicine produced small extra fatigue improvements at 12 weeks that were not sustained at 24 weeks. Rivaroxaban did not improve fatigue.
Thinking and memory: Cognition was not the primary outcome; no direct cognitive-treatment claim follows.
Important limit: Open-label and fatigue-focused. Small average changes aren't grounds for cure claims.
(25)STIMULATE-ICP integrated care pathway trialPhase 3 cluster-randomized trial · 1,152 participants; 122 primary-care clusters
Who was studied: Adults referred to six NHS Long COVID clinics
How long: 12 and 24 weeks
What it found: All specialist-care groups improved in fatigue. Added multi-organ MRI did not improve fatigue; digital rehabilitation did not improve the 12-week primary outcome and showed only small secondary differences later.
Thinking and memory: The main endpoint was fatigue, not cognition.
Important limit: Cluster design; usual specialist care itself was active and multidisciplinary.
(11)Low-dose naltrexone for Long COVID: systematic review and meta-analysisSystematic review and meta-analysis · 4 observational pre-post studies; 155 participants; no RCTs
Who was studied: Adults with Long COVID in LDN studies
How long: Search through 5 May 2026
What it found: Pooled before-and-after results favored fatigue, brain fog, sleep, pain and function, but the review found no randomized trial.
Thinking and memory: Brain fog improved in pooled before-and-after data (Hedges g about -0.53), but randomized proof is missing.
Important limit: Without concurrent controls, natural change, selection and placebo/context effects stay mixed together. Certainty is low.
(24)Guanfacine for marked Long COVID cognitive impairment: case reportCase report · 1 participant
Who was studied: One 32-year-old woman with objective cognitive deficits after COVID-19
How long: 6-month follow-up
What it found: Subjective and objective attention, working-memory and executive-function measures improved after guanfacine treatment.
Thinking and memory: Cognition was directly measured and improved in this single patient.
Important limit: With guanfacine, watch blood pressure, drowsiness and drug interactions.
(36)Low-dose aripiprazole in ME/CFSRetrospective study · 101 patients
Who was studied: People with ME/CFS treated at one center
How long: Retrospective clinical follow-up
What it found: A subset reported lower fatigue, brain-fog and unrefreshing-sleep scores.
Thinking and memory: It reported brain-fog scores, but an uncontrolled design can't prove benefit.
Important limit: No control group; selection and reporting bias are substantial. This is ME/CFS evidence, not a Long COVID trial.
(26)Pyridostigmine physiology trial in ME/CFSRandomized double-blind placebo-controlled physiology trial · 45 participants
Who was studied: Adults with ME/CFS undergoing invasive exercise testing
How long: Acute repeat exercise testing
What it found: Pyridostigmine improved acute peak oxygen uptake and hemodynamics compared with placebo.
Thinking and memory: Cognition was not the treatment endpoint.
Important limit: A short-term exercise-test result doesn't prove lasting symptom or cognitive benefit. The study was not a Long COVID trial.
(15)Diagnosis and management of POTSClinical review · Review
Who was studied: People with POTS
How long: Current clinical management
What it found: Supports fluids/sodium when appropriate, compression, trigger reduction and individualized medicines such as beta-blockers, ivabradine, midodrine, fludrocortisone and pyridostigmine.
Thinking and memory: Treating standing symptoms may help you function upright. It's unproven for Long COVID thinking itself.
Important limit: Most treatment evidence is small and this is not Long COVID-specific disease-modification evidence.
(13)POTS after COVID-19: systematic review of interventionsSystematic review of reports · 21 reports; 68 people
Who was studied: Reported cases of POTS after COVID-19
How long: Reports through Sep 2022
What it found: Describes diagnostic and treatment strategies used for post-COVID POTS.
Thinking and memory: Cognitive outcomes were not established.
Important limit: Mostly case reports/series; no strong comparative treatment estimate.
(14)SIM01 synbiotic trial for post-acute COVID syndromeRandomized double-blind placebo-controlled trial · 463 randomized
Who was studied: Adults with post-acute COVID symptoms in Hong Kong
How long: 6 months
What it found: Fatigue, memory loss, trouble concentrating and other symptoms improved more often with the product than placebo.
Thinking and memory: Memory and concentration were directly included as symptom outcomes.
Important limit: Single product-specific trial from one setting; does not validate generic probiotics, microbiome tests or FMT.
(28)High-dose CoQ10 for post-COVID conditionRandomized double-blind crossover trial · 121 randomized
Who was studied: Adults with post-COVID condition
How long: Two 6-week periods with washout
What it found: High-dose CoQ10 did not significantly reduce the number or severity of post-COVID symptoms versus placebo.
Thinking and memory: No convincing cognitive benefit was established.
Important limit: One preparation and regimen; does not answer every mitochondrial supplement question.
(29)HBOT sham-controlled Long COVID trialRandomized double-blind sham-controlled trial · 73 randomized
Who was studied: Adults with post-COVID symptoms for at least 3 months
How long: 40 sessions; assessment shortly after course
What it found: Overall thinking, attention, executive function, energy, sleep and pain interference improved more than with sham.
Thinking and memory: Cognition was directly measured and favored HBOT in this study.
Important limit: Small, intensive single-program study with high time/cost burden. It needed independent replication.
(31)Normobaric/hyperbaric oxygen Long COVID trialRandomized placebo-controlled double-blind trial · 101 randomized
Who was studied: Adults with Long COVID
How long: 10 chamber sessions; 3-month follow-up
What it found: Found no significant between-group differences in symptoms, walking capacity or five neurocognitive tests.
Thinking and memory: Five neurocognitive tests showed no significant treatment advantage.
Important limit: Different oxygen/chamber protocol from the earlier positive trial, which may partly explain discordance.
(32)COVIVA taVNS pilot trialRandomized sham-controlled pilot trial · 45 randomized
Who was studied: Adults with Long COVID-related fatigue
How long: 4 weeks
What it found: The treatment was doable and mostly well tolerated, but real stimulation didn't prove better than sham for fatigue.
Thinking and memory: Cognition was not the primary outcome.
Important limit: Pilot-sized and fatigue-focused; device protocol was intensive.
(33)COVID-OUT metformin follow-upPhase 3 randomized acute-COVID trial follow-up · 1,126 participants in long-COVID follow-up
Who was studied: Overweight/obese adults treated during acute COVID-19
How long: 10 months
What it found: Metformin started during acute infection reduced later clinician-diagnosed Long COVID (6.3% vs 10.4%; HR 0.59).
Thinking and memory: No established treatment effect on existing cognitive symptoms.
Important limit: Prevention evidence. It doesn't show that metformin treats established Long COVID.
(37)Metformin or UDCA for established PASCRandomized double-blind placebo-controlled trial · 396 randomized
Who was studied: Adults with established PASC
How long: 14-day treatment; 8-week outcome
What it found: Neither metformin nor UDCA improved recovery compared with placebo.
Thinking and memory: No direct cognitive benefit was established.
Important limit: Relatively young sample; severe/very persistent disease may be underrepresented.
(38)Rovunaptabin (BC007) reCOVer phase IIaExploratory randomized double-blind placebo-controlled phase IIa trial · 30 randomized
Who was studied: Post-COVID patients positive for functional GPCR autoantibodies with fatigue
How long: Crossover treatment with short follow-up
What it found: Reported improvements in fatigue and quality-of-life measures in this small selected group.
Thinking and memory: Cognition was not a primary endpoint.
Important limit: Proof-of-concept sample, biomarker-selected population and secondary clinical endpoints. It needs bigger trials.
(35)Rituximab phase III ME/CFS trialRandomized placebo-controlled phase III trial · 151 randomized in the underlying trial report
Who was studied: Adults with ME/CFS
How long: 24-month study
What it found: The larger trial failed to confirm earlier promising B-cell-depletion results.
Thinking and memory: It found no reliable cognitive-treatment benefit.
Important limit: ME/CFS trial, not Long COVID. Useful as a negative precedent for mechanism-led immune therapy.
(27)Systematic review of mental health, cognition and wellbeing interventions in Long COVIDSystematic review · Multiple intervention studies
Who was studied: People with Long COVID
How long: Search in late 2023
What it found: Found a small and heterogeneous evidence base for cognitive and psychological interventions.
Thinking and memory: Direct cognition evidence was limited and heterogeneous.
Important limit: Evidence was sparse and predates RECOVER-NEURO.
(18)Pulmonary rehabilitation in Long COVID: systematic review/meta-analysisSystematic review and meta-analysis · Multiple rehabilitation studies
Who was studied: People with Long COVID in pulmonary rehabilitation studies
How long: Published 2024
What it found: Reported improvements in exercise capacity and selected symptoms in studied populations.
Thinking and memory: Cognition was not the central outcome.
Important limit: PEM identification and severe/housebound representation varied. The results shouldn't be applied to people with delayed crashes.
(10)Specialist Long COVID integrated-care trialPhase 3 cluster randomized trial · 1,152 participants
Who was studied: Adults in NHS Long COVID clinics
How long: 24 weeks
What it found: Specialist clinic care was linked to fatigue improvement across all groups. Extra MRI or digital rehab added little at the main follow-up.
Thinking and memory: Cognition was not the primary endpoint.
Important limit: Does not isolate which usual-care component mattered.
(30)STIMULATE rivaroxaban resultRandomized controlled trial · Part of a multisite trial approaching 800 participants
Who was studied: Adults with post-COVID condition and fatigue
How long: 12 weeks
What it found: Rivaroxaban did not improve fatigue compared with supportive specialist care.
Thinking and memory: Cognition was not the main outcome.
Important limit: The trial tested one use, routine rivaroxaban for fatigue, and is direct evidence against it.
(34)Small-fiber neuropathy after COVID-19: retrospective case-control studyRetrospective case-control study · 16 patients: 9 received IVIG, 7 did not
Who was studied: Selected patients with skin-biopsy-confirmed small-fiber neuropathy after COVID-19
How long: Retrospective clinical follow-up
What it found: Neuropathic symptoms improved in all 9 IVIG-treated patients and in 3 of 7 patients who did not receive IVIG.
Thinking and memory: The study did not establish a cognitive treatment benefit.
Important limit: Small, nonrandomized study. Treatment selection, insurance access and lack of blinding limit causal interpretation. It does not establish routine IVIG treatment for Long COVID.
(21)Individual cognitive rehabilitation for Long COVIDRandomized trial · 78 randomized: 38 rehabilitation, 40 usual care
Who was studied: Adults aged 30–60 with Long COVID and measured cognitive impairment at three English sites
How long: Ten weekly one-hour sessions; outcomes at three and six months
What it found: Participants receiving individualized rehabilitation reported greater attainment of three personal functional goals at three months; the difference persisted at six months.
Thinking and memory: The main benefit was that people did better at reaching everyday goals.
Important limit: Small trial with a participant-reported primary outcome. Results concern this program and studied population, not every rehabilitation method or severity of illness.
(20)Questions people askPEM, medicines, expensive treatments and what the trials actually found.
How do I know if this is PEM?
PEM means a disproportionate worsening after physical, cognitive, social or upright effort, often delayed and prolonged. The PEM screener and crash timing matter more than whether the activity looked strenuous.
Check whether effort causes PEM · Use the crash log to compare preceding events
Why can thinking make me crash?
Mental effort can trigger PEM even when you stay seated. Long meetings, screens, reading or emotional stress may cause symptoms to worsen later.
Keep demanding thinking manageable · Find the level you can repeat without crashing
What if exercise makes me worse?
End any preset progression that brings delayed worsening. Screen for PEM, return to a repeatable baseline and use energy management.
Check whether effort causes PEM · Know why fixed activity increases don't fit PEM · Find the level you can repeat without crashing
What if I do not have PEM?
If repeated activity doesn't make you worse later, tailored rehab can target weakness, breathlessness or lost fitness. The program must still follow your symptoms, not a generic target.
Match rehabilitation to symptoms and delayed effects · Match pulmonary rehabilitation to the breathing problem
Why is standing worse for my brain?
Orthostatic intolerance can reduce upright tolerance and make attention, dizziness and weakness worse. Check heart rate, blood pressure and symptoms instead of treating it as general fatigue.
Check what standing does to you · Compare POTS medicines by the problem they target
What actually improves cognition?
No treatment has strong, repeated evidence of restoring all thinking skills in Long COVID. One 2026 trial found better attainment of personal goals with individualized rehabilitation. The larger RECOVER-NEURO trial found no added benefit from its different tested programs. Choose practical goals and a program you can tolerate.
Use written reminders and fixed places for essentials · Work on daily tasks with an occupational or speech-language therapist · Treat commercial brain training skeptically
Is LDN worth trying?
It has encouraging before-and-after reports, including people saying their brain fog improved, but the 2026 systematic review found no randomized Long COVID trials. Treat it as an off-label uncertain option.
What about guanfacine plus NAC?
Published cognitive improvement includes case-level evidence. That's too small to estimate a reliable benefit, and it doesn't prove NAC adds an independent effect.
Do antihistamines work?
A 2026 randomized trial found a small short-term fatigue benefit for famotidine-loratadine, but it wasn't sustained at 24 weeks and doesn't prove MCAS or cognitive recovery.
Antihistamines now have one small randomized result · A response to antihistamines (H1/H2 drugs) isn't an MCAS diagnosis
Does Paxlovid treat established Long COVID?
The large 2026 RECOVER-VITAL trial and the earlier STOP-PASC trial did not show a meaningful overall benefit for established Long COVID. Acute infection treatment is a separate question.
Does metformin help once I already have Long COVID?
In the COVID-OUT trial, starting metformin during the first infection reduced later Long COVID diagnoses. In randomized trials of people who already had Long COVID, it didn't help them recover.
See what the Paxlovid trials actually found · Consider a registered clinical trial for experimental treatment
Is hyperbaric oxygen worth paying for?
Studies disagree. A 2022 sham-controlled (fake-treatment) study reported better thinking, while a 2025 double-blind 101-person trial found no meaningful symptom or thinking benefit.
Hyperbaric oxygen (HBOT) has conflicting randomized evidence
Do microclots mean I should take blood thinners?
No. The microclot theory doesn't show that blood thinners help Long COVID. In STIMULATE, rivaroxaban did not improve fatigue, while bleeding risk remains real.
Does HELP apheresis remove the cause?
There is no convincing randomized evidence that HELP apheresis provides net benefit for Long COVID. It's invasive, expensive and not a proven way to remove the disease.
What about BC007?
A small 30-person biomarker-selected phase IIa trial reported gains in fatigue and quality of life. That makes it interesting research, not established treatment.
What about low-dose aripiprazole?
The main ME/CFS evidence is an uncontrolled retrospective series. It cannot tell us the true benefit rate, and the medicine has meaningful adverse effects.
Should I pay for brain training?
In the largest RECOVER cognitive trial, the tested BrainHQ-based programs didn't beat the control groups. Workarounds and task-specific rehab remain easier to justify.
Treat commercial brain training skeptically · Work on daily tasks with an occupational or speech-language therapist
What can I do if I am housebound?
Spend limited capacity on essentials. Adapt self-care, use seating or mobility aids, lower sensory load, and use remote care where possible. Severe illness shouldn't be judged by trials of people who can get around.
Make necessary tasks cost less energy · Use mobility and seating aids to preserve capacity · Make light, sound and communication more manageable
Why can my tests look normal when I feel terrible?
Routine tests can rule out other important causes without measuring PEM, orthostatic intolerance or every thinking problem. Normal results don't make your limits less real.
Check whether effort causes PEM · Check what standing does to you · Document function and PEM clearly
What is most likely to waste money?
Be skeptical when a clinic sells a mechanism, proprietary test and treatment as one package. HBOT, apheresis, microclot protocols, commercial immune panels and device programs need the same controlled-outcome standard as cheaper treatments.
Hyperbaric oxygen (HBOT) has conflicting randomized evidence · Vagus stimulation is still experimental · Do not self-treat a microclot theory with blood thinners · Commercial immune protocols need controlled evidence
This Week
What to try next
Choose one task that became harder after the illness. Write what happens when you try it and how you feel later that day and over the next two days. Use the activity plan or PEM screen below if it helps you describe the problem.
Describe the problem in terms a clinician can assess.
Review one change you have tried, such as splitting a task or resting before it. Did you have fewer delayed flares, or manage an essential task more reliably? Adjust to your symptoms rather than a fixed percentage of your former activity.
Judge the change by what happens in ordinary life.
Ask one person for a specific kind of help this week: a meal, a ride or a check-in on Thursday. Explain which activities worsen your symptoms and agree on a manageable way to stay in touch.
Ask for a specific kind of help.
Activity plan
Plan your daily activities
List the activities you are considering. This checklist does not calculate a safe energy budget. Compare what you actually do with symptoms that follow, including the next day.
ACTIVITY RECORD
Daily activity plan
Choose the activities you plan to do today. Afterward, note what you actually did and how you felt in a separate diary, including symptoms that worsen the next day.
How do you feel this morning?
Resting heart rate, optional record
Body
Break up tasks that repeatedly cause delayed symptom flares and plan rest before and afterward. Use the amount of activity you can manage without a flare as a starting point.
Food
Use simple foods you can prepare or ask someone to bring: soup, eggs on toast, canned fish, rice or a sandwich. Enough food matters more than an elaborate diet. Ask for help if poor appetite or gut symptoms are causing weight loss.
Water
Drink regularly according to your needs and medical advice. If you have confirmed POTS, ask whether extra fluid or salt fits your health. Extra salt or fluid can be unsafe with some heart, kidney or blood-pressure conditions.
Environment
Reduce light, noise and interruptions when they worsen symptoms. Keep the sleeping space comfortable and discuss persistent insomnia, snoring or daytime sleepiness. No fixed room temperature or screen rule treats Long COVID.
Connection
Ask for one specific kind of help, such as a meal, grocery delivery or a ride to an appointment. Explain that long calls or busy visits may worsen symptoms, and suggest a manageable way to stay in touch.
Ask
Record activities and symptoms briefly, including delayed flares. A wearable may add information, but no heart-rate formula guarantees that an activity is safe.
Avoid
If you have PEM, avoid fixed exercise increases that ignore symptoms. Ask for an individualized plan. Treatment for coexisting stress, anxiety or depression can help those problems without replacing physical assessment.
Treatment and support
How is it treated?
Lifestyle
Pacing / Energy Envelope
Break up tasks that repeatedly cause delayed symptom flares and plan rest before and afterward. Include reading, conversation and time upright as well as physical tasks. Use what you can manage without a flare as a starting point.
Pacing adjusts activity and rest to reduce post-exertional symptom flares. The biological causes of PEM are still being studied.
Caution If activity causes delayed worsening, tell the clinician before exercise testing or rehabilitation. Avoid fixed increases regardless of symptoms.
Evidence and sources
Recommended energy-management approach in NICE NG206; the guideline does not promise recovery or specify one safe activity formula.
NICE NG206 ME/CFS guideline 2021; ME/CFS Clinician Coalition clinical management guidance
Sleep assessment and support
Ask about sleep apnea if you snore, gasp during sleep or remain very sleepy in the day. Insomnia, restless legs and medicine effects may need separate attention. Make the room comfortable and change sleep habits gradually. With severe ME/CFS, rigid wake times or restrictions on daytime rest may be unmanageable; adapt the plan to symptoms and needed rest.
Poor sleep can worsen daytime fatigue and attention. Sleep apnea, insomnia and other sleep disorders may coexist with Long COVID or ME/CFS.
Evidence and sources
Guidelines recommend assessing sleep problems and tailoring sleep advice to the person. Treating a sleep disorder may help without resolving every Long COVID symptom.
CDC ME/CFS clinical care; NICE NG188 and NG206
Manageable meals and nutrition
Use simple foods you can prepare or ask someone to bring: soup, eggs on toast, canned fish, rice or a sandwich. Enough food matters more than an elaborate diet. Ask for help if poor appetite or gut symptoms are causing weight loss.
Inadequate intake and nutritional deficiencies can add to fatigue. A varied diet supports general health but has not been shown to repair a specific Long COVID brain mechanism.
Evidence and sources
Supportive nutrition care. No single diet is an established treatment for Long COVID brain fog.
NICE NG206: dietary management and strategies
Relaxation and breathing support
Use comfortable breathing or relaxation only if it eases symptoms. Do not force breath holds, cold-water immersion or strenuous routines. Persistent breathlessness needs assessment for its cause.
Comfortable breathing may help symptoms in selected people. It has not been shown that these home practices treat Long COVID by activating an anti-inflammatory nerve pathway.
Evidence and sources
Breathing studies in other groups of people can't show what treats Long COVID. Vagus-nerve devices remain experimental for this purpose.
Balban et al., Cell Reports Medicine, 2023; DOI 10.1016/j.xcrm.2022.100895
Support for stress, loss and isolation
Choose support for an actual need, such as anxiety, grief, pain coping or isolation. A short conversation, practical help or psychological therapy may be more useful than a demanding daily routine.
Caution Keep any practice within what you can manage. Even talking, journaling or relaxation exercises may be tiring during severe illness.
Evidence and sources
Psychological and practical support can help people manage distress and daily life. This doesn't prove that stress is the cause of Long COVID.
Treat the symptoms causing the most difficulty
Agree priorities based on the symptoms and daily tasks causing the most difficulty. Assess standing symptoms, sleep disorders, pain and mood problems while accounting for any PEM.
Evidence and sources
Symptom-directed clinical care; a symptom cluster is not proof of a single biological mechanism.
Investigations
Baseline Cognitive Assessment
Ask whether a brief validated cognitive screen would be useful. Persistent daily difficulties may warrant fuller assessment even with a normal screen. A self-report questionnaire can document symptoms but not their cause.
Evidence and sources
NICE NG188 recommends a validated screening tool when new cognitive symptoms are reported.
NICE NG188 Long COVID guideline 2024 update
Orthostatic Vitals (POTS Screening)
Ask about supervised lying and standing measurements when symptoms worsen upright. Record blood pressure, heart rate and symptoms. POTS requires a sustained heart-rate pattern, compatible symptoms and exclusion of other causes; a blood-pressure drop suggests a different or additional problem.
Evidence and sources
Established assessment for orthostatic symptoms. The cited 20-patient case series does not estimate prevalence in all Long COVID.
Blitshteyn & Whitelaw, Immunol Res, 2021. DOI: 10.1007/s12026-021-09185-5. PMID: 33786700
Blood Panel
Choose tests after reviewing symptoms and examination findings. Blood counts, kidney and liver tests, thyroid function, glucose, ferritin or B12 may be useful. Broad autoimmune, cortisol or viral panels are not routine tests for everyone with brain fog.
Evidence and sources
Tests look for alternative or additional conditions; none confirms Long COVID by itself.
NICE NG188 assessment and investigations; CDC Long COVID clinical guidance
PROMIS Cognitive Function (8-item)
Evidence and sources
PROMIS Cognitive Function Short Form
This self-report scale records perceived cognitive difficulty. Use the correct version and scoring instructions if a clinician recommends it.
Moderate - validated symptom tracking instrument used in chronic-illness and rehab settings.
PSS-10 Perceived Stress Scale
Evidence and sources
PSS-10
This ten-item questionnaire records perceived stress. The score bands people often quote aren't clinical cut-offs that apply everywhere. It may help identify support needs alongside physical care.
Moderate - validated stress instrument that can help structure follow-up and support planning.
MSPSS Social Support Scale
Evidence and sources
MSPSS
This 12-item questionnaire asks about support from family, friends and a significant other. Use it to identify practical gaps, such as help with food, appointments or rest.
Moderate - validated support instrument useful when isolation is clearly worsening illness management.
Medical options
Low-Dose Naltrexone (LDN)
LDN is off-label for Long COVID and requires a prescription. Agree on the symptom being treated, dose schedule, review date and reasons to stop. Tell the prescriber about any opioid medicine: naltrexone blocks opioids and can precipitate withdrawal. Do not copy a research dose or increase it on your own.
Researchers have proposed immune and nerve-signaling effects.
Evidence and sources
A 2026 review included four before-and-after studies with 155 participants and no randomized Long COVID trial. Some symptoms improved, but without concurrent controls the studies cannot separate treatment effects from other changes. The 36-person LDN plus NAD+ pilot also cannot isolate LDN’s effect.
Low-dose naltrexone systematic review, 2026, PMID 42463201; Isman et al. 2024, PMID 38352659
Cognitive Rehabilitation / Occupational Therapy
Work on specific tasks such as reading instructions, keeping appointments or returning to work. Agree on practical goals, session length and adjustments for delayed symptom flares.
Written aids, task changes and rehearsed strategies may help daily function without proving that the underlying illness has resolved.
Evidence and sources
RECOVER-NEURO randomized 328 people and found no added benefit from its tested programs versus controls. A separate 2026 trial randomized 78 adults with measured cognitive impairment; ten individual weekly sessions improved reported attainment of personal goals at three and six months. The different programs and outcomes matter.
Knopman et al. 2025, PMID 41212544; Vanova et al. 2026, PMID 42384384
Multidisciplinary Long COVID Clinic
Ask for coordinated care or referral to the specialist suited to the symptom. Availability of dedicated Long COVID and ME/CFS services varies.
Evidence and sources
NICE recommends a coordinated assessment and management plan. A dedicated clinic is not available in every area.
NICE NG188 2024
Supplements
Coenzyme Q10 (CoQ10/Ubiquinol)
No CoQ10 dose is established for Long COVID brain fog. A trial in established post-COVID illness used high-dose CoQ10 and did not show a significant symptom benefit.
Consider the actual trial result and cost before treating CoQ10 as a recovery supplement.
CoQ10 participates in cellular energy production. That role does not by itself establish treatment benefit.
Evidence and sources
A randomized crossover trial enrolled 121 participants and compared two six-week periods. CoQ10 did not significantly improve symptom number or severity versus placebo.
Hansen et al. 2023, PMID 36337437
Creatine Monohydrate
No dose is established for treating Long COVID brain fog. Discuss use first if you have kidney disease or take medicines that affect kidney function.
Judge the evidence for the actual product and outcome, rather than claims of repairing brain energy.
Creatine supports the recycling of ATP in cells. That doesn't prove a supplement improves thinking and memory in Long COVID.
Evidence and sources
Small preliminary studies don't show a reliable cognitive benefit for Long COVID.
Ostojic, Nutrients, 2025
Magnesium, ashwagandha and L-theanine combinations
There is no established dose or tested combination for Long COVID brain fog.
Trials of individual ingredients for stress or sleep don't show that combining them treats Long COVID. Multiple new ingredients also make side effects harder to identify.
Evidence and sources
No Long COVID combination trial is cited here.
PMID 23439798 (ashwagandha stress reactivity RCT); PMID 31623400 (L-theanine cognitive function); PMID 41601871 (magnesium L-threonate, heart-rate stress marker RCT).
Butyrate (Sodium or Tributyrin)
The cited studies don't set a dose for Long COVID brain fog.
Butyrate is produced by some gut bacteria. These papers examine diet or proposed gut and brain mechanisms. They don't prove that taking sodium butyrate or tributyrin improves thinking after COVID.
Evidence and sources
The cited papers examine mechanisms or dietary associations, not an established Long COVID treatment.
PMID 40266405 (2025 butyrate gut-brain review); PMC4903954 (butyrate neuroepigenetics); PMC11985818 (2025 dietary butyrate and cognitive function)
Simple meals when preparation is difficult
Fatigue, nausea and difficulty preparing food can make it hard to eat enough.
When to use: Choose small, manageable meals or snacks if larger meals are difficult. Use foods you tolerate, and ask for help with shopping or preparation. Soup, eggs, toast, rice, canned fish and fruit are examples, not a prescribed menu.
Ask for medical or dietetic help if you are losing weight or struggling to eat or drink. Electrolyte supplements are not necessary for everyone.
A supervised low-FODMAP trial for IBS symptoms
This approach can help some people with IBS. It is not an established treatment for Long COVID itself.
When to use: With a dietitian, try low-FODMAP substitutions for 2–6 weeks. Then reintroduce FODMAP groups systematically and keep a varied long-term diet based on what you tolerate. Portion sizes matter; the Monash app can help with these.
The restrictive phase is temporary. Reintroduction helps avoid excluding foods unnecessarily.
Supportive nutrition care, not a proven disease-specific diet.
Daily Practices
Low-risk options
Pacing / energy envelope
Break up tasks that repeatedly cause delayed symptom flares and plan rest before and afterward. Include reading, conversation and time upright as well as physical tasks. Use what you can manage without a flare as a starting point.
Evidence and sources
NICE recommends individualized energy management for ME/CFS. It aims to reduce symptom flares and is not a cure.
Brief relaxation if comfortable
Try a brief comfortable relaxation method only if it helps. Stop if it causes breathlessness, dizziness or worse symptoms.
Evidence and sources
Relaxation may help distress. Humming, gargling or breathing exercises are not proven Long COVID treatments and still require effort.
Warm (not hot) bath with Epsom salts
Use a comfortable temperature and a short session if bathing helps. Avoid hot baths if heat worsens standing symptoms; use support if dizziness makes bathing unsafe.
Evidence and sources
Warmth may ease discomfort, but Epsom salts are not an established treatment for Long COVID or ME/CFS.
Discuss stress and practical support
Describe what makes care harder: money, food preparation, work, isolation or lack of help. Ask what practical or psychological support is available.
Evidence and sources
Stress and support questionnaires can organize a conversation. They do not measure the cause or severity of Long COVID.
Choose the symptom that needs attention first
List the two or three problems most affecting daily life. Use them to agree priorities for assessment and treatment.
Evidence and sources
Guidelines recommend treating the symptoms that most affect daily life and reviewing whether the plan helps.
Therapy
When therapy or coaching is actually useful here
Look for a therapist who understands Long COVID and ME/CFS. Occupational therapy can help adapt tasks, pacing and work. Psychological therapy may help with distress, grief or trauma, while continuing care for physical symptoms. Any plan should account for delayed worsening after effort.
What else can make thinking worse?
Dizziness while upright, poor sleep and medicine effects can add to thinking problems after an infection. Their timing helps decide what to assess.
- Note when thinking gets worse. Record meal times, activity, whether you were lying down, sitting or standing, and how you slept.
- Describe whether tiredness or trouble thinking starts suddenly or stays about the same all day.
- Also tell the clinician about sleep problems, symptoms while standing, anxiety and any medicine effects you have noticed.
Timing can help guide an assessment. It cannot diagnose a hormone, blood sugar or blood-flow problem by itself.
Clinical Evidence
The research at a glance
PEM changes the plan
If physical or mental activity causes delayed symptom flares, adapt activity and rest to your current limits. Tell your clinician about the delay so it is considered in testing and rehabilitation.
NICE NG188 Long COVID; NICE NG206 ME/CFS
Brain Imaging
Finding: A 2022 UK Biobank study found average imaging changes after COVID in adults aged 51–81. It doesn't show visible damage in every person with brain fog.
Douaud et al., Nature 2022. DOI 10.1038/s41586-022-04569-5
Cognitive Scores
Finding: A large 2024 community study found lower average cognitive scores in people with unresolved symptoms. Group differences do not measure an individual’s lost IQ.
Hampshire et al., NEJM 2024. PMID 38416429
Activity Guidance
Finding: NICE NG206 advises against fixed incremental exercise programs for ME/CFS and recommends individualized energy management.
NICE NG206, recommendations 1.11.2–1.11.14
What real patients keep noticing
What Helped
- Reducing a demanding activity or splitting it into shorter parts, then checking how symptoms changed over the next few days.
- Written reminders, fewer simultaneous tasks and help with appointments.
- Assessment for dizziness or palpitations while upright, rather than assuming every symptom has the same cause.
- Practical help with meals, childcare and travel so rest is possible.
What Didn't Help
- Being told to push through a delayed worsening of symptoms.
- Having persistent symptoms dismissed because routine tests were normal.
- Repeatedly paying for supplements without a clear benefit.
- Advice to rest that ignores work, caring duties or the need to earn a living.
Surprises
- Thinking clearly for a short time but being unable to sustain reading, a meeting or a conversation.
- Feeling reasonably well during an activity, then worse the next day.
- Having symptoms fluctuate for months or years despite careful attempts to manage them.
Common Mistakes
- Treating a better day as proof that the illness has gone.
- Counting exercise but overlooking the effort of work, screens, social contact and appointments.
- Using another person’s recovery story as a timetable for your own.
- Assuming a symptom diary can prove what caused a crash.
Community Tip
Start with the task that is causing the most trouble. Describe what happens during it and afterward, and ask for a specific change: a shorter meeting, written instructions, a seat or help with travel. These are recurring community experiences, not treatment-effect estimates.
Crash record
Record what happened before a crash
Save the symptoms and events before each flare. From three entries, compare the events you recorded most often.
Compare crash records
Crash activity record
After symptoms worsen, record what happened beforehand. From three saved entries, this tool counts the events you selected most often. Those counts can't prove what caused a crash or calculate a safe activity limit.
How bad is this crash?
How long since the crash started?
What happened in the hours or days before symptoms worsened? Select anything relevant. The times below are examples, not safe limits.
Anything else that might be relevant? (optional)
Which other causes need checking?
Before you assume one cause
Ask which other conditions could explain your symptoms or occur alongside Long COVID.
-
Choose tests for your symptoms
Your symptoms and examination should guide which tests to use. The checklist below gives examples of when each test may help.
Doctor Prep
How to bring this to a clinician
Opening script
Since [infection and date], I have had [thinking problems] and can no longer manage [specific tasks] as before. I want to discuss Long COVID, whether I meet ME/CFS criteria, and other treatable causes. I have noticed [describe any worsening after activity, its timing and duration, or say that you have not noticed this].
Tests to discuss
- CBC and CMP when symptoms or history warrant blood counts and metabolic checks
- TSH, B12 and ferritin when symptoms or history suggest a thyroid problem or deficiency
- HbA1c when blood sugar assessment is indicated
- Lying and standing vital signs or an active stand test for symptoms while upright
- Sleep study when symptoms suggest sleep apnea or another sleep disorder
- Cognitive assessment to document thinking difficulties
- Medication review for possible effects on thinking, sleep or fatigue
Points to raise
- Long COVID can cause symptoms in several body systems. Symptoms can stay, go away and return, or begin after the first illness seemed to end. A positive COVID test is helpful but is not required by CDC guidance.
- Post-exertional malaise means that activity causes an unusually large worsening of symptoms. Walking, showering, reading, talking, concentrating, stress, or social time can bring it on. Symptoms often worsen 12–48 hours later, but can begin sooner and last for days or longer.
- Under the US Institute of Medicine criteria, ME/CFS requires a major drop in previous activity for more than six months, post-exertional malaise, and unrefreshing sleep. The person must also have thinking problems or symptoms that become worse while upright.
- NICE uses a three-month symptom duration for an ME/CFS diagnosis in the UK. Long COVID and ME/CFS overlap, but a person with Long COVID does not automatically have ME/CFS.
- No post-exertional malaise makes ME/CFS less likely. It does not rule out Long COVID, because not everyone with Long COVID has post-exertional malaise.
- Anemia, thyroid disease, vitamin B12 deficiency, diabetes, sleep apnea, migraine, and medicine effects can cause similar symptoms. Depression, anxiety, heart or lung disease, and an abnormal response to standing may also need checking.
What to bring
- Bring a dated list of suspected or confirmed COVID infections and other infections. Include positive tests if you have them, but do not worry if testing was unavailable or negative.
- Write what you could do before the illness and what you can do now. Use real examples from work, school, reading, driving, shopping, showering, cooking, childcare, exercise, and social time.
- If you can, keep brief notes on demanding activities and how you feel later that day and over the next two days. Bring the notes you have; do not delay an appointment or cause a crash to complete a diary.
- List the symptoms that become worse together, such as brain fog, heavy fatigue, pain, sore throat, headache, poor sleep, dizziness, racing heart, breathlessness, or sound and light sensitivity.
- Bring prior blood tests, heart or lung tests, scans, sleep results, and visit notes from before and after the infection. Dates matter.
- Bring every prescription, over-the-counter medicine, supplement, inhaler, stimulant, sleep aid, antihistamine, and pain medicine. Include timing and what changed after starting it.
- If you already measure heart rate, blood pressure, oxygen, temperature, sleep, or steps, bring a short dated summary. Skip repeated testing or exercise done just to produce data.
- Bring forms or a short list of the work, school, driving, mobility, or care tasks that now need an adjustment.
Screening tools
- Long COVID is diagnosed from the infection and symptom history, examination, and tests chosen for the symptoms. CDC says a positive COVID test is not required and there is no laboratory test that can rule Long COVID in or out.
- The US Institute of Medicine criteria check for more than six months of reduced function, post-exertional malaise, unrefreshing sleep, and either thinking problems or symptoms that become worse while upright.
- NICE allows an ME/CFS diagnosis after three months when the required symptoms persist and another condition does not explain them. Ask which criteria the clinician is using.
- A short activity and symptom diary can show whether several symptoms get worse after physical, mental, emotional, or social activity. Record ordinary life only and skip any planned exercise challenge.
- Heart rate and blood pressure while lying and standing can identify an abnormal response to being upright. A clinician may use an active stand or tilt table test when the symptoms give a reason. A pulse number alone can't confirm the diagnosis; blood pressure, symptoms and medical history matter too.
- A brief thinking test can record attention, memory, language, or processing problems. Describe everyday difficulties even if the test score is normal.
- A sleep study can identify sleep apnea or another sleep disorder. Unrefreshing sleep can also occur in ME/CFS even when a sleep study does not find apnea.
When concerns are dismissed
- Treatment Not Working
Activity makes my symptoms worse after [delay]. How will the plan account for possible PEM? I understand NICE advises against fixed increases in exercise for ME/CFS.
NICE NG206 2021; NICE NG188 2024; Institute of Medicine diagnostic criteria 2015
- Test Results
I understand normal tests do not rule out Long COVID. Could we document the effect on daily life and agree what needs assessment or treatment next?
NICE NG206 2021; NICE NG188 2024; Institute of Medicine diagnostic criteria 2015
- Second Opinion
I am open to assessing depression. Could we also assess my physical symptoms, thinking problems and any worsening after activity, rather than assume one diagnosis explains everything?
NICE NG206 2021; NICE NG188 2024; Institute of Medicine diagnostic criteria 2015
Healthcare Navigation
Country-aware healthcare guidance
Healthcare guidance
CDC Long COVID and ME/CFS clinical guidance, with the 2024 National Academies Long COVID definition
- •CDC says Long COVID can be diagnosed from the history and examination. A positive COVID test is not required, and no laboratory test can prove or rule out the condition.
- •The 2024 National Academies definition describes Long COVID as a condition after SARS-CoV-2 infection that lasts at least three months. It can be continuous, come and go, or become worse over time.
- •CDC uses the Institute of Medicine ME/CFS criteria, including more than six months of reduced function. Ask the clinician to record the functional loss, post-exertional malaise, sleep, thinking, and standing symptoms.
Long COVID / ME/CFS healthcare: United States
Where people usually start, what happens next, and common access barriers
Start with primary care. Ask for a symptom-by-symptom assessment, a record of the functional loss, and referral based on the problem that needs specialist care.
If your insurance denies coverage
Tools to appeal denials (US-specific)
A template you can adapt for an appeal
Tip:Fill in the blanks with your specific scores and symptoms. Customize as needed.
Check your insurer's current policies. If the insurer doesn't reverse the denial, a patient advocate can take over the appeal. Many hospitals and disease-specific nonprofits have one on staff.
Safety considerations
Driving
ME/CFS and Long COVID can cause cognitive impairment, delayed reactions, and post-exertional worsening that may affect driving safety. If experiencing significant cognitive symptoms or crashes, avoid driving. In UK, inform DVLA if symptoms affect safe driving.
Work and occupational safety
Long COVID and ME/CFS can limit work. With PEM, symptoms often worsen 12–48 hours after physical or mental effort and can last days or weeks. Possible adjustments include shorter hours, fewer meetings, written instructions, home working and rest breaks. Review the response to a work change before adding more duties.
Pregnancy
Tell your maternity team about Long COVID or ME/CFS and review medicines, symptoms and practical support with them. Evidence about the course of these illnesses during pregnancy remains limited.
Escalation
When Should You See a Doctor for Long COVID Brain Fog?
Arrange an assessment when brain fog after COVID persists, worsens or interferes with daily life. Bring examples of what changed and any delayed symptoms after activity.
Symptoms affect everyday tasks
Ask for an assessment if concentration, memory or fatigue interferes with work, study, driving or self-care.
Your abilities are declining
Seek earlier review if you need increasing help or cannot manage food, fluids, medicines or basic care.
Another problem may be treatable
Mention snoring or breathing pauses, dizziness while standing, new headaches, medicine changes and other symptoms that may guide testing.
A new emergency symptom
Sudden weakness or speech trouble, a sudden severe headache, severe breathlessness or persistent chest pain needs urgent care.
Is Long COVID / ME/CFS Brain Fog Reversible?
Some people improve or recover, while others remain limited for years. Follow changes in daily life as well as symptom scores: fewer crashes, a longer manageable conversation or less help with self-care can all matter. Pacing aims to reduce flares; it does not guarantee recovery.
Typical timeline: Symptoms can improve, fluctuate or worsen over months and years. There is no reliable way to predict one person’s recovery date.
The symptoms and functional limitations present
Treatable coexisting conditions, including POTS, sleep disorders and migraine
Access to care and practical help with food, work and daily activities
Reinfection and other illnesses that may cause setbacks
Research Horizon
What research is exploring
Emerging studies that may change how this cause is understood or treated. Not yet clinical standard of care.
2024 Researchers study brain-wave changes after COVID
Key finding: Babiloni and colleagues studied people reporting brain fog about a year after hospitalization for COVID-19. More than 90% had no cognitive or psychiatric disorder on the study assessments, yet the group had lower alpha-wave activity in posterior brain regions than matched controls. This was a group comparison, not a test that could diagnose one person’s brain fog.
This finding concerns a small study group. It doesn't show that an EEG can diagnose the cause of one person’s brain fog. EEG for this purpose is not a routine Long COVID test.
Babiloni et al. - Clinical Neurophysiology
2024 A small study followed brain-response timing
Key finding: This study included 40 participants, some with post-COVID cognitive symptoms and some healthy controls. Researchers measured brain activity at one and eight months after recovery from the acute infection. Differences in P300 responses and beta rhythms were still present at eight months. Participants with cognitive symptoms did not differ significantly according to whether they had lost their sense of smell.
A slower average response in a study is not a measurement of your own thinking speed. The study did not test a treatment or predict how long an individual’s symptoms would last.
Gangemi, Suriano and Fabio - Journal of Integrative Neuroscience
2024 Some brain-wave findings occur in several conditions
Key finding: A 2024 review compared electrical brain measurements reported after COVID-19 with those in Alzheimer’s disease and related dementias. Some findings overlapped, including lower alpha activity. The authors discussed possible shared processes, such as inflammation and injury to blood vessels. Similar measurements do not mean that the diseases have the same cause or course.
Similar brain-wave findings don't show that Long COVID progresses to Alzheimer’s disease. These measurements are not specific enough to diagnose the cause of brain fog by themselves.
Jiang et al. - Alzheimer's & Dementia
2023 Researchers compare immune findings in Long COVID
Key finding: Klein and colleagues enrolled 275 participants and included 268 after exclusions. The study compared immune cells, antibodies and hormones in people with and without Long COVID. It found group differences, including stronger antibody responses to EBV and lower cortisol levels among participants with Long COVID. These were one-time measurements. They don't show that viral reactivation or low cortisol caused the illness.
The study identified group differences that may help future research. Antibodies, hormone levels and immune-cell patterns are not yet a validated diagnostic panel for Long COVID, and the findings do not establish which treatment an individual needs.
Klein J et al. (Iwasaki lab and Mount Sinai) - Nature
2022 Researchers investigate small fibrin clots
Key finding: Kell, Laubscher and Pretorius proposed that unusually resistant fibrin clots could contribute to Long COVID. Their 2022 paper reviews a possible mechanism rather than reporting a treatment trial. Related laboratory studies described clot and platelet abnormalities in selected patient samples. These findings still need methods that reliably distinguish illness from health and trials showing whether treatment helps.
Microclots are an active research question. A proposed mechanism or a commercial test doesn't prove that blood thinners or apheresis will help. These treatments can cause serious harm, including bleeding, and should not be started for a theory alone.
Kell DB, Laubscher GJ, Pretorius E - Biochemical Journal
2024 RECOVER-Adult Long COVID Research Index, 2024 update
Key finding: The 2024 update used data from 13,647 RECOVER-Adult participants and examined 52 symptoms, eight more than the earlier study. The revised research index classified 20% of participants with a known prior infection as likely Long COVID and 39% as possible Long COVID; 4% without a known prior infection were classified as likely. It also described five symptom groups. These percentages describe the research cohort, not population prevalence.
The index classifies participants for research. The symptom list may help prepare for a visit.
RECOVER-Adult Research Consortium - JAMA
FAQ
Questions that actually matter here
Is it this cause
How is Long COVID / ME/CFS brain fog different from sleep apnea?
Snoring, witnessed breathing pauses and daytime sleepiness suggest checking for sleep apnea. Long COVID can include delayed worsening after activity and symptoms while standing. Timing alone can't separate them, and both can occur together. Treating sleep apnea may help even when some Long COVID symptoms remain.
Clinical observation consistent with NICE NG206 ME/CFS 2021 and NICE NG188 Long COVID 2024. These timing differences come from clinical observation, not one study.
Can Long COVID / ME/CFS cause brain fog?
Yes. Both can affect attention, memory and thinking speed. They overlap but are different diagnoses. Some people with Long COVID meet ME/CFS criteria, which include post-exertional malaise, unrefreshing sleep and a lasting reduction in activity. Others have cognitive symptoms without PEM.
What does Long COVID / ME/CFS brain fog usually feel like?
You may lose words, forget instructions or need longer to follow a conversation. Some people can think clearly for a short time but become exhausted after reading or talking. Record both what is difficult and how long you can do it. If symptoms worsen later after activity, tell your clinician about that delay too.
Long COVID brain fog vs depression: how to tell
Depression can affect concentration, energy, sleep and interest in activities. A delayed flare of several symptoms after small amounts of physical or mental activity raises a separate question about PEM. Neither motivation nor a response to exercise can diagnose the cause. Depression and Long COVID can coexist and each deserves care.
How quickly can I tell whether this path is helping?
Compare symptoms and ordinary activities over time, including the day or two after demanding tasks. Look for fewer flares or a specific task you can manage more reliably. If a plan repeatedly worsens symptoms, ask for it to be adjusted rather than continuing to increase activity.
Does metformin or blood sugar overlap matter in Long COVID / ME/CFS brain fog?
Meal-related symptoms deserve assessment, but they do not by themselves prove a blood-sugar problem. Blood pressure changes after meals and diabetes are among the possibilities. Metformin studied during acute COVID to reduce later Long COVID risk is a different question from using it for established Long COVID. Do not start it for brain fog without a medical indication.
Testing
What tests should I discuss for Long COVID / ME/CFS brain fog?
No single test confirms Long COVID or ME/CFS. The history and examination guide checks for other causes and treatable problems. Depending on your symptoms, these may include blood counts, thyroid function, B12, iron, glucose, sleep testing or supervised heart-rate and blood-pressure measurements while standing. Cognitive testing can document difficulties but doesn't identify the cause by itself. Two-day exercise testing can provoke a prolonged flare and is not routine screening. Research tests of microclots, immune proteins or brain inflammation are not established diagnostic tests.
Treatment
Long COVID hit and my brain never recovered. Does anyone actually get better?
Some people improve or recover, while others remain limited for years. There is no reliable individual recovery deadline. Track changes in everyday function as well as symptoms: fewer crashes, longer manageable conversations or less help with self-care may matter. Pacing aims to reduce post-exertional flares; it does not guarantee recovery.
Clinical observation consistent with NICE NG206 ME/CFS 2021 and NICE NG188 Long COVID 2024. These timing differences come from clinical observation, not one study.
What should I try first if I think Long COVID / ME/CFS is involved?
Record when symptoms began, what you can do now compared with before the infection, and whether physical or mental activity makes symptoms worse later. The five-question PEM screen on this page can help organize part of that history. If activity causes delayed flares, reduce or break up those activities and plan rest while you arrange an assessment.
When to see a clinician
My doctor says Long COVID brain fog will resolve on its own. Should I trust that?
Improvement is possible, but no one can promise when your symptoms will resolve. Ask what supports that expectation in your case, what treatable problems have been checked, and when to review progress. A follow-up plan should include changes in daily function and what to do if symptoms worsen. Waiting for recovery should not mean going without symptom treatment or practical support.
NICE NG188: COVID-19 rapid guideline: managing the long-term effects of COVID-19
When should I bring Long COVID / ME/CFS brain fog to a clinician?
Arrange an assessment when brain fog persists, affects daily tasks or worsens after COVID. You do not need to finish a trial of pacing first. Ask sooner if you are losing the ability to work, study or care for yourself. Sudden one-sided weakness, new speech trouble, a sudden severe headache, severe breathlessness or persistent chest pain needs urgent care.
Bottom Line
Summary takeaways
- Long COVID and ME/CFS overlap but are different diagnoses.
- Record the effect of activity, including symptoms that worsen later.
- No single score, blood test or response to exercise confirms the cause of brain fog.
Supporter: I'm helping someone with Long COVID or ME/CFS
Help with the tasks that are hardest now
Ask what would make today easier and offer one specific job. Meals, errands, written instructions or shorter conversations may help without using more of the person’s limited energy.
FOR SOMEONE YOU CARE ABOUT
How to support someone with COVID or Long COVID
Help with the next few hours or days. Offer a specific task, listen to what they need and let them decide what help to accept.
Acute COVID and Long COVID need different support. The first three routes cover acute illness and treatment timing. The later routes focus on ongoing Long COVID and recovery.
They just tested positiveHelp with home care, reduce infection risk and check whether early treatment is needed.
Three places to start
Protect the shared air first
Reduce household transmission while they are still contagious.
- Try this
- Improve airflow or filtration where possible, keep distance when useful, and wear a well-fitting mask around vulnerable household members or when you must be close.
- Why
- Lowers exposure risk for other people in the home.
- Keep in mind
- Public-health recommendations change with the situation and jurisdiction, so keep the core principle while following local rules.
Read the evidence
Evidence: High: current public-health guidance
CDC: Respiratory Virus Guidance, precautions when sick
Use: Resume normal activities once symptoms improve and 24 fever-free hours pass without fever-reducing medication, then add five days of precautions.
Limit: Jurisdictional rules can differ; this package uses current CDC public-health guidance as the default acute-COVID reference.
WHO: Coronavirus disease (COVID-19)
Use: Supports ventilation, masking in appropriate contexts, symptom monitoring and urgent assessment for serious symptoms.
Limit: Country-specific public-health rules and treatment access vary.
Use the current symptom-based stay-home rule
Help them recover without forcing a fixed countdown that ignores symptoms.
- Try this
- Support staying home while acutely ill. Under current CDC guidance, normal activities resume when symptoms are improving overall and they've been fever-free for at least 24 hours without fever-reducing medicine. Five extra days of precautions follow.
- Why
- Reduces avoidable transmission while keeping the guidance current.
- Keep in mind
- Local requirements may differ. Emergency symptoms override routine stay-home rules.
Read the evidence
Evidence: High: current CDC guidance
CDC: Respiratory Virus Guidance, precautions when sick
Use: Resume normal activities once symptoms improve and 24 fever-free hours pass without fever-reducing medication, then add five days of precautions.
Limit: Jurisdictional rules can differ; this package uses current CDC public-health guidance as the default acute-COVID reference.
Screen for high-risk status early
Treatment windows are short, so waiting to see how bad it gets can lose options.
- Try this
- On day one of illness, check age, immune health and major medical conditions, then help them reach a clinician or pharmacist if risk is unclear.
- Why
- Protects access to time-sensitive treatment when appropriate.
- Keep in mind
- The supporter should arrange review, not decide eligibility alone.
Read the evidence
Evidence: High: current clinical guidance
CDC: COVID-19 outpatient treatment
Use: If they're high-risk, ask early whether antivirals could help. Nirmatrelvir/ritonavir generally starts within five days of first symptoms, and outpatient remdesivir within seven.
Limit: Eligibility, contraindications, renal/hepatic issues and drug interactions require clinical/pharmacy review.
They are high-risk or symptoms just startedHelp them contact care promptly about early antiviral treatment.
Three places to start
Ask about antiviral treatment early
Antiviral treatment for people at higher risk needs to start promptly after symptoms begin.
- Try this
- Write down when symptoms started and help them contact a clinician or pharmacist promptly. Paxlovid generally needs to start within five days; outpatient remdesivir within seven days.
- Why
- Makes time-sensitive treatment assessment easier.
- Keep in mind
- A clinician must check eligibility, medicine interactions and kidney or liver issues. The timing depends on the treatment.
Read the evidence
Evidence: High: current clinical guidance
CDC: COVID-19 outpatient treatment
Use: If they're high-risk, ask early whether antivirals could help. Nirmatrelvir/ritonavir generally starts within five days of first symptoms, and outpatient remdesivir within seven.
Limit: Eligibility, contraindications, renal/hepatic issues and drug interactions require clinical/pharmacy review.
Make medication use safer and easier
A clean medication list reduces confusion when someone is sick and cognitively overloaded.
- Try this
- Keep one up-to-date list of prescriptions, over-the-counter products and supplements, and share it with the prescribing clinician or pharmacist.
- Why
- Helps interaction checking and reduces repeated explanations.
- Keep in mind
- Ask the clinician before stopping, adding or changing prescriptions.
Read the evidence
Evidence: High for safety, practical for organization
CDC: COVID-19 outpatient treatment
Use: If they're high-risk, ask early whether antivirals could help. Nirmatrelvir/ritonavir generally starts within five days of first symptoms, and outpatient remdesivir within seven.
Limit: Eligibility, contraindications, renal/hepatic issues and drug interactions require clinical/pharmacy review.
Agree on a check-in plan
Set check times ahead, so you can spot changes without hovering.
- Try this
- Agree on set times with them, such as morning and evening, and with their clinician if they have one. At each check, look at their breathing, whether they can drink and eat, how alert they seem, and anything the clinician asked you to watch. If they use My Fog, save the checks there together to show any change when someone asks.
- Why
- Real change is easier to spot, and easier to hand to a clinician.
- Keep in mind
- If they look or feel much worse, act on that instead of waiting for the next check.
Read the evidence
Evidence: Moderate: patient-centered monitoring principle
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
CDC: COVID-19 symptoms and emergency warning signs
Use: Emergency warning signs include trouble breathing, persistent chest pain or pressure, new confusion, being unable to wake or stay awake, and pale, gray or blue skin, lips or nails.
Limit: Not an exhaustive list; obvious deterioration or other severe symptoms still require urgent assessment.
Their breathing feels worseAct on emergency symptoms and follow the clinical plan for home readings.
Three places to start
Keep emergency warning signs visible
Supporters should know when home monitoring is no longer the job.
- Try this
- Keep a short list visible: trouble breathing, persistent chest pain or pressure, new confusion, inability to wake or stay awake, or pale, gray or blue lips/skin/nail beds. When these appear, use emergency care instead of another home check.
- Why
- Reduces delay when serious deterioration occurs.
- Keep in mind
- The list is not exhaustive; any severe or alarming deterioration can justify urgent help.
Read the evidence
Evidence: High: emergency guidance
CDC: COVID-19 symptoms and emergency warning signs
Use: Emergency warning signs include trouble breathing, persistent chest pain or pressure, new confusion, being unable to wake or stay awake, and pale, gray or blue skin, lips or nails.
Limit: Not an exhaustive list; obvious deterioration or other severe symptoms still require urgent assessment.
WHO: Coronavirus disease (COVID-19)
Use: Supports ventilation, masking in appropriate contexts, symptom monitoring and urgent assessment for serious symptoms.
Limit: Country-specific public-health rules and treatment access vary.
Treat pulse oximetry as one guide, not a verdict
A device number should not overrule the person in front of you.
- Try this
- If a clinician recommended home oximeter checks, act at the numbers they set, retake surprising readings properly, and check the number against symptoms and trends.
- Why
- Uses monitoring without false reassurance or panic.
- Keep in mind
- Consumer devices have limitations, including documented measurement bias in some populations.
Read the evidence
Evidence: Moderate: safety guidance plus systematic review
FDA: Pulse oximeter limitations and accuracy
Use: Pulse oximeters aren't always accurate, and several things can change a reading. Their symptoms and overall condition matter.
Limit: A pulse oximeter can complement a clinical plan but should not be used as the sole gatekeeper for emergency care.
Systematic review of pulse oximetry accuracy and skin pigmentation
Use: Found clinically relevant measurement bias associated with skin pigmentation/ethnicity in parts of the literature.
Limit: Devices and study methods vary. In practice, read each number alongside symptoms and the clinician's instructions.
Remote monitoring for COVID-19: systematic review
Use: Remote monitoring has been used to support home care and escalation pathways.
Limit: Programs vary in staffing, devices and thresholds; it does not make any single home measurement definitive.
Home oxygen needs a prescription
Buying an oxygen concentrator isn't a substitute for assessment.
- Try this
- With an oxygen prescription, help follow it and the equipment instructions. Do not choose a flow rate or start oxygen independently.
- Why
- Avoids unsafe under-treatment, over-treatment and delayed emergency care.
- Keep in mind
- Severe breathlessness or other emergency signs need urgent evaluation even if oxygen equipment is available.
Read the evidence
Evidence: High: FDA safety guidance
FDA: Home oxygen concentrator safety
Use: Warns against using oxygen concentrators without a prescription and notes that incorrect oxygen use can be harmful.
Limit: Prescribed home oxygen and emergency oxygen use are separate clinical contexts.
CDC: COVID-19 symptoms and emergency warning signs
Use: Emergency warning signs include trouble breathing, persistent chest pain or pressure, new confusion, being unable to wake or stay awake, and pale, gray or blue skin, lips or nails.
Limit: Not an exhaustive list; obvious deterioration or other severe symptoms still require urgent assessment.
I cannot be there in personRemote help should remove work, not add another call to answer.
Three places to start
Make remote support remove work
Checking in is more useful when it takes work off the person instead of adding another conversation.
- Try this
- Check in at set times, use contactless deliveries, pick up prescriptions, and agree on one place for clinician questions and one person to update family.
- Why
- Reduces repeated explanations and admin.
- Keep in mind
- Remote support doesn't replace urgent clinical assessment when deterioration occurs.
Read the evidence
Evidence: Moderate: remote-monitoring evidence plus practical coordination
Remote monitoring for COVID-19: systematic review
Use: Remote monitoring has been used to support home care and escalation pathways.
Limit: Programs vary in staffing, devices and thresholds; it does not make any single home measurement definitive.
CDC: Respiratory Virus Guidance, precautions when sick
Use: Resume normal activities once symptoms improve and 24 fever-free hours pass without fever-reducing medication, then add five days of precautions.
Limit: Jurisdictional rules can differ; this package uses current CDC public-health guidance as the default acute-COVID reference.
Make ordinary home care easier
The most useful help is often food, fluids, rest and logistics, not more instructions.
- Try this
- Put drinks, simple food, tissues, medicines, chargers and other basics within easy reach, and take over one practical task.
- Why
- Reduces the work of being sick.
- Keep in mind
- Seek clinical advice when symptoms worsen or home care is no longer enough.
Read the evidence
Evidence: Moderate: supportive-care guidance
NHS: COVID-19 symptoms and what to do
Use: Supports rest, fluids, appropriate symptom relief and seeking help when symptoms are concerning or worsening.
Limit: UK-specific public guidance; this package uses it as supportive rather than normative for U.S. treatment timing.
CDC: COVID-19 outpatient treatment
Use: If they're high-risk, ask early whether antivirals could help. Nirmatrelvir/ritonavir generally starts within five days of first symptoms, and outpatient remdesivir within seven.
Limit: Eligibility, contraindications, renal/hepatic issues and drug interactions require clinical/pharmacy review.
Agree on a check-in plan
Set check times ahead, so you can spot changes without hovering.
- Try this
- Agree on set times with them, such as morning and evening, and with their clinician if they have one. At each check, look at their breathing, whether they can drink and eat, how alert they seem, and anything the clinician asked you to watch. If they use My Fog, save the checks there together to show any change when someone asks.
- Why
- Real change is easier to spot, and easier to hand to a clinician.
- Keep in mind
- If they look or feel much worse, act on that instead of waiting for the next check.
Read the evidence
Evidence: Moderate: patient-centered monitoring principle
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
CDC: COVID-19 symptoms and emergency warning signs
Use: Emergency warning signs include trouble breathing, persistent chest pain or pressure, new confusion, being unable to wake or stay awake, and pale, gray or blue skin, lips or nails.
Limit: Not an exhaustive list; obvious deterioration or other severe symptoms still require urgent assessment.
Food, fluids or medicines are slippingPut essentials within reach and offer to handle one practical task.
Three places to start
Make ordinary home care easier
The most useful help is often food, fluids, rest and logistics, not more instructions.
- Try this
- Put drinks, simple food, tissues, medicines, chargers and other basics within easy reach, and take over one practical task.
- Why
- Reduces the work of being sick.
- Keep in mind
- Seek clinical advice when symptoms worsen or home care is no longer enough.
Read the evidence
Evidence: Moderate: supportive-care guidance
NHS: COVID-19 symptoms and what to do
Use: Supports rest, fluids, appropriate symptom relief and seeking help when symptoms are concerning or worsening.
Limit: UK-specific public guidance; this package uses it as supportive rather than normative for U.S. treatment timing.
CDC: COVID-19 outpatient treatment
Use: If they're high-risk, ask early whether antivirals could help. Nirmatrelvir/ritonavir generally starts within five days of first symptoms, and outpatient remdesivir within seven.
Limit: Eligibility, contraindications, renal/hepatic issues and drug interactions require clinical/pharmacy review.
Make medication use safer and easier
A clean medication list reduces confusion when someone is sick and cognitively overloaded.
- Try this
- Keep one up-to-date list of prescriptions, over-the-counter products and supplements, and share it with the prescribing clinician or pharmacist.
- Why
- Helps interaction checking and reduces repeated explanations.
- Keep in mind
- Ask the clinician before stopping, adding or changing prescriptions.
Read the evidence
Evidence: High for safety, practical for organization
CDC: COVID-19 outpatient treatment
Use: If they're high-risk, ask early whether antivirals could help. Nirmatrelvir/ritonavir generally starts within five days of first symptoms, and outpatient remdesivir within seven.
Limit: Eligibility, contraindications, renal/hepatic issues and drug interactions require clinical/pharmacy review.
Offer to handle one practical task
“What can I do?” can be harder to answer than a specific offer.
- Try this
- Offer one clear task, such as groceries, pharmacy pickup, benefits paperwork, rides, organizing meals, childcare or booking appointments.
- Why
- Immediate reduction in cognitive and physical load.
- Keep in mind
- Get consent before handling private information or finances.
Read the evidence
Evidence: High for the problem, practical for the intervention
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
CDC: Long COVID resources
Use: Provides workplace, school, disability, caregiver and support-resource links.
Limit: A resource hub, not intervention evidence.
Reddit community: caregiver support
Use: Used to identify themes around concrete relief, respite and supporter overload.
Limit: Community material is question discovery only.
Activity keeps making them crashHelp reduce activities that leave them worse later.
Three places to start
Recognize post-exertional worsening
A delayed crash changes how you should support activity.
- Try this
- If activity reliably leaves them worse a day or two later, stop treating “do a little more” as the default. Take optional demands off them and let them stay inside what they can manage.
- Why
- Can reduce boom-bust cycles and show clinicians the activity-crash link.
- Keep in mind
- Pacing is not permanent bed rest, and not every tired person has PEM.
Read the evidence
Evidence: High for PEM recognition, moderate for supporter tactics
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
Offer to handle one practical task
“What can I do?” can be harder to answer than a specific offer.
- Try this
- Offer one clear task, such as groceries, pharmacy pickup, benefits paperwork, rides, organizing meals, childcare or booking appointments.
- Why
- Immediate reduction in cognitive and physical load.
- Keep in mind
- Get consent before handling private information or finances.
Read the evidence
Evidence: High for the problem, practical for the intervention
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
CDC: Long COVID resources
Use: Provides workplace, school, disability, caregiver and support-resource links.
Limit: A resource hub, not intervention evidence.
Reddit community: caregiver support
Use: Used to identify themes around concrete relief, respite and supporter overload.
Limit: Community material is question discovery only.
Make conversations and tasks easier to follow
A conversation or a form can be exhausting when someone has trouble concentrating or remembering.
- Try this
- Ask one question at a time. With their agreement, write down decisions and the next step so they do not have to remember everything.
- Why
- Leaves less information to remember at once.
- Keep in mind
- New confusion is different from familiar brain fog and can be an emergency sign.
Read the evidence
Evidence: Practical consensus grounded in recognized cognitive impairment
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
They are foggy, overwhelmed or forgetfulWrite things down, offer one choice at a time and help with practical tasks.
Three places to start
Make conversations and tasks easier to follow
A conversation or a form can be exhausting when someone has trouble concentrating or remembering.
- Try this
- Ask one question at a time. With their agreement, write down decisions and the next step so they do not have to remember everything.
- Why
- Leaves less information to remember at once.
- Keep in mind
- New confusion is different from familiar brain fog and can be an emergency sign.
Read the evidence
Evidence: Practical consensus grounded in recognized cognitive impairment
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
Believe first, problem-solve second
Repeatedly proving the illness is its own cognitive and emotional burden.
- Try this
- Start with “I believe you.” Then ask whether they want listening, practical help, company or problem-solving.
- Why
- Builds trust and reduces the cost of being disbelieved.
- Keep in mind
- Validation doesn't mean assuming Long COVID causes every new symptom.
Read the evidence
Evidence: High consensus; community used only for tone
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
Reddit thread: not wanting pity with Long COVID
Use: Used to refine tone toward respect, autonomy and specific help rather than pity.
Limit: Anecdotal lived experience, not efficacy evidence.
Offer to handle one practical task
“What can I do?” can be harder to answer than a specific offer.
- Try this
- Offer one clear task, such as groceries, pharmacy pickup, benefits paperwork, rides, organizing meals, childcare or booking appointments.
- Why
- Immediate reduction in cognitive and physical load.
- Keep in mind
- Get consent before handling private information or finances.
Read the evidence
Evidence: High for the problem, practical for the intervention
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
CDC: Long COVID resources
Use: Provides workplace, school, disability, caregiver and support-resource links.
Limit: A resource hub, not intervention evidence.
Reddit community: caregiver support
Use: Used to identify themes around concrete relief, respite and supporter overload.
Limit: Community material is question discovery only.
Work or school is becoming impossibleDescribe the task they cannot manage and ask for a specific adjustment.
Three places to start
Help with work or school only with permission
Functional limits are easier to communicate when they are concrete.
- Try this
- Help draft a short request for what they need, like shorter hours, remote work, fewer meetings, rest breaks or flexible deadlines. Keep medical details brief.
- Why
- Can reduce work/school load and preserve participation.
- Keep in mind
- Rights and processes vary by jurisdiction.
Read the evidence
Evidence: High for functional impact; accommodations individualized
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
CDC: Long COVID resources
Use: Provides workplace, school, disability, caregiver and support-resource links.
Limit: A resource hub, not intervention evidence.
Offer to handle one practical task
“What can I do?” can be harder to answer than a specific offer.
- Try this
- Offer one clear task, such as groceries, pharmacy pickup, benefits paperwork, rides, organizing meals, childcare or booking appointments.
- Why
- Immediate reduction in cognitive and physical load.
- Keep in mind
- Get consent before handling private information or finances.
Read the evidence
Evidence: High for the problem, practical for the intervention
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
CDC: Long COVID resources
Use: Provides workplace, school, disability, caregiver and support-resource links.
Limit: A resource hub, not intervention evidence.
Reddit community: caregiver support
Use: Used to identify themes around concrete relief, respite and supporter overload.
Limit: Community material is question discovery only.
Recognize post-exertional worsening
A delayed crash changes how you should support activity.
- Try this
- If activity reliably leaves them worse a day or two later, stop treating “do a little more” as the default. Take optional demands off them and let them stay inside what they can manage.
- Why
- Can reduce boom-bust cycles and show clinicians the activity-crash link.
- Keep in mind
- Pacing is not permanent bed rest, and not every tired person has PEM.
Read the evidence
Evidence: High for PEM recognition, moderate for supporter tactics
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
They are frightened, lonely or emotionally exhaustedListen and stay in touch without expecting a long conversation or a quick reply.
Three places to start
Believe first, problem-solve second
Repeatedly proving the illness is its own cognitive and emotional burden.
- Try this
- Start with “I believe you.” Then ask whether they want listening, practical help, company or problem-solving.
- Why
- Builds trust and reduces the cost of being disbelieved.
- Keep in mind
- Validation doesn't mean assuming Long COVID causes every new symptom.
Read the evidence
Evidence: High consensus; community used only for tone
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
Reddit thread: not wanting pity with Long COVID
Use: Used to refine tone toward respect, autonomy and specific help rather than pity.
Limit: Anecdotal lived experience, not efficacy evidence.
Support their mental health and take physical symptoms seriously
Distress can coexist with a physical post-viral illness.
- Try this
- Ask how they're coping and stay in touch. If distress turns unsafe or overwhelming, help them reach mental-health or crisis support. Keep taking the physical symptoms seriously.
- Why
- Supports emotional safety without dismissing the illness.
- Keep in mind
- Getting mental-health care doesn't mean Long COVID is “just anxiety.”
Read the evidence
Evidence: Moderate/consensus
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
SAMHSA: Coping tips after disasters and traumatic events
Use: Supports practical and professional support when distress becomes difficult to manage.
Limit: General mental-health guidance.
Make remote support remove work
Checking in is more useful when it takes work off the person instead of adding another conversation.
- Try this
- Check in at set times, use contactless deliveries, pick up prescriptions, and agree on one place for clinician questions and one person to update family.
- Why
- Reduces repeated explanations and admin.
- Keep in mind
- Remote support doesn't replace urgent clinical assessment when deterioration occurs.
Read the evidence
Evidence: Moderate: remote-monitoring evidence plus practical coordination
Remote monitoring for COVID-19: systematic review
Use: Remote monitoring has been used to support home care and escalation pathways.
Limit: Programs vary in staffing, devices and thresholds; it does not make any single home measurement definitive.
CDC: Respiratory Virus Guidance, precautions when sick
Use: Resume normal activities once symptoms improve and 24 fever-free hours pass without fever-reducing medication, then add five days of precautions.
Limit: Jurisdictional rules can differ; this package uses current CDC public-health guidance as the default acute-COVID reference.
I am getting exhausted tooSupport works better when one person is not carrying everything.
Three places to start
Get real relief for the supporter too
One person may struggle to manage every task, night and decision. Arrange backup before you reach that point.
- Try this
- Hand one regular task to another person or service. Protect some time off, and use peer or mental-health support if needed.
- Why
- Makes support more sustainable.
- Keep in mind
- The ill person shouldn’t have to manage the supporter’s distress.
Read the evidence
Evidence: Moderate/practical; community used only for question discovery
CDC: Long COVID resources
Use: Provides workplace, school, disability, caregiver and support-resource links.
Limit: A resource hub, not intervention evidence.
Reddit community: caregiver support
Use: Used to identify themes around concrete relief, respite and supporter overload.
Limit: Community material is question discovery only.
Reddit thread: watching someone you love suffer from Long COVID
Use: Used only to identify caregiver burden and relationship questions.
Limit: Anecdotal lived experience, not efficacy evidence.
Offer to handle one practical task
“What can I do?” can be harder to answer than a specific offer.
- Try this
- Offer one clear task, such as groceries, pharmacy pickup, benefits paperwork, rides, organizing meals, childcare or booking appointments.
- Why
- Immediate reduction in cognitive and physical load.
- Keep in mind
- Get consent before handling private information or finances.
Read the evidence
Evidence: High for the problem, practical for the intervention
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
CDC: Long COVID resources
Use: Provides workplace, school, disability, caregiver and support-resource links.
Limit: A resource hub, not intervention evidence.
Reddit community: caregiver support
Use: Used to identify themes around concrete relief, respite and supporter overload.
Limit: Community material is question discovery only.
Believe first, problem-solve second
Repeatedly proving the illness is its own cognitive and emotional burden.
- Try this
- Start with “I believe you.” Then ask whether they want listening, practical help, company or problem-solving.
- Why
- Builds trust and reduces the cost of being disbelieved.
- Keep in mind
- Validation doesn't mean assuming Long COVID causes every new symptom.
Read the evidence
Evidence: High consensus; community used only for tone
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
Reddit thread: not wanting pity with Long COVID
Use: Used to refine tone toward respect, autonomy and specific help rather than pity.
Limit: Anecdotal lived experience, not efficacy evidence.
See every support option 19
No matching support option.
Protect the shared air first
Reduce household transmission while they are still contagious.
- Try this
- Improve airflow or filtration where possible, keep distance when useful, and wear a well-fitting mask around vulnerable household members or when you must be close.
- Why
- Lowers exposure risk for other people in the home.
- Keep in mind
- Public-health recommendations change with the situation and jurisdiction, so keep the core principle while following local rules.
Read the evidence
Evidence: High: current public-health guidance
CDC: Respiratory Virus Guidance, precautions when sick
Use: Resume normal activities once symptoms improve and 24 fever-free hours pass without fever-reducing medication, then add five days of precautions.
Limit: Jurisdictional rules can differ; this package uses current CDC public-health guidance as the default acute-COVID reference.
WHO: Coronavirus disease (COVID-19)
Use: Supports ventilation, masking in appropriate contexts, symptom monitoring and urgent assessment for serious symptoms.
Limit: Country-specific public-health rules and treatment access vary.
Use the current symptom-based stay-home rule
Help them recover without forcing a fixed countdown that ignores symptoms.
- Try this
- Support staying home while acutely ill. Under current CDC guidance, normal activities resume when symptoms are improving overall and they've been fever-free for at least 24 hours without fever-reducing medicine. Five extra days of precautions follow.
- Why
- Reduces avoidable transmission while keeping the guidance current.
- Keep in mind
- Local requirements may differ. Emergency symptoms override routine stay-home rules.
Read the evidence
Evidence: High: current CDC guidance
CDC: Respiratory Virus Guidance, precautions when sick
Use: Resume normal activities once symptoms improve and 24 fever-free hours pass without fever-reducing medication, then add five days of precautions.
Limit: Jurisdictional rules can differ; this package uses current CDC public-health guidance as the default acute-COVID reference.
Screen for high-risk status early
Treatment windows are short, so waiting to see how bad it gets can lose options.
- Try this
- On day one of illness, check age, immune health and major medical conditions, then help them reach a clinician or pharmacist if risk is unclear.
- Why
- Protects access to time-sensitive treatment when appropriate.
- Keep in mind
- The supporter should arrange review, not decide eligibility alone.
Read the evidence
Evidence: High: current clinical guidance
CDC: COVID-19 outpatient treatment
Use: If they're high-risk, ask early whether antivirals could help. Nirmatrelvir/ritonavir generally starts within five days of first symptoms, and outpatient remdesivir within seven.
Limit: Eligibility, contraindications, renal/hepatic issues and drug interactions require clinical/pharmacy review.
Ask about antiviral treatment early
Antiviral treatment for people at higher risk needs to start promptly after symptoms begin.
- Try this
- Write down when symptoms started and help them contact a clinician or pharmacist promptly. Paxlovid generally needs to start within five days; outpatient remdesivir within seven days.
- Why
- Makes time-sensitive treatment assessment easier.
- Keep in mind
- A clinician must check eligibility, medicine interactions and kidney or liver issues. The timing depends on the treatment.
Read the evidence
Evidence: High: current clinical guidance
CDC: COVID-19 outpatient treatment
Use: If they're high-risk, ask early whether antivirals could help. Nirmatrelvir/ritonavir generally starts within five days of first symptoms, and outpatient remdesivir within seven.
Limit: Eligibility, contraindications, renal/hepatic issues and drug interactions require clinical/pharmacy review.
Make medication use safer and easier
A clean medication list reduces confusion when someone is sick and cognitively overloaded.
- Try this
- Keep one up-to-date list of prescriptions, over-the-counter products and supplements, and share it with the prescribing clinician or pharmacist.
- Why
- Helps interaction checking and reduces repeated explanations.
- Keep in mind
- Ask the clinician before stopping, adding or changing prescriptions.
Read the evidence
Evidence: High for safety, practical for organization
CDC: COVID-19 outpatient treatment
Use: If they're high-risk, ask early whether antivirals could help. Nirmatrelvir/ritonavir generally starts within five days of first symptoms, and outpatient remdesivir within seven.
Limit: Eligibility, contraindications, renal/hepatic issues and drug interactions require clinical/pharmacy review.
Agree on a check-in plan
Set check times ahead, so you can spot changes without hovering.
- Try this
- Agree on set times with them, such as morning and evening, and with their clinician if they have one. At each check, look at their breathing, whether they can drink and eat, how alert they seem, and anything the clinician asked you to watch. If they use My Fog, save the checks there together to show any change when someone asks.
- Why
- Real change is easier to spot, and easier to hand to a clinician.
- Keep in mind
- If they look or feel much worse, act on that instead of waiting for the next check.
Read the evidence
Evidence: Moderate: patient-centered monitoring principle
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
CDC: COVID-19 symptoms and emergency warning signs
Use: Emergency warning signs include trouble breathing, persistent chest pain or pressure, new confusion, being unable to wake or stay awake, and pale, gray or blue skin, lips or nails.
Limit: Not an exhaustive list; obvious deterioration or other severe symptoms still require urgent assessment.
Keep emergency warning signs visible
Supporters should know when home monitoring is no longer the job.
- Try this
- Keep a short list visible: trouble breathing, persistent chest pain or pressure, new confusion, inability to wake or stay awake, or pale, gray or blue lips/skin/nail beds. When these appear, use emergency care instead of another home check.
- Why
- Reduces delay when serious deterioration occurs.
- Keep in mind
- The list is not exhaustive; any severe or alarming deterioration can justify urgent help.
Read the evidence
Evidence: High: emergency guidance
CDC: COVID-19 symptoms and emergency warning signs
Use: Emergency warning signs include trouble breathing, persistent chest pain or pressure, new confusion, being unable to wake or stay awake, and pale, gray or blue skin, lips or nails.
Limit: Not an exhaustive list; obvious deterioration or other severe symptoms still require urgent assessment.
WHO: Coronavirus disease (COVID-19)
Use: Supports ventilation, masking in appropriate contexts, symptom monitoring and urgent assessment for serious symptoms.
Limit: Country-specific public-health rules and treatment access vary.
Treat pulse oximetry as one guide, not a verdict
A device number should not overrule the person in front of you.
- Try this
- If a clinician recommended home oximeter checks, act at the numbers they set, retake surprising readings properly, and check the number against symptoms and trends.
- Why
- Uses monitoring without false reassurance or panic.
- Keep in mind
- Consumer devices have limitations, including documented measurement bias in some populations.
Read the evidence
Evidence: Moderate: safety guidance plus systematic review
FDA: Pulse oximeter limitations and accuracy
Use: Pulse oximeters aren't always accurate, and several things can change a reading. Their symptoms and overall condition matter.
Limit: A pulse oximeter can complement a clinical plan but should not be used as the sole gatekeeper for emergency care.
Systematic review of pulse oximetry accuracy and skin pigmentation
Use: Found clinically relevant measurement bias associated with skin pigmentation/ethnicity in parts of the literature.
Limit: Devices and study methods vary. In practice, read each number alongside symptoms and the clinician's instructions.
Remote monitoring for COVID-19: systematic review
Use: Remote monitoring has been used to support home care and escalation pathways.
Limit: Programs vary in staffing, devices and thresholds; it does not make any single home measurement definitive.
Home oxygen needs a prescription
Buying an oxygen concentrator isn't a substitute for assessment.
- Try this
- With an oxygen prescription, help follow it and the equipment instructions. Do not choose a flow rate or start oxygen independently.
- Why
- Avoids unsafe under-treatment, over-treatment and delayed emergency care.
- Keep in mind
- Severe breathlessness or other emergency signs need urgent evaluation even if oxygen equipment is available.
Read the evidence
Evidence: High: FDA safety guidance
FDA: Home oxygen concentrator safety
Use: Warns against using oxygen concentrators without a prescription and notes that incorrect oxygen use can be harmful.
Limit: Prescribed home oxygen and emergency oxygen use are separate clinical contexts.
CDC: COVID-19 symptoms and emergency warning signs
Use: Emergency warning signs include trouble breathing, persistent chest pain or pressure, new confusion, being unable to wake or stay awake, and pale, gray or blue skin, lips or nails.
Limit: Not an exhaustive list; obvious deterioration or other severe symptoms still require urgent assessment.
Make ordinary home care easier
The most useful help is often food, fluids, rest and logistics, not more instructions.
- Try this
- Put drinks, simple food, tissues, medicines, chargers and other basics within easy reach, and take over one practical task.
- Why
- Reduces the work of being sick.
- Keep in mind
- Seek clinical advice when symptoms worsen or home care is no longer enough.
Read the evidence
Evidence: Moderate: supportive-care guidance
NHS: COVID-19 symptoms and what to do
Use: Supports rest, fluids, appropriate symptom relief and seeking help when symptoms are concerning or worsening.
Limit: UK-specific public guidance; this package uses it as supportive rather than normative for U.S. treatment timing.
CDC: COVID-19 outpatient treatment
Use: If they're high-risk, ask early whether antivirals could help. Nirmatrelvir/ritonavir generally starts within five days of first symptoms, and outpatient remdesivir within seven.
Limit: Eligibility, contraindications, renal/hepatic issues and drug interactions require clinical/pharmacy review.
Make remote support remove work
Checking in is more useful when it takes work off the person instead of adding another conversation.
- Try this
- Check in at set times, use contactless deliveries, pick up prescriptions, and agree on one place for clinician questions and one person to update family.
- Why
- Reduces repeated explanations and admin.
- Keep in mind
- Remote support doesn't replace urgent clinical assessment when deterioration occurs.
Read the evidence
Evidence: Moderate: remote-monitoring evidence plus practical coordination
Remote monitoring for COVID-19: systematic review
Use: Remote monitoring has been used to support home care and escalation pathways.
Limit: Programs vary in staffing, devices and thresholds; it does not make any single home measurement definitive.
CDC: Respiratory Virus Guidance, precautions when sick
Use: Resume normal activities once symptoms improve and 24 fever-free hours pass without fever-reducing medication, then add five days of precautions.
Limit: Jurisdictional rules can differ; this package uses current CDC public-health guidance as the default acute-COVID reference.
Recognize post-exertional worsening
A delayed crash changes how you should support activity.
- Try this
- If activity reliably leaves them worse a day or two later, stop treating “do a little more” as the default. Take optional demands off them and let them stay inside what they can manage.
- Why
- Can reduce boom-bust cycles and show clinicians the activity-crash link.
- Keep in mind
- Pacing is not permanent bed rest, and not every tired person has PEM.
Read the evidence
Evidence: High for PEM recognition, moderate for supporter tactics
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
Make conversations and tasks easier to follow
A conversation or a form can be exhausting when someone has trouble concentrating or remembering.
- Try this
- Ask one question at a time. With their agreement, write down decisions and the next step so they do not have to remember everything.
- Why
- Leaves less information to remember at once.
- Keep in mind
- New confusion is different from familiar brain fog and can be an emergency sign.
Read the evidence
Evidence: Practical consensus grounded in recognized cognitive impairment
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
Believe first, problem-solve second
Repeatedly proving the illness is its own cognitive and emotional burden.
- Try this
- Start with “I believe you.” Then ask whether they want listening, practical help, company or problem-solving.
- Why
- Builds trust and reduces the cost of being disbelieved.
- Keep in mind
- Validation doesn't mean assuming Long COVID causes every new symptom.
Read the evidence
Evidence: High consensus; community used only for tone
CDC: Long COVID clinical guidance
Use: Recognizes fluctuating multisystem illness, cognitive symptoms and post-exertional malaise, and recommends patient-centered symptom/function management.
Limit: Long COVID is heterogeneous and no single management strategy fits every phenotype.
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
Reddit thread: not wanting pity with Long COVID
Use: Used to refine tone toward respect, autonomy and specific help rather than pity.
Limit: Anecdotal lived experience, not efficacy evidence.
Support their mental health and take physical symptoms seriously
Distress can coexist with a physical post-viral illness.
- Try this
- Ask how they're coping and stay in touch. If distress turns unsafe or overwhelming, help them reach mental-health or crisis support. Keep taking the physical symptoms seriously.
- Why
- Supports emotional safety without dismissing the illness.
- Keep in mind
- Getting mental-health care doesn't mean Long COVID is “just anxiety.”
Read the evidence
Evidence: Moderate/consensus
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
SAMHSA: Coping tips after disasters and traumatic events
Use: Supports practical and professional support when distress becomes difficult to manage.
Limit: General mental-health guidance.
Help with work or school only with permission
Functional limits are easier to communicate when they are concrete.
- Try this
- Help draft a short request for what they need, like shorter hours, remote work, fewer meetings, rest breaks or flexible deadlines. Keep medical details brief.
- Why
- Can reduce work/school load and preserve participation.
- Keep in mind
- Rights and processes vary by jurisdiction.
Read the evidence
Evidence: High for functional impact; accommodations individualized
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
CDC: Long COVID resources
Use: Provides workplace, school, disability, caregiver and support-resource links.
Limit: A resource hub, not intervention evidence.
Offer to handle one practical task
“What can I do?” can be harder to answer than a specific offer.
- Try this
- Offer one clear task, such as groceries, pharmacy pickup, benefits paperwork, rides, organizing meals, childcare or booking appointments.
- Why
- Immediate reduction in cognitive and physical load.
- Keep in mind
- Get consent before handling private information or finances.
Read the evidence
Evidence: High for the problem, practical for the intervention
CDC: Living with Long COVID
Use: This CDC page stresses believing the person, helping with daily tasks, tracking symptoms, and how Long COVID affects work, school, relationships and money.
Limit: Support guidance doesn't show that a specific treatment works.
CDC: Long COVID resources
Use: Provides workplace, school, disability, caregiver and support-resource links.
Limit: A resource hub, not intervention evidence.
Reddit community: caregiver support
Use: Used to identify themes around concrete relief, respite and supporter overload.
Limit: Community material is question discovery only.
Stay after the immediate crisis
Bereavement support often disappears after the first wave of attention.
- Try this
- Keep contact going, offer specific practical help, remember significant dates, and help find grief counseling or peer support if wanted.
- Why
- Reduces isolation after COVID-related loss.
- Keep in mind
- Grief does not follow one timetable.
Read the evidence
Evidence: Moderate/consensus
SAMHSA: Coping with bereavement and grief
Use: Lists counseling, peer support and grief groups among options for bereavement support.
Limit: Grief support should fit the person and culture; it is not a Long COVID treatment.
Get real relief for the supporter too
One person may struggle to manage every task, night and decision. Arrange backup before you reach that point.
- Try this
- Hand one regular task to another person or service. Protect some time off, and use peer or mental-health support if needed.
- Why
- Makes support more sustainable.
- Keep in mind
- The ill person shouldn’t have to manage the supporter’s distress.
Read the evidence
Evidence: Moderate/practical; community used only for question discovery
CDC: Long COVID resources
Use: Provides workplace, school, disability, caregiver and support-resource links.
Limit: A resource hub, not intervention evidence.
Reddit community: caregiver support
Use: Used to identify themes around concrete relief, respite and supporter overload.
Limit: Community material is question discovery only.
Reddit thread: watching someone you love suffer from Long COVID
Use: Used only to identify caregiver burden and relationship questions.
Limit: Anecdotal lived experience, not efficacy evidence.
What helps, and what can backfire
| Common response | Why it can backfire | Try instead |
|---|---|---|
| “You look fine.” | Makes the person prove an invisible illness before receiving help. | “I believe you. What costs the most energy today?” |
| “Try to do a little more every day.” | Can worsen boom-bust cycles when PEM is present. | Judge activity by the delayed response and protect recovery after demanding days. |
| Ask several questions at once | Makes it harder to remember each question and answer it. | One question at a time, then say the plan back to them. |
| Watch the pulse oximeter constantly | Creates false reassurance or panic around an imperfect device. | Use clinician thresholds, trends and symptoms together. |
| “Just rest until you are cured.” | Can delay assessment of symptoms that have treatment options. | Help reduce demanding tasks and arrange follow-up for continuing or changing symptoms. |
| Do everything for them | Can erase autonomy and make the supporter indispensable. | Offer one concrete task and get permission before taking over more. |
| Push them to socialize | Uses limited capacity on reassurance for other people. | Keep contact low-demand and let plans stay cancellable. |
| Assume every new symptom is Long COVID | Risks missing reinfection or another treatable condition. | Treat major new or changing symptoms as new information that may need reassessment. |
| “Your tests are normal.” | Normal routine tests do not rule out Long COVID or explain every symptom. | Ask what the results rule out and what the next step is for the remaining symptoms. |
| Carry all care alone | Creates a fragile support system and caregiver burnout. | Build backup and move recurring tasks to other people or services. |
Questions supporters actually ask
What do I say right after they test positive?
Keep the next few hours simple: shared-air precautions, basic home care and a quick check for time-sensitive treatment eligibility.
Protect the shared air first · Screen for high-risk status early
How do I bring up antiviral treatment without frightening them?
Frame it as a time-window question: “Some treatments have to start early. Want me to help check whether one fits you?”
Ask about antiviral treatment early · Screen for high-risk status early
Should I tell them to exercise so they do not get deconditioned?
Not automatically. If activity causes a delayed crash, increasing activity can be the wrong goal.
They are resting constantly. Am I enabling them?
Rest during acute illness is ordinary care. In Long COVID, judge activity by what it does later, not by whether rest looks excessive.
Make ordinary home care easier · Recognize post-exertional worsening
What if the pulse oximeter scares us?
Follow the clinician’s threshold and the person’s symptoms. Unexpected readings deserve context and repeat measurement, but emergency symptoms should not wait on the device.
Treat pulse oximetry as one guide, not a verdict · Keep emergency warning signs visible
Should I buy an oxygen concentrator just in case?
No. Oxygen should follow a prescription and clinical plan.
How long do they have to isolate or stay home?
Current CDC guidance is symptom-based, followed by five days of additional precautions after resuming normal activities. Local rules can differ.
How do I help with brain fog without treating them like a child?
Offer written information, fewer choices and help with one task, then let them decide what support they want.
Make conversations and tasks easier to follow · Offer to handle one practical task
What do I say when doctors or relatives have made them feel disbelieved?
Start with “I believe you.” Validation reduces the burden of having to prove the illness before receiving help.
What if they keep cancelling plans?
Keep contact flexible and low-demand. Cancelling can be symptom management, not rejection.
Believe first, problem-solve second · Make remote support remove work
What can I do from another city?
Own one recurring job such as groceries, medication delivery, appointment reminders or family updates.
Make remote support remove work · Offer to handle one practical task
Should I contact their employer?
Only with permission. Focus on function and accommodations, and share no more health information than necessary.
What about a child or teenager missing school?
Use the same principle: describe the functional problem and ask for specific flexibility. Pediatric Long COVID needs age-appropriate clinical review.
Money and paperwork are becoming a crisis. What actually helps?
Take one concrete admin task, so the ill person doesn't have to design a whole support plan.
They are irritable or withdrawn. Should I keep trying to cheer them up?
Ask whether company, quiet or practical help feels easiest. Free them from having to act okay.
Support their mental health and take physical symptoms seriously · Believe first, problem-solve second
I am becoming exhausted as the supporter. Is that selfish?
No. Move one recurring task to someone else and protect some off-duty time before the whole support system fails.
What if someone dies after COVID?
Stay present after the immediate crisis, offer specific help and support access to grief or peer care when wanted.
Recognition
What it often feels like
Thinking problems after COVID can include poor concentration, slow thinking, trouble finding words or mental exhaustion. Some people also have delayed symptom flares after activity.
What changed after the illness, and what happens during and after ordinary activities?
Sleep problems, symptoms while upright and medicine effects may need assessment alongside the post-COVID symptoms.
- Timing
A normal errand or mental push can wipe me out at the time and later too.
- Helped
Rest helps a little, but it doesn't bring me back to my old baseline.
- Trigger
All of this started after a viral illness and never really went away.
- Symptom
When I crash, it's more than fatigue. My body, brain, and sensory tolerance all drop together.
- Harmed
Pushing through usually costs me later, even if I look fine while I am doing it.
How people describe it
People describe several kinds of thinking problems. One person may lose words during a conversation; another can think clearly for a few minutes but becomes exhausted by reading or a meeting. Some also feel worse later that day or the next.
-
Some people report delayed flares after physical, mental or social activity. This is important to assess, but not everyone with Long COVID has PEM.
-
Some can think clearly for a short time but cannot sustain reading, work or conversation. Others struggle with memory or word finding from the start.
-
Describe the task, how long you can manage it and what happens afterward, rather than relying only on the phrase brain fog.
Compare
Long COVID Brain Fog vs Depression
Similar symptoms can have more than one cause. These clues guide assessment; none diagnoses or excludes Long COVID by itself.
vs Depression
Depression can affect concentration, energy, sleep and interest in activities. A delayed flare of several symptoms after small amounts of physical or mental activity raises a separate question about PEM. Neither motivation nor a response to exercise can diagnose the cause. Depression and Long COVID can coexist and each deserves care.
vs Sleep Apnea
Snoring, witnessed breathing pauses and daytime sleepiness suggest checking for sleep apnea. Long COVID can include delayed worsening after activity and symptoms while standing. Timing alone can't separate them, and both can occur together. Treating sleep apnea may help even when some Long COVID symptoms remain.
vs Thyroid
Thyroid disease can cause fatigue and slow thinking, sometimes with constipation, cold intolerance or weight changes. Blood tests can check thyroid function. A thyroid problem and Long COVID can occur together.
How this differs from conditions it gets mistaken for
Sleep Apnea
Both can involve poor concentration, unrefreshing sleep and daytime fatigue. Snoring, breathing pauses and sleepiness suggest checking for apnea. Delayed flares after activity suggest assessing PEM. Both conditions can coexist.
Key question: Do you have snoring or breathing pauses, delayed flares after activity, or both?
Sleep
Poor sleep can worsen thinking whether or not Long COVID is present. Improvement after better sleep does not rule out Long COVID, and persistent symptoms do not identify one cause.
Key question: Which symptoms change when sleep improves, and which remain?
POTS
POTS and other causes of symptoms while upright can occur alongside Long COVID. Dizziness, palpitations or worse thinking while standing need assessment.
Key question: Do standing or sitting upright worsen symptoms, and does lying down help?
EBV
EBV can cause an acute illness and remains in the body afterward. Evidence of past EBV infection is common and doesn't show that EBV is causing current Long COVID symptoms.
Key question: Is there evidence of a current EBV-related illness, or only antibodies from a past infection?
Hypoperfusion
Reduced brain blood flow is being studied in some patients, especially during upright testing. It is a possible contributor, not a separate diagnosis that can be chosen from a symptom list.
Key question: Are symptoms related to being upright, and would supervised circulation testing change care?
Medication Side Effects
Medicines used for sleep, allergies, pain or heart rate can add sleepiness or thinking problems. Medicine effects and post-viral symptoms may occur together.
Key question: What changed after each medicine or dose change, and what was already happening before it?
Burnout
Work stress, poor sleep and Long COVID can all reduce concentration. Delayed flares after ordinary activity warrant assessment for PEM, but improvement on vacation or a difficult workday cannot by itself separate the causes.
Key question: What happens after small amounts of activity on workdays and days off, and when did the change begin?
References
- Greene et al., Nat Neurosci, 2024 - Blood-brain barrier disruption in Long COVID
- NICE NG206 ME/CFS guideline (2021/2024)
- NICE NG188 Long COVID guideline (2024)
- Institute of Medicine (National Academy of Medicine), 2015 - diagnostic criteria for ME/CFS
- Davis HE et al., Nat Rev Microbiol, 2023 - Long COVID: major findings, mechanisms and recommendations
- NICE NG206 ME/CFS 2021; Davis et al., Nat Rev Microbiol 2023; Komaroff & Lipkin, Lancet 2023
- NICE NG206: ME/CFS diagnosis and management — Clinical guideline — Open source
- CDC: Clinical care of ME/CFS — Clinical guidance — Open source
- WHO: Clinical management of COVID-19 living guideline and post-COVID rehabilitation — International guidance — Open source
- Pulmonary rehabilitation in Long COVID: systematic review/meta-analysis — Systematic review and meta-analysis — Open source
- STIMULATE-ICP integrated care pathway trial — Phase 3 cluster-randomized trial — Open source
- CDC: Long COVID clinical guidance — Clinical guidance — Open source
- Diagnosis and management of POTS — Clinical review — Open source
- POTS after COVID-19: systematic review of interventions — Systematic review of reports — Open source
- Pyridostigmine physiology trial in ME/CFS — Randomized double-blind placebo-controlled physiology trial — Open source
- NICE NG188: managing the long-term effects of COVID-19 — Clinical guideline — Open source
- Interventions for long COVID: living systematic review — Living systematic review — Open source
- Systematic review of mental health, cognition and wellbeing interventions in Long COVID — Systematic review — Open source
- RECOVER-NEURO randomized cognitive intervention trial — Multicenter randomized trial — Open source
- Individual cognitive rehabilitation for Long COVID — Randomized trial — Open source
- Small-fiber neuropathy after COVID-19: retrospective case-control study — Retrospective case-control study — Open source
- RECOVER-VITAL: nirmatrelvir/ritonavir for established Long COVID — Phase 2 randomized placebo-controlled trial — Open source
- STOP-PASC nirmatrelvir/ritonavir trial — Randomized placebo-controlled trial — Open source
- Low-dose naltrexone for Long COVID: systematic review and meta-analysis — Systematic review and meta-analysis — Open source
- STIMULATE-ICP pharmacologic trial — Multisite open-label randomized controlled trial — Open source
- Low-dose aripiprazole in ME/CFS — Retrospective study — Open source
- Rituximab phase III ME/CFS trial — Randomized placebo-controlled phase III trial — Open source
- SIM01 synbiotic trial for post-acute COVID syndrome — Randomized double-blind placebo-controlled trial — Open source
- High-dose CoQ10 for post-COVID condition — Randomized double-blind crossover trial — Open source
- Specialist Long COVID integrated-care trial — Phase 3 cluster randomized trial — Open source
- HBOT sham-controlled Long COVID trial — Randomized double-blind sham-controlled trial — Open source
- Normobaric/hyperbaric oxygen Long COVID trial — Randomized placebo-controlled double-blind trial — Open source
- COVIVA taVNS pilot trial — Randomized sham-controlled pilot trial — Open source
- STIMULATE rivaroxaban result — Randomized controlled trial — Open source
- Rovunaptabin (BC007) reCOVer phase IIa — Exploratory randomized double-blind placebo-controlled phase IIa trial — Open source
- Guanfacine for marked Long COVID cognitive impairment: case report — Case report — Open source
- COVID-OUT metformin follow-up — Phase 3 randomized acute-COVID trial follow-up — Open source
- Metformin or UDCA for established PASC — Randomized double-blind placebo-controlled trial — Open source
- [Jason 2015]
- [mecfscliniciancoalition.org]
- [Holt-Lunstad 2015]
- [NICE]
Related context
Clinical Summary
Thinking problems after COVID can include poor concentration, slow thinking, trouble finding words or mental exhaustion. Some people also have delayed symptom flares after activity.
High - NICE NG188/NG206
NICE NG188 Long COVID (updated Jan 2024); NICE NG206 ME/CFS (2021, surveillance 2025)
Last reviewed: 2026-03-23
Reviewed by: Dr. Alexandru-Theodor Amarfei, M.D.
Country Pathways
US: See Long COVID clinic or ME/CFS specialist
UK: See Long COVID clinic or ME/CFS specialist service
AU: See immunologist, cardiologist (for POTS), or ME/CFS clinic
Dietary Approach
Fatigue, nausea and difficulty preparing food can reduce intake. Keep meals manageable and ask for help with shopping or preparation when needed.
Supplements
- Coenzyme Q10 (CoQ10/Ubiquinol) No CoQ10 dose is established for Long COVID brain fog. A trial in established post-COVID illness used high-dose CoQ10 and did not show a significant symptom benefit.A randomized crossover trial enrolled 121 participants and compared two six-week periods. CoQ10 did not significantly improve symptom number or severity versus placebo.
- Creatine Monohydrate No dose is established for treating Long COVID brain fog. Discuss use first if you have kidney disease or take medicines that affect kidney function.Small preliminary studies don't show a reliable cognitive benefit for Long COVID.
- Magnesium, ashwagandha and L-theanine combinations There is no established dose or tested combination for Long COVID brain fog.No Long COVID combination trial is cited here.
- Butyrate (Sodium or Tributyrin) The cited studies don't set a dose for Long COVID brain fog.The cited papers examine mechanisms or dietary associations, not an established Long COVID treatment.
Connected Causes
Long COVID can affect several body systems. Sleep problems, symptoms while upright, migraine, medicine effects and mental health conditions can add to thinking problems. Assess each problem rather than assume that every symptom has one cause.